TW201030060A - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device - Google Patents
Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device Download PDFInfo
- Publication number
- TW201030060A TW201030060A TW098140868A TW98140868A TW201030060A TW 201030060 A TW201030060 A TW 201030060A TW 098140868 A TW098140868 A TW 098140868A TW 98140868 A TW98140868 A TW 98140868A TW 201030060 A TW201030060 A TW 201030060A
- Authority
- TW
- Taiwan
- Prior art keywords
- formula
- liquid crystal
- group
- crystal alignment
- structural formula
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 254
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 106
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims abstract description 121
- 150000004985 diamines Chemical class 0.000 claims abstract description 115
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims abstract description 79
- 229920005575 poly(amic acid) Polymers 0.000 claims abstract description 19
- -1 -OH Chemical group 0.000 claims description 168
- 150000001875 compounds Chemical class 0.000 claims description 158
- 125000004432 carbon atom Chemical group C* 0.000 claims description 98
- 125000000217 alkyl group Chemical group 0.000 claims description 85
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 69
- 229910052799 carbon Inorganic materials 0.000 claims description 65
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 61
- 239000002253 acid Substances 0.000 claims description 60
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine group Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 52
- 239000004593 Epoxy Substances 0.000 claims description 51
- 125000003342 alkenyl group Chemical group 0.000 claims description 37
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 34
- 239000000758 substrate Substances 0.000 claims description 32
- 239000000126 substance Substances 0.000 claims description 26
- 125000003545 alkoxy group Chemical group 0.000 claims description 22
- 238000000576 coating method Methods 0.000 claims description 17
- 239000001257 hydrogen Substances 0.000 claims description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 15
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 229920000656 polylysine Polymers 0.000 claims description 12
- 108010039918 Polylysine Proteins 0.000 claims description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 11
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 9
- 125000001931 aliphatic group Chemical group 0.000 claims description 9
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 9
- 150000003254 radicals Chemical class 0.000 claims description 9
- 125000002723 alicyclic group Chemical group 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 7
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 239000007795 chemical reaction product Substances 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 239000011737 fluorine Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000002345 steroid group Chemical group 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 150000002431 hydrogen Chemical group 0.000 claims description 4
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 4
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 2
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 claims 2
- 125000005714 2,5- (1,3-dioxanylene) group Chemical group [H]C1([H])OC([H])([*:1])OC([H])([H])C1([H])[*:2] 0.000 claims 1
- 125000001118 alkylidene group Chemical group 0.000 claims 1
- 125000004653 anthracenylene group Chemical group 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 description 47
- 238000003786 synthesis reaction Methods 0.000 description 46
- 229910052757 nitrogen Inorganic materials 0.000 description 45
- 238000000034 method Methods 0.000 description 40
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 27
- 150000002466 imines Chemical group 0.000 description 24
- 150000004060 quinone imines Chemical class 0.000 description 24
- 239000002904 solvent Substances 0.000 description 24
- 239000000178 monomer Substances 0.000 description 23
- 229920001577 copolymer Polymers 0.000 description 22
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 20
- 229920000642 polymer Polymers 0.000 description 18
- 108010026466 polyproline Proteins 0.000 description 17
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 229920000647 polyepoxide Polymers 0.000 description 13
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 11
- 150000001412 amines Chemical class 0.000 description 10
- 239000001294 propane Substances 0.000 description 10
- FVCSARBUZVPSQF-UHFFFAOYSA-N 5-(2,4-dioxooxolan-3-yl)-7-methyl-3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C(C(OC2=O)=O)C2C(C)=CC1C1C(=O)COC1=O FVCSARBUZVPSQF-UHFFFAOYSA-N 0.000 description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 9
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 9
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229960003742 phenol Drugs 0.000 description 7
- 229920000768 polyamine Polymers 0.000 description 7
- 108010094020 polyglycine Proteins 0.000 description 7
- 229920000232 polyglycine polymer Polymers 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- 239000000052 vinegar Substances 0.000 description 7
- 235000021419 vinegar Nutrition 0.000 description 7
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical group N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 6
- 230000005684 electric field Effects 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 6
- 239000002966 varnish Substances 0.000 description 6
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 5
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 238000001354 calcination Methods 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 239000003822 epoxy resin Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 5
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 5
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical group C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 5
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 5
- AFEQENGXSMURHA-UHFFFAOYSA-N oxiran-2-ylmethanamine Chemical compound NCC1CO1 AFEQENGXSMURHA-UHFFFAOYSA-N 0.000 description 5
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 5
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 4
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 4
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 4
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 4
- 125000003700 epoxy group Chemical group 0.000 description 4
- IFQUWYZCAGRUJN-UHFFFAOYSA-N ethylenediaminediacetic acid Chemical compound OC(=O)CNCCNCC(O)=O IFQUWYZCAGRUJN-UHFFFAOYSA-N 0.000 description 4
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 4
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N furo[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1=C2C(=O)OC(=O)C2=CC2=C1C(=O)OC2=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 125000000466 oxiranyl group Chemical group 0.000 description 4
- 229920002959 polymer blend Polymers 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- XQUPVDVFXZDTLT-UHFFFAOYSA-N 1-[4-[[4-(2,5-dioxopyrrol-1-yl)phenyl]methyl]phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C(C=C1)=CC=C1CC1=CC=C(N2C(C=CC2=O)=O)C=C1 XQUPVDVFXZDTLT-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 3
- DAWJJMYZJQJLPZ-UHFFFAOYSA-N 2-sulfanylprop-2-enoic acid Chemical class OC(=O)C(S)=C DAWJJMYZJQJLPZ-UHFFFAOYSA-N 0.000 description 3
- POLIXZIAIMAECK-UHFFFAOYSA-N 4-[2-(2,6-dioxomorpholin-4-yl)ethyl]morpholine-2,6-dione Chemical compound C1C(=O)OC(=O)CN1CCN1CC(=O)OC(=O)C1 POLIXZIAIMAECK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- 229930185605 Bisphenol Natural products 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 229920000037 Polyproline Polymers 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 150000001336 alkenes Chemical class 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 3
- 239000001273 butane Substances 0.000 description 3
- WVOLTBSCXRRQFR-DLBZAZTESA-M cannabidiolate Chemical compound OC1=C(C([O-])=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-M 0.000 description 3
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 229930003658 monoterpene Natural products 0.000 description 3
- 235000002577 monoterpenes Nutrition 0.000 description 3
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 229920003986 novolac Polymers 0.000 description 3
- 125000000962 organic group Chemical group 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000004584 polyacrylic acid Substances 0.000 description 3
- 150000003141 primary amines Chemical class 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 229910052707 ruthenium Inorganic materials 0.000 description 3
- 238000004528 spin coating Methods 0.000 description 3
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 2
- KATAXDCYPGGJNJ-UHFFFAOYSA-N 1,3-bis(oxiran-2-ylmethoxy)propan-2-ol Chemical compound C1OC1COCC(O)COCC1CO1 KATAXDCYPGGJNJ-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 2
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- ZXTHWIZHGLNEPG-UHFFFAOYSA-N 2-phenyl-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=CC=C1 ZXTHWIZHGLNEPG-UHFFFAOYSA-N 0.000 description 2
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 2
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 2
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- VPLKXGORNUYFBO-UHFFFAOYSA-N C1(CC2C(CC1)O2)CCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C1(CC2C(CC1)O2)CCC(C(OC)(OC)OC)CCCCCCCC VPLKXGORNUYFBO-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000004235 Orange GGN Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical group [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000004178 amaranth Substances 0.000 description 2
- 235000012735 amaranth Nutrition 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 150000001448 anilines Chemical group 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 239000004109 brown FK Substances 0.000 description 2
- 239000001678 brown HT Substances 0.000 description 2
- 235000012670 brown HT Nutrition 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 239000001679 citrus red 2 Substances 0.000 description 2
- 235000013986 citrus red 2 Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 150000004141 diterpene derivatives Chemical class 0.000 description 2
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N mono-n-propyl amine Natural products CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- JAYXSROKFZAHRQ-UHFFFAOYSA-N n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC=CC=1)CC1CO1 JAYXSROKFZAHRQ-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000004893 oxazines Chemical class 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229920003192 poly(bis maleimide) Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000005077 polysulfide Substances 0.000 description 2
- 229920001021 polysulfide Polymers 0.000 description 2
- 150000008117 polysulfides Polymers 0.000 description 2
- 239000004175 ponceau 4R Substances 0.000 description 2
- 235000012731 ponceau 4R Nutrition 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229910021647 smectite Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000004173 sunset yellow FCF Substances 0.000 description 2
- 235000012751 sunset yellow FCF Nutrition 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000004108 vegetable carbon Substances 0.000 description 2
- 235000012712 vegetable carbon Nutrition 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- KNDQHSIWLOJIGP-UMRXKNAASA-N (3ar,4s,7r,7as)-rel-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione Chemical class O=C1OC(=O)[C@@H]2[C@H]1[C@]1([H])C=C[C@@]2([H])C1 KNDQHSIWLOJIGP-UMRXKNAASA-N 0.000 description 1
- GDASXAAUCLPIRP-UHFFFAOYSA-N 1,2,6,7-tetraoxaspiro[7.11]nonadecane Chemical compound O1OCCCOOC11CCCCCCCCCCC1 GDASXAAUCLPIRP-UHFFFAOYSA-N 0.000 description 1
- TXVWTOBHDDIASC-UHFFFAOYSA-N 1,2-diphenylethene-1,2-diamine Chemical compound C=1C=CC=CC=1C(N)=C(N)C1=CC=CC=C1 TXVWTOBHDDIASC-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- HYYJOCXNESGFSB-UHFFFAOYSA-N 1-(oxiran-2-yl)-n-(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CNCC1CO1 HYYJOCXNESGFSB-UHFFFAOYSA-N 0.000 description 1
- NBZYOWJKOWTTRO-UHFFFAOYSA-N 1-(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1NC(=O)NC(=O)N1CC1OC1 NBZYOWJKOWTTRO-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- KMBSSXSNDSJXCG-UHFFFAOYSA-N 1-[2-(2-hydroxyundecylamino)ethylamino]undecan-2-ol Chemical compound CCCCCCCCCC(O)CNCCNCC(O)CCCCCCCCC KMBSSXSNDSJXCG-UHFFFAOYSA-N 0.000 description 1
- IPJGAEWUPXWFPL-UHFFFAOYSA-N 1-[3-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC(N2C(C=CC2=O)=O)=C1 IPJGAEWUPXWFPL-UHFFFAOYSA-N 0.000 description 1
- JPZYXGPCHFZBHO-UHFFFAOYSA-N 1-aminopentadecane Chemical compound CCCCCCCCCCCCCCCN JPZYXGPCHFZBHO-UHFFFAOYSA-N 0.000 description 1
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 1
- BQTPKSBXMONSJI-UHFFFAOYSA-N 1-cyclohexylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1CCCCC1 BQTPKSBXMONSJI-UHFFFAOYSA-N 0.000 description 1
- BDQNKCYCTYYMAA-UHFFFAOYSA-N 1-isocyanatonaphthalene Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1 BDQNKCYCTYYMAA-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- WOQLPPITHNQPLR-UHFFFAOYSA-N 1-sulfanylpyrrolidin-2-one Chemical compound SN1CCCC1=O WOQLPPITHNQPLR-UHFFFAOYSA-N 0.000 description 1
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- QHHCBVYZWRKFLZ-UHFFFAOYSA-N 2-(1,1,2,2,3,3,4,4,4-nonafluorobutyl)oxirane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C1CO1 QHHCBVYZWRKFLZ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- DRSDQADBHIDJCU-UHFFFAOYSA-N 2-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctoxymethyl)oxirane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCOCC1CO1 DRSDQADBHIDJCU-UHFFFAOYSA-N 0.000 description 1
- SUTCVRHWHOUKJP-UHFFFAOYSA-N 2-(7-oxabicyclo[4.1.0]heptan-4-yl)acetic acid Chemical compound C1C(CC(=O)O)CCC2OC21 SUTCVRHWHOUKJP-UHFFFAOYSA-N 0.000 description 1
- YSUQLAYJZDEMOT-UHFFFAOYSA-N 2-(butoxymethyl)oxirane Chemical compound CCCCOCC1CO1 YSUQLAYJZDEMOT-UHFFFAOYSA-N 0.000 description 1
- KUBDPQJOLOUJRM-UHFFFAOYSA-N 2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound ClCC1CO1.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 KUBDPQJOLOUJRM-UHFFFAOYSA-N 0.000 description 1
- DUILGEYLVHGSEE-UHFFFAOYSA-N 2-(oxiran-2-ylmethyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC1CO1 DUILGEYLVHGSEE-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- DZRLZBYMIRXJGO-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxy]ethanol Chemical compound OCCOCCOCC1CO1 DZRLZBYMIRXJGO-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 1
- XXZCIYUJYUESMD-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(morpholin-4-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCOCC1 XXZCIYUJYUESMD-UHFFFAOYSA-N 0.000 description 1
- PRJQBLZFLQSJOM-UHFFFAOYSA-N 2-[[1,3-dibromo-2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C(C1CO1)OC(C(C)(C(OCC1CO1)Br)C)Br PRJQBLZFLQSJOM-UHFFFAOYSA-N 0.000 description 1
- XOSCKTQMAZSFBZ-UHFFFAOYSA-N 2-[[1-[[2,7-bis(oxiran-2-ylmethoxy)naphthalen-1-yl]methyl]-7-(oxiran-2-ylmethoxy)naphthalen-2-yl]oxymethyl]oxirane Chemical compound C1OC1COC(C=C1C=2CC=3C4=CC(OCC5OC5)=CC=C4C=CC=3OCC3OC3)=CC=C1C=CC=2OCC1CO1 XOSCKTQMAZSFBZ-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- NKANYVMWDXJHLE-UHFFFAOYSA-N 2-[[2-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane Chemical compound C1OC1COC1=CC=CC=C1OCC1CO1 NKANYVMWDXJHLE-UHFFFAOYSA-N 0.000 description 1
- FSYPIGPPWAJCJG-UHFFFAOYSA-N 2-[[4-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane Chemical compound C1OC1COC(C=C1)=CC=C1OCC1CO1 FSYPIGPPWAJCJG-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- FDIPWBUDOCPIMH-UHFFFAOYSA-N 2-decylphenol Chemical compound CCCCCCCCCCC1=CC=CC=C1O FDIPWBUDOCPIMH-UHFFFAOYSA-N 0.000 description 1
- UUODQIKUTGWMPT-UHFFFAOYSA-N 2-fluoro-5-(trifluoromethyl)pyridine Chemical compound FC1=CC=C(C(F)(F)F)C=N1 UUODQIKUTGWMPT-UHFFFAOYSA-N 0.000 description 1
- IJSVVICYGLOZHA-UHFFFAOYSA-N 2-methyl-n-phenylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=CC=C1 IJSVVICYGLOZHA-UHFFFAOYSA-N 0.000 description 1
- CCIDRBFZPRURMU-UHFFFAOYSA-N 2-methyl-n-propylprop-2-enamide Chemical compound CCCNC(=O)C(C)=C CCIDRBFZPRURMU-UHFFFAOYSA-N 0.000 description 1
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 description 1
- ABZJDNLKVWSLPM-UHFFFAOYSA-N 2-sulfanylethyl prop-2-enoate Chemical compound SCCOC(=O)C=C ABZJDNLKVWSLPM-UHFFFAOYSA-N 0.000 description 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 description 1
- DQRFCVHLNUNVPL-UHFFFAOYSA-N 2h-1,3-oxazol-5-one Chemical compound O=C1OCN=C1 DQRFCVHLNUNVPL-UHFFFAOYSA-N 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- 229940018563 3-aminophenol Drugs 0.000 description 1
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical compound ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 description 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- RXXCIBALSKQCAE-UHFFFAOYSA-N 3-methylbutoxymethylbenzene Chemical compound CC(C)CCOCC1=CC=CC=C1 RXXCIBALSKQCAE-UHFFFAOYSA-N 0.000 description 1
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 description 1
- QEQVCPKISCKMOQ-UHFFFAOYSA-N 3h-benzo[f][1,2]benzoxazine Chemical compound C1=CC=CC2=C(C=CNO3)C3=CC=C21 QEQVCPKISCKMOQ-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- FBYNCGWFJFJKKP-UHFFFAOYSA-N 4-(trimethoxy-lambda4-sulfanyl)aniline Chemical compound NC1=CC=C(C=C1)S(OC)(OC)OC FBYNCGWFJFJKKP-UHFFFAOYSA-N 0.000 description 1
- DFYGYTNMHPUJBY-UHFFFAOYSA-N 4-(trimethoxymethyl)dodecane-1-thiol Chemical compound SCCCC(C(OC)(OC)OC)CCCCCCCC DFYGYTNMHPUJBY-UHFFFAOYSA-N 0.000 description 1
- HSBOCPVKJMBWTF-UHFFFAOYSA-N 4-[1-(4-aminophenyl)ethyl]aniline Chemical compound C=1C=C(N)C=CC=1C(C)C1=CC=C(N)C=C1 HSBOCPVKJMBWTF-UHFFFAOYSA-N 0.000 description 1
- WQNBIRGALIEKLM-UHFFFAOYSA-N 4-[3,4-bis[bis(oxiran-2-ylmethyl)amino]phenyl]-1-n,1-n,2-n,2-n-tetrakis(oxiran-2-ylmethyl)benzene-1,2-diamine Chemical group C1OC1CN(C=1C(=CC(=CC=1)C=1C=C(C(N(CC2OC2)CC2OC2)=CC=1)N(CC1OC1)CC1OC1)N(CC1OC1)CC1OC1)CC1CO1 WQNBIRGALIEKLM-UHFFFAOYSA-N 0.000 description 1
- KMKWGXGSGPYISJ-UHFFFAOYSA-N 4-[4-[2-[4-(4-aminophenoxy)phenyl]propan-2-yl]phenoxy]aniline Chemical compound C=1C=C(OC=2C=CC(N)=CC=2)C=CC=1C(C)(C)C(C=C1)=CC=C1OC1=CC=C(N)C=C1 KMKWGXGSGPYISJ-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- QLTJWBNNVYZFTQ-UHFFFAOYSA-N 4-aminophenol aniline Chemical compound NC1=CC=CC=C1.NC1=CC=C(O)C=C1 QLTJWBNNVYZFTQ-UHFFFAOYSA-N 0.000 description 1
- GTYAMROJMXVPHD-UHFFFAOYSA-N 4-methyl-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1=CC(C)=CC=C1N(CC1OC1)CC1OC1 GTYAMROJMXVPHD-UHFFFAOYSA-N 0.000 description 1
- DPMGLJUMNRDNMX-UHFFFAOYSA-N 4-tert-butyl-2-[2-(4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl)propan-2-yl]-4,5-dihydro-1,3-oxazole Chemical compound CC(C)(C)C1COC(C(C)(C)C=2OCC(N=2)C(C)(C)C)=N1 DPMGLJUMNRDNMX-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- CYSPWCARDHRYJX-UHFFFAOYSA-N 9h-fluoren-1-amine Chemical compound C12=CC=CC=C2CC2=C1C=CC=C2N CYSPWCARDHRYJX-UHFFFAOYSA-N 0.000 description 1
- IBPADELTPKRSCQ-UHFFFAOYSA-N 9h-fluoren-1-yl prop-2-enoate Chemical compound C1C2=CC=CC=C2C2=C1C(OC(=O)C=C)=CC=C2 IBPADELTPKRSCQ-UHFFFAOYSA-N 0.000 description 1
- HTPXFGUCAUTOEL-UHFFFAOYSA-N 9h-fluorene-1-carboxylic acid Chemical compound C1C2=CC=CC=C2C2=C1C(C(=O)O)=CC=C2 HTPXFGUCAUTOEL-UHFFFAOYSA-N 0.000 description 1
- OQLZINXFSUDMHM-UHFFFAOYSA-N Acetamidine Chemical compound CC(N)=N OQLZINXFSUDMHM-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004229 Alkannin Substances 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical group NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 101001053401 Arabidopsis thaliana Acid beta-fructofuranosidase 3, vacuolar Proteins 0.000 description 1
- 101100132433 Arabidopsis thaliana VIII-1 gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- DPGZFPAOHQORHA-UHFFFAOYSA-N C(C)N(CCCCCCCCCC)CC.NN Chemical compound C(C)N(CCCCCCCCCC)CC.NN DPGZFPAOHQORHA-UHFFFAOYSA-N 0.000 description 1
- DERUOKWMYGXKGG-UHFFFAOYSA-N C(C1CO1)N(C1=C(C=C(C=C1Br)Br)Br)CC1CO1.NN Chemical compound C(C1CO1)N(C1=C(C=C(C=C1Br)Br)Br)CC1CO1.NN DERUOKWMYGXKGG-UHFFFAOYSA-N 0.000 description 1
- GKLXZYMUWOOVDQ-UHFFFAOYSA-N C(C1CO1)OCCCC(C(OC)(OC)C)CCCCCCCC Chemical compound C(C1CO1)OCCCC(C(OC)(OC)C)CCCCCCCC GKLXZYMUWOOVDQ-UHFFFAOYSA-N 0.000 description 1
- XBHXXPQFSPXXRO-UHFFFAOYSA-N C(C=C)(=O)N(C(C)C)CCCCCCCCCC Chemical compound C(C=C)(=O)N(C(C)C)CCCCCCCCCC XBHXXPQFSPXXRO-UHFFFAOYSA-N 0.000 description 1
- CSZVNULYDTZQQH-UHFFFAOYSA-N C(C=C)(=O)N(CC1CCCO1)CCCCCCCCCC Chemical compound C(C=C)(=O)N(CC1CCCO1)CCCCCCCCCC CSZVNULYDTZQQH-UHFFFAOYSA-N 0.000 description 1
- XRNDMACZMJPCRX-UHFFFAOYSA-N C(CC)C(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(CC)C(C(OCC)(OCC)OCC)CCCCCCCC XRNDMACZMJPCRX-UHFFFAOYSA-N 0.000 description 1
- DEVPYPAGSMTSSP-UHFFFAOYSA-N C1(=CC=C(C=2C(=CC=C(C12)CCCCCCCCCC(=O)O)CCCCCCCCCC(=O)O)CCCCCCCCCC(=O)O)CCCCCCCCCC(=O)O Chemical compound C1(=CC=C(C=2C(=CC=C(C12)CCCCCCCCCC(=O)O)CCCCCCCCCC(=O)O)CCCCCCCCCC(=O)O)CCCCCCCCCC(=O)O DEVPYPAGSMTSSP-UHFFFAOYSA-N 0.000 description 1
- PGFDFNHMVWFPGY-UHFFFAOYSA-N C1(CCCCC1)C=1C(=O)NC(C1)=O.C1=CC=CC=2C3=CC=CC=C3CC12 Chemical compound C1(CCCCC1)C=1C(=O)NC(C1)=O.C1=CC=CC=2C3=CC=CC=C3CC12 PGFDFNHMVWFPGY-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- COVDQHMMLLDQKU-UHFFFAOYSA-N ClCCCCCCCCCCC=CC1=CC=CC=C1 Chemical compound ClCCCCCCCCCCC=CC1=CC=CC=C1 COVDQHMMLLDQKU-UHFFFAOYSA-N 0.000 description 1
- 102100024133 Coiled-coil domain-containing protein 50 Human genes 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000004214 Fast Green FCF Substances 0.000 description 1
- 239000004230 Fast Yellow AB Substances 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 101000910772 Homo sapiens Coiled-coil domain-containing protein 50 Proteins 0.000 description 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 1
- IYBZJKJDULZGGZ-UHFFFAOYSA-N N1C(=CC2=CC=CC=C12)C1N=COC1 Chemical compound N1C(=CC2=CC=CC=C12)C1N=COC1 IYBZJKJDULZGGZ-UHFFFAOYSA-N 0.000 description 1
- QBEDRAYIJQIKRU-UHFFFAOYSA-N N1C(=O)NC=2NC(=O)NC2C1=O.[C-]#N Chemical class N1C(=O)NC=2NC(=O)NC2C1=O.[C-]#N QBEDRAYIJQIKRU-UHFFFAOYSA-N 0.000 description 1
- IHZTXQOQYHXBQD-UHFFFAOYSA-N NC(C(C1=CC=CC=C1)(C1=CC=CC=C1)N)CCCCCCCC Chemical compound NC(C(C1=CC=CC=C1)(C1=CC=CC=C1)N)CCCCCCCC IHZTXQOQYHXBQD-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- PCKPVGOLPKLUHR-UHFFFAOYSA-N OH-Indolxyl Natural products C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- FQYUMYWMJTYZTK-UHFFFAOYSA-N Phenyl glycidyl ether Chemical compound C1OC1COC1=CC=CC=C1 FQYUMYWMJTYZTK-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 239000004237 Ponceau 6R Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 1
- 239000004231 Riboflavin-5-Sodium Phosphate Substances 0.000 description 1
- HNGJQPKSYZKBMO-UHFFFAOYSA-N SCC=COCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound SCC=COCCCC(C(OC)(OC)OC)CCCCCCCC HNGJQPKSYZKBMO-UHFFFAOYSA-N 0.000 description 1
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 1
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 239000004234 Yellow 2G Substances 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- VCFFZAQQHCLMNH-UHFFFAOYSA-N [3-(6-prop-2-enoyloxyhexanoyloxy)-2-[[3-(6-prop-2-enoyloxyhexanoyloxy)-2,2-bis(6-prop-2-enoyloxyhexanoyloxymethyl)propoxy]methyl]-2-(6-prop-2-enoyloxyhexanoyloxymethyl)propyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(COC(=O)CCCCCOC(=O)C=C)(COC(=O)CCCCCOC(=O)C=C)COCC(COC(=O)CCCCCOC(=O)C=C)(COC(=O)CCCCCOC(=O)C=C)COC(=O)CCCCCOC(=O)C=C VCFFZAQQHCLMNH-UHFFFAOYSA-N 0.000 description 1
- HTMMMSIQFWMMIJ-UHFFFAOYSA-N [3-[2,2-dimethyl-3-(6-prop-2-enoyloxyhexanoyloxy)propanoyl]oxy-2,2-dimethylpropyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(C)(C)COC(=O)C(C)(C)COC(=O)CCCCCOC(=O)C=C HTMMMSIQFWMMIJ-UHFFFAOYSA-N 0.000 description 1
- YNTQTLGBCMXNFX-UHFFFAOYSA-N [5-ethyl-2-(2-methyl-1-prop-2-enoyloxypropan-2-yl)-1,3-dioxan-5-yl]methyl prop-2-enoate Chemical compound C=CC(=O)OCC1(CC)COC(C(C)(C)COC(=O)C=C)OC1 YNTQTLGBCMXNFX-UHFFFAOYSA-N 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- VYTBPJNGNGMRFH-UHFFFAOYSA-N acetic acid;azane Chemical compound N.N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O VYTBPJNGNGMRFH-UHFFFAOYSA-N 0.000 description 1
- DKHWSSASUDAWSP-UHFFFAOYSA-N acetic acid;benzene-1,4-diamine Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NC1=CC=C(N)C=C1 DKHWSSASUDAWSP-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- PXAJQJMDEXJWFB-UHFFFAOYSA-N acetone oxime Chemical compound CC(C)=NO PXAJQJMDEXJWFB-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000004844 aliphatic epoxy resin Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000004176 azorubin Substances 0.000 description 1
- 235000012733 azorubine Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- ZFVMWEVVKGLCIJ-UHFFFAOYSA-N bisphenol AF Chemical compound C1=CC(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C=C1 ZFVMWEVVKGLCIJ-UHFFFAOYSA-N 0.000 description 1
- WKDNYTOXBCRNPV-UHFFFAOYSA-N bpda Chemical compound C1=C2C(=O)OC(=O)C2=CC(C=2C=C3C(=O)OC(C3=CC=2)=O)=C1 WKDNYTOXBCRNPV-UHFFFAOYSA-N 0.000 description 1
- 239000004126 brilliant black BN Substances 0.000 description 1
- 235000012709 brilliant black BN Nutrition 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- XKLVLDXNZDIDKQ-UHFFFAOYSA-N butylhydrazine Chemical compound CCCCNN XKLVLDXNZDIDKQ-UHFFFAOYSA-N 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical group C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- ZWAJLVLEBYIOTI-UHFFFAOYSA-N cyclohexene oxide Chemical compound C1CCCC2OC21 ZWAJLVLEBYIOTI-UHFFFAOYSA-N 0.000 description 1
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohexene oxide Natural products O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000006159 dianhydride group Chemical group 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 150000002013 dioxins Chemical class 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- OTTZHAVKAVGASB-UHFFFAOYSA-N hept-2-ene Chemical compound CCCCC=CC OTTZHAVKAVGASB-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- MSTLSCNJAHAQNU-UHFFFAOYSA-N heptylcyclohexane Chemical compound CCCCCCCC1CCCCC1 MSTLSCNJAHAQNU-UHFFFAOYSA-N 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical group C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- SBPKYZJVJFUKBS-UHFFFAOYSA-N methane;phenylhydrazine Chemical compound C.NNC1=CC=CC=C1 SBPKYZJVJFUKBS-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- QRWZCJXEAOZAAW-UHFFFAOYSA-N n,n,2-trimethylprop-2-enamide Chemical compound CN(C)C(=O)C(C)=C QRWZCJXEAOZAAW-UHFFFAOYSA-N 0.000 description 1
- FXJADUPVIYKCMH-UHFFFAOYSA-N n,n-bis(sulfanyl)aniline Chemical compound SN(S)C1=CC=CC=C1 FXJADUPVIYKCMH-UHFFFAOYSA-N 0.000 description 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 1
- YLQHOUDDHYMERA-UHFFFAOYSA-N n-(2-ethoxyethyl)prop-2-enamide Chemical compound CCOCCNC(=O)C=C YLQHOUDDHYMERA-UHFFFAOYSA-N 0.000 description 1
- XZSZONUJSGDIFI-UHFFFAOYSA-N n-(4-hydroxyphenyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=C(O)C=C1 XZSZONUJSGDIFI-UHFFFAOYSA-N 0.000 description 1
- JDTXSWGCYBOHDZ-UHFFFAOYSA-N n-(9h-fluoren-1-yl)prop-2-enamide Chemical class C1C2=CC=CC=C2C2=C1C(NC(=O)C=C)=CC=C2 JDTXSWGCYBOHDZ-UHFFFAOYSA-N 0.000 description 1
- VAUOPRZOGIRSMI-UHFFFAOYSA-N n-(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CNC1=CC=CC=C1 VAUOPRZOGIRSMI-UHFFFAOYSA-N 0.000 description 1
- KPEKHIHQXHOSRM-UHFFFAOYSA-N n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound C=CC(=O)NCC1CCCO1 KPEKHIHQXHOSRM-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- VQGWOOIHSXNRPW-UHFFFAOYSA-N n-butyl-2-methylprop-2-enamide Chemical compound CCCCNC(=O)C(C)=C VQGWOOIHSXNRPW-UHFFFAOYSA-N 0.000 description 1
- XQEJVKQYWYLGAA-UHFFFAOYSA-N n-butyl-2-methylsulfanylpyrido[2,3-d]pyrimidin-4-amine Chemical compound C1=CC=C2C(NCCCC)=NC(SC)=NC2=N1 XQEJVKQYWYLGAA-UHFFFAOYSA-N 0.000 description 1
- FIBUWQFQYAAXHD-UHFFFAOYSA-N n-cyclopropyl-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1CC1 FIBUWQFQYAAXHD-UHFFFAOYSA-N 0.000 description 1
- LCXIFAOALNZGDO-UHFFFAOYSA-N n-cyclopropylprop-2-enamide Chemical compound C=CC(=O)NC1CC1 LCXIFAOALNZGDO-UHFFFAOYSA-N 0.000 description 1
- SWPMNMYLORDLJE-UHFFFAOYSA-N n-ethylprop-2-enamide Chemical compound CCNC(=O)C=C SWPMNMYLORDLJE-UHFFFAOYSA-N 0.000 description 1
- COYVWKMZTCAFHO-UHFFFAOYSA-N n-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)N(C)C(=O)C=C COYVWKMZTCAFHO-UHFFFAOYSA-N 0.000 description 1
- QJQAMHYHNCADNR-UHFFFAOYSA-N n-methylpropanamide Chemical compound CCC(=O)NC QJQAMHYHNCADNR-UHFFFAOYSA-N 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- WDFKEEALECCKTJ-UHFFFAOYSA-N n-propylprop-2-enamide Chemical compound CCCNC(=O)C=C WDFKEEALECCKTJ-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- FJDUDHYHRVPMJZ-UHFFFAOYSA-N nonan-1-amine Chemical compound CCCCCCCCCN FJDUDHYHRVPMJZ-UHFFFAOYSA-N 0.000 description 1
- JLIGLXIOYMCYMB-UHFFFAOYSA-N nonane-1,2,5,7-tetrol Chemical compound C(C(O)CO)CC(CC(CC)O)O JLIGLXIOYMCYMB-UHFFFAOYSA-N 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-UHFFFAOYSA-N norbornene Chemical compound C1C2CCC1C=C2 JFNLZVQOOSMTJK-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N omega-Hydroxydodecanoic acid Natural products OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-M phenylacetate Chemical compound [O-]C(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-M 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920002454 poly(glycidyl methacrylate) polymer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 150000004032 porphyrins Chemical group 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000013020 steam cleaning Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- BGKZULDOBMANRY-UHFFFAOYSA-N sulfanyl prop-2-enoate Chemical compound SOC(=O)C=C BGKZULDOBMANRY-UHFFFAOYSA-N 0.000 description 1
- YOMKMQNSLRQZHC-UHFFFAOYSA-N sulfanyl propanoate Chemical compound CCC(=O)OS YOMKMQNSLRQZHC-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000005628 tolylene group Chemical group 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
- C08L79/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C08L79/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nonlinear Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
201030060.doc 六、發明說明: 【發明所屬之技術領域】 本發明涉及一種含有聚醯胺酸或其衍生物的液晶配 向劑、由該液晶配向劑所形成的液晶配向膜以及具備該液 晶配向膜的液晶顯示元件。 【先前技術】 液晶顯示元件被用於以筆記型電腦(note personal computer)或臺式電腦(desktop personal computer)的顯示器 (monitor)為代表的攝像機(vide〇 camera)的取景器 (viewfinder)、投影顯示器等各種液晶顯示裝置中,最近也 被用於電視(television)中。另外,液晶顯示元件也被用於 光學打印頭(optical printer head)、光學傅裡葉變換元件 (optical Fourier transform device)、光閥(light valve)等光電 子相關元件中。 液晶顯示元件已知了各種元件,但液晶顯示元件的技 術發展不僅可通過對液晶顯示元件的驅動方式或液晶顯示 元件的結構進行改良來達成的,而且可通過對液晶顯示元 件中所使用的構成構件進行改良來達成的。通常情況下, 液晶顯示元件具有用來將液晶層中的液晶組成物配向在特 定方向上的液晶配向膜。液晶配向膜是與液晶顯示元件的 顯示品質相關的一個重要要素’液晶配向膜的作用隨著液 晶顯示元件的品質提高而逐年變得重要。 液晶配向膜是由液晶配向劑所製備的。目前,主要使 用的液晶配向劑是將聚醢胺酸或可溶性聚酿亞胺 201030060u.doc (polyimide)溶解在有機溶媒中所獲得的溶液。將此種溶液 塗布在基板上之後,利用加熱等方法進行成膜,由此而形 成液晶配向膜。 關於液晶配向膜,例如已知使用二胺四醋酸二酐的液 晶配向膜,且揭示了該液晶配向膜改善超扭曲向列型 (Super Twisted Nematic ’ STN)模式、主動矩陣顯示器(active matrix display)中的電壓保持率(參照美國專利第552〇845 號說明書)。 ® 另外,揭示了通過使用乙二胺四醋酸二酐的液晶配向 膜來改善串擾(crosstalk)的方法(參照曰本專利特開平 6-75229號公報)。 另外,揭示了一種使用乙二胺四醋酸二酐中鍵結有光 反應基的高分子物質與其他酸酐的共聚物的液晶配向膜 (參照曰本專利特開2006-350347號公報)。 作為支配液晶顯示元件的電光性能(electr〇_〇phc property)的參數(parameter),可以列舉液晶配向膜的延遲 O (Retardatlon ’ R)。該延遲(R)的值越高’液晶配向膜的單轴 配向性越高,液晶顯示元件的黑色顯示變得良好。因此, 已知了一種使用單軸配向性較高的液晶配向膜來使液晶顯 示元件中的液晶分子更加一致地配向,從而提升黑色顯示 特性的技術(日本專利特開2005-258397號公報)。另外, 作為液晶面板(liquid crystal panel)的製造步驟中所產生的 液晶面板的顯示不良的一種,已知一種將液晶分子注入于 液晶面板時,液晶分子固定在注入時的流動方向上的現象 201030060idoc 即流動配向’但作為液晶顯示元件,要求它不產生流動配 向。 但是’需要一種進一步提高與液晶顯示元件的延遲與 流動配向相關的特性的技術。 【發明内容】 本發明提供一種在延遲與流動配向方面具有優異性 能的液晶顯示元件、在此液晶顯示元件中達成所述特性顯 現的液晶配向膜以及可以形成該液晶配向膜的液晶配向 劑。 本發明者等人發現將含有以特定的四羧酸二酐 (tetracarboxylic dianhydride)與該四羧酸二酐以外的四叛酸 二酐作為原料的聚醯胺酸或其衍生物的組成物用於液晶配 向劑,具有由此液晶配向劑所形成的液晶配向膜的液晶顯 示元件具有所需的性能,從而完成本發明。 本發明包含以下的構成。 [1]一種液晶配向劑,其含有作為四羧酸二酐與二胺 (diamine)的反應生成物的聚醯胺酸或其衍生物,所述液晶 配向劑的特徵在於: 所述四缓酸一針含有以下述通式(TC-1)〜通式(TC-14) 所表示的四羧酸二酐的一種或一種以上、以及其他四羧酸 二酐的一種或一種以上。 201030060 'Ai.doc[Technical Field] The present invention relates to a liquid crystal alignment agent containing polylysine or a derivative thereof, a liquid crystal alignment film formed from the liquid crystal alignment agent, and the liquid crystal alignment film Liquid crystal display element. [Prior Art] The liquid crystal display element is used for a viewfinder and projection of a video camera (vide〇camera) typified by a monitor of a personal computer or a desktop personal computer. Various liquid crystal display devices such as displays have recently been used in televisions. Further, the liquid crystal display element is also used in a photonic-related element such as an optical printer head, an optical Fourier transform device, or a light valve. Various components are known for liquid crystal display elements, but the technical development of liquid crystal display elements can be achieved not only by the driving method of the liquid crystal display element or the structure of the liquid crystal display element, but also by the composition used in the liquid crystal display element. The components are improved to achieve. In general, a liquid crystal display element has a liquid crystal alignment film for aligning a liquid crystal composition in a liquid crystal layer in a specific direction. The liquid crystal alignment film is an important factor related to the display quality of the liquid crystal display element. The function of the liquid crystal alignment film has become important year by year as the quality of the liquid crystal display element is improved. The liquid crystal alignment film is prepared from a liquid crystal alignment agent. At present, a liquid crystal alignment agent mainly used is a solution obtained by dissolving polyacrylic acid or soluble polyamidene 201030060u.doc (polyimide) in an organic solvent. After the solution is applied onto a substrate, film formation is carried out by heating or the like to form a liquid crystal alignment film. Regarding the liquid crystal alignment film, for example, a liquid crystal alignment film using diamine tetraacetic acid dianhydride is known, and the liquid crystal alignment film is improved in a super Twisted Nematic 'STN mode, an active matrix display. The voltage holding ratio in (refer to the specification of U.S. Patent No. 552〇845). Further, a method of improving crosstalk by using a liquid crystal alignment film of ethylenediaminetetraacetic acid dianhydride has been disclosed (refer to Japanese Laid-Open Patent Publication No. Hei 6-75229). Further, a liquid crystal alignment film using a copolymer of a polymer material having a photoreactive group bonded to an acid anhydride in ethylenediaminetetraacetic acid dianhydride is disclosed (refer to Japanese Laid-Open Patent Publication No. 2006-350347). The parameter O which governs the electro-optical performance (electr〇_〇phc property) of the liquid crystal display element is a retardation O (Retardatlon' R) of the liquid crystal alignment film. The higher the value of the retardation (R), the higher the uniaxial alignment of the liquid crystal alignment film, and the black display of the liquid crystal display element becomes good. Therefore, a technique of using a liquid crystal alignment film having a high uniaxial alignment property to more uniformly align liquid crystal molecules in a liquid crystal display element to enhance black display characteristics has been known (Japanese Patent Laid-Open Publication No. Hei No. 2005-258397). Further, as one type of display failure of the liquid crystal panel which is produced in the manufacturing process of the liquid crystal panel, a phenomenon in which liquid crystal molecules are fixed in the flow direction at the time of injection when liquid crystal molecules are injected into the liquid crystal panel is known. 201030060idoc That is, the flow alignment 'but as a liquid crystal display element, it is required not to generate a flow alignment. However, there is a need for a technique for further improving characteristics relating to retardation and flow alignment of liquid crystal display elements. SUMMARY OF THE INVENTION The present invention provides a liquid crystal display element having excellent performance in retardation and flow alignment, a liquid crystal alignment film in which the characteristics are exhibited in the liquid crystal display element, and a liquid crystal alignment agent which can form the liquid crystal alignment film. The present inventors have found that a composition containing polyamic acid or a derivative thereof, which is a raw material of tetracarboxylic dianhydride and tetracarboxylic acid dianhydride other than the tetracarboxylic dianhydride, is used. The liquid crystal alignment element having the liquid crystal alignment film formed by the liquid crystal alignment agent has a desired property, thereby completing the present invention. The present invention includes the following constitutions. [1] A liquid crystal alignment agent containing polyamic acid or a derivative thereof as a reaction product of a tetracarboxylic dianhydride and a diamine, the liquid crystal alignment agent characterized by: One needle contains one or more kinds of tetracarboxylic dianhydride represented by the following general formula (TC-1) to formula (TC-14), and one or more kinds of other tetracarboxylic dianhydrides. 201030060 'Ai.doc
7 20103 0060.u〇c [化2]7 20103 0060.u〇c [Chemical 2]
Ad H 0 N-R1 Λ~f -r R1-N ) M O O (TC-8)Ad H 0 N-R1 Λ~f -r R1-N ) M O O (TC-8)
(A'L ( a2)„ (a1^ (通式(TC-1)中’ X表不-(CH2)m- ’兩個或兩個以下的 -CH2-可獨立地被·〇_(但不連續)、-s-、-COO·、-oco-、 -CO- 、-CONH- 、-CnH2nN(CmH2mCOOH)CnH2n-、 -CH(CmH2mOH)-、·αΗ((:ηΗ2η+1)-、-CH=CH-或-OC-所取代 ii.doc 201030060 (m獨立地表示〇〜3〇的整數,n獨立地表示1〜3〇的整 數)。通式(TC-4)〜通式(TC-7)中,Y獨立地表示單鍵、_〇·、 _S_、-S-S-、-S〇2-、_CO_、-CONH-、-NHCO-、_NH_、 •N(CH3)-(CH2)nrN(CH3)-、-C(CH3)2-、-C(CF3)2·、-(CH2)m-、 -0-(CH2)m-0-、-S-(CH2)m-S-(m 表示 1 〜6 的整數)。通式 (TC-5)中’ Z表示單鍵或不存在。通式(tc-2)〜通式(TC-7) 中,鍵結於環己烷(cyclohexane)環或苯(benzene)環上的氫 獨立’且可以被-F、-CH3、-CF3、-OH、-COOH、-S03H、 ® -P〇3H2所取代,通式(TC-3)中的鍵結於苯環上的氫可以被 苄基(benzyl)所取代。通式(TC-2)〜通式(TC-8)中,R1獨立 地表示-(CH2)m-,兩個或兩個以下的_ch2-可獨立地被 -0-(但不連續)、-S_、-COO-、-OCO-、-CO-、-CONH-、 -CH(CmH2mOH)-、-CH(CmH2m+1)-、-CH=CH-或-OC-所取 代(m獨立地表示〇〜30的整數)。通式(TC-8)中,A1獨立 為碳數1〜10的燒基、碳數1〜10的烧氧基(alk〇Xy)、乙醢 胺(acetamide)、氟、氯或漠,A2獨立地表示碳數1〜3的烷 ❿ 基,m表示0〜3的整數,η表示0〜4的整數。通式(TC-9) 中,R33及R34分別獨立地表示碳數1〜3的烷基或苯基 (phenyl) ’ Α3獨立地表示亞甲基(methylene)、次苯基 (phenylene)或被烷基取代的次苯基,1表示1〜6的整數, m表示1〜10的整數。通式(TC-10)中’ A3表示單鍵、_〇、 -COO-、-OCO-、_CO_、-CONH·或-(CH2)m,(m 表示 1 ^ 6 的整數),R1表示具有類固醇(steroid)骨架的基或者以下述 通式(B)所表示的基,當鍵結於苯環上的兩個氨基(amin0) 9 201030060“doc 的位置關係為對位時,R1進一步包含碳數1〜30的烧基’ 當其位置關係為間位時,R1進一步包含碳數1〜30的烧基· 或苯基,於該烷基中,任意的-CH2-可獨立地被-CF2_、 -CHF---0-(但不連續)、-CH=CH-或-OC-所取代 ’ _CHs 可以被-CH2F、-CHF2或-CF3所取代,該苯基的氫獨立’且 可以被-F、-CH3、-OCH3、-OCH2F、-OCHF2 或-ocf3 所取 代。 [化3](A'L ( a2) „ (a1^ (in the general formula (TC-1), 'X is not -(CH2)m- 'two or less -CH2- can be independently 〇 _ (but Discontinuous), -s-, -COO·, -oco-, -CO-, -CONH-, -CnH2nN(CmH2mCOOH)CnH2n-, -CH(CmH2mOH)-, ·αΗ((:ηΗ2η+1)-, -CH=CH- or -OC-substituted ii.doc 201030060 (m independently represents an integer of 〇~3〇, n independently represents an integer of 1 to 3〇). Formula (TC-4) to Formula ( In TC-7), Y independently represents a single bond, _〇·, _S_, -SS-, -S〇2-, _CO_, -CONH-, -NHCO-, _NH_, •N(CH3)-(CH2) nrN(CH3)-, -C(CH3)2-, -C(CF3)2·, -(CH2)m-, -0-(CH2)m-0-, -S-(CH2)mS-(m An integer of 1 to 6 is represented. In the formula (TC-5), 'Z represents a single bond or does not exist. In the formula (tc-2) to (TC-7), it is bonded to cyclohexane (cyclohexane). The hydrogen on the ring or the benzene ring is independent and can be substituted by -F, -CH3, -CF3, -OH, -COOH, -S03H, ® -P〇3H2, in the formula (TC-3) The hydrogen bonded to the benzene ring may be substituted by benzyl. In the formula (TC-2) to the formula (TC-8), R1 independently represents -(CH2)m-, two or Two or less _ch2- can be independently -0-(but not continuous), -S_, -COO-, -OCO-, -CO-, -CONH-, -CH(CmH2mOH)-, -CH(CmH2m+1)-, -CH=CH- or -OC- is substituted (m independently represents an integer of 〇30). In the formula (TC-8), A1 is independently a carbon group having a carbon number of 1 to 10 and a carbon number of 1 to 10. Alkoxy group (alk〇Xy), acetamide, fluorine, chlorine or desert, A2 independently represents an alkylene group having 1 to 3 carbon atoms, m represents an integer of 0 to 3, and η represents 0 to 4 In the formula (TC-9), R33 and R34 each independently represent an alkyl group having 1 to 3 carbon atoms or a phenyl group. Α3 independently represents a methylene group or a phenylene group. Or a subphenyl group substituted by an alkyl group, 1 represents an integer of 1 to 6, and m represents an integer of 1 to 10. In the formula (TC-10), 'A3 represents a single bond, _〇, -COO-, -OCO- , _CO_, -CONH· or -(CH2)m, (m represents an integer of 1 ^ 6), R1 represents a group having a steroid skeleton or a group represented by the following formula (B), when bonded Two amino groups on the benzene ring (amin0) 9 201030060 "The positional relationship of doc is the alignment, and R1 further contains a carbon number of 1 to 30." In the meta position, R1 further contains a C 1 or 30 alkyl group or a phenyl group, and in the alkyl group, any -CH 2 - may be independently -CF 2 _, -CHF - 0 - (but not discontinuous) , -CH=CH- or -OC-substituted '_CHs may be substituted by -CH2F, -CHF2 or -CF3, the hydrogen of the phenyl group is independent' and may be -F, -CH3, -OCH3, -OCH2F, Replaced by -OCHF2 or -ocf3. [Chemical 3]
通式(B)中,A4及A5分別獨立地表示單鍵、(但不 連續)、-COO-、-OCO-、-CONH·、-CH=CH-或碳數 1 〜12 的烷烯基(alkylene),R2及R3分別獨立地表示_F或心氏, 環S獨立地表示1,4-次苯基、ι,4_環己婦 (1,4-cyclohexylene) 、 1,3_ 二惡烷 _2,5_ 二基 (l,3-dioxane-2,5-diyl) ' 嘧 啶 _2,5_ 二 基 (pyrimidine-2,5-diyl)、吡啶-i/-二基(pyridine_14_diyl)、萘 -1,5-二基(naphthalene-l,5-diyl)、萘_2,7-二基或蒽_9,1〇-二基 (anthraCene-9,10-diyl),R4 表示·Η、·Ρ、碳數 i 〜^的烷基、 碳數1〜30的被氟取代的烷基、碳數丨〜3〇的烷氧基、 ON、-OCH2F、-〇CHF2 或-〇CF3,a 及 b 分別表示 〇〜4 的整數,c、d及e分別表示〇〜3的整數,f及g分別獨立 u.doc 201030060 地表示0〜2的整數,且c + d+e^l。通式(TC-ll)及通式 (TC-12)中’ R5獨立地表示-H或-CH3,R6表示-H、或者碳 數1〜20的烧基或碳數2〜20的烯基,A6獨立地表示單 鍵、-CO-或-CH2-。通式(TC-12)中,R7及R8分別獨立地表 示-H、碳數1〜20的烷基或苯基。通式(TC-13)及通式 (TC-14)中,A7獨立地表示-0-或碳數1〜6的烧稀基。通式 (TC-13)中’ R9表示-H或碳數1〜30的烧基,該说基中, 碳數2〜30的烧基的任意的-CH2·可以被-〇_(但不連續)、 ❹ -CH=CH-或-C=C-所取代,A8表示單鍵或碳數1〜3的烷烯 基,環T表示1,4-次苯基或1,4-環己烯,h表示〇或1。通 式(TC-14)中,R1G表示碳數6〜22的烷基,R11表示·Η或 碳數1〜22的烷基)。 [2] 根據[1]所述的液晶配向劑’其特徵在於:所述其他 四羧酸二酐包含芳香族四羧酸二酐。 [3] 根據[2]所述的液晶配向劑,其特徵在於:所述芳香 族四羧酸二酐是以下述結構式(1)、結構式(2)、結構式(5) φ 〜結構式(7)、結構式(10)、結構式(13)及結構式(14)所表示 的化合物中的至少一種。 201030060, _____ j__j.doc [化4]In the general formula (B), A4 and A5 each independently represent a single bond, (but not discontinuous), -COO-, -OCO-, -CONH., -CH=CH- or an alkenyl group having 1 to 12 carbon atoms. (alkylene), R2 and R3 each independently represent _F or heart, and ring S independently represents 1,4-phenylene, iota, 4-cyclohexylene, 1,3_ dioxins Alkano-2,5-diyl (l,3-dioxane-2,5-diyl) 'pyrimidine-2,5-diyl, pyridine-i/-diyl (pyridine_14_diyl), naphthalene -1,5-diyl (naphthalene-l, 5-diyl), naphthalene-2,7-diyl or 蒽_9,1〇-diyl (anthraCene-9,10-diyl), R4 represents Η, Ρ, an alkyl group having a carbon number i to ^, an alkyl group substituted with fluorine having 1 to 30 carbon atoms, an alkoxy group having a carbon number of 丨3 to 3, ON, -OCH2F, -〇CHF2 or -〇CF3,a And b denotes an integer of 〇~4, respectively, c, d, and e represent integers of 〇~3, respectively, and f and g are independent of u.doc 201030060, respectively, and represent an integer of 0 to 2, and c + d+e^l. In the formula (TC-ll) and the formula (TC-12), 'R5 independently represents -H or -CH3, and R6 represents -H, or a carbon number of 1 to 20 or an alkenyl group having 2 to 20 carbon atoms. A6 independently represents a single bond, -CO- or -CH2-. In the formula (TC-12), R7 and R8 each independently represent -H, an alkyl group having 1 to 20 carbon atoms or a phenyl group. In the formula (TC-13) and the formula (TC-14), A7 independently represents a -0- or a carbon number of 1 to 6. In the formula (TC-13), 'R9 represents -H or a carbon number of 1 to 30, and in the group, any -CH2· of the alkyl group having 2 to 30 carbon atoms may be -〇( (but not Continuous), ❹ -CH=CH- or -C=C- is substituted, A8 represents a single bond or an alkylene group having 1 to 3 carbon atoms, and ring T represents a 1,4-phenylene group or a 1,4-cyclohexyl group. Alkene, h represents hydrazine or 1. In the formula (TC-14), R1G represents an alkyl group having 6 to 22 carbon atoms, and R11 represents an anthracene or an alkyl group having 1 to 22 carbon atoms. [2] The liquid crystal alignment agent according to [1], wherein the other tetracarboxylic dianhydride comprises an aromatic tetracarboxylic dianhydride. [3] The liquid crystal alignment agent according to [2], wherein the aromatic tetracarboxylic dianhydride is represented by the following structural formula (1), structural formula (2), and structural formula (5) φ ~ structure At least one of the compounds represented by the formula (7), the structural formula (10), the structural formula (13) and the structural formula (14). 201030060, _____ j__j.doc [Chemical 4]
[4] 根據[1]〜[3]中任一項所述的液晶配向劑,其特徵 在於:所述四羧酸二酐包含脂環式四羧酸二酐及脂肪族四 羧_酸二酐中的一方或雙方。 [5] 根據[4]所述的液晶配向劑,其特徵在於:所述脂環 式四羧酸二酐及脂肪族四羧酸二酐是以下述結構式(15)、 結構式(16)、結構式(21)〜結構式(25)及結構式(29)〜結構 式(31)所表示的化合物中的至少一種。 12 ir.doc 201030060[4] The liquid crystal alignment agent according to any one of [1] to [3] wherein the tetracarboxylic dianhydride comprises an alicyclic tetracarboxylic dianhydride and an aliphatic tetracarboxylic acid-acid One or both of the anhydrides. [5] The liquid crystal alignment agent according to [4], wherein the alicyclic tetracarboxylic dianhydride and the aliphatic tetracarboxylic dianhydride are the following structural formula (15), structural formula (16) At least one of the compounds represented by the structural formula (21) to the structural formula (25) and the structural formula (29) to the structural formula (31). 12 ir.doc 201030060
[化5][Chemical 5]
[6]根據[1]〜[5]中任一項所述的液晶配向劑,其特徵 在於:所述二胺進一步包含以下述通式(I)及通式(II)所表示 的具有侧鏈結構的二胺的一種或一種以上。 參 13 201030060doc [化6] R12[6] The liquid crystal alignment agent according to any one of [1] to [5] wherein the diamine further comprises a side represented by the following general formula (I) and formula (II) One or more of the diamines of the chain structure. Reference 13 201030060doc [Chemical 6] R12
(通式(I)及通式(II)中,A9獨立地表示_〇·或碳數1〜6 的烧烯基’通式⑴中’ R12表示-H或碳數1〜3〇的烧基, 該烷基中’碳數2〜30的烷基的任意的_CH2-可以被-〇_(但 不連續)、-CH==CH-或-CSC-所取代’ A1G表示單鍵或碳數1 〜3的烷烯基’環T表示1,4-次苯基或1,4-環己烯,h表示 〇或1,通式(II)中,R15表示碳數6〜22的烷基,r]6表示 ❹ 碳數1〜22的烷基)。 [7]根據[6]所述的液晶配向劑,其特徵在於:所述具有 侧鏈結構的二胺是選自以下述通式(I-1)、通式(1_2)、通式 (1-4)以及通式(1_7)所表示的化合物中的至少一種。 14 u.doc(In the general formula (I) and the general formula (II), A9 independently represents _〇· or an alkylene group having 1 to 6 carbon atoms. In the formula (1), R12 represents -H or a carbon number of 1 to 3 Å. Any _CH2- of the alkyl group having a carbon number of 2 to 30 in the alkyl group may be substituted by -〇- (but discontinuous), -CH==CH- or -CSC-, and A1G represents a single bond or The alkenyl group of the carbon number of 1 to 3 represents a 1,4-phenylene group or a 1,4-cyclohexene, and h represents hydrazine or 1, and in the formula (II), R15 represents a carbon number of 6 to 22. The alkyl group, r]6 represents an alkyl group having 1 to 22 carbon atoms. [7] The liquid crystal alignment agent according to [6], wherein the diamine having a side chain structure is selected from the group consisting of the following general formula (I-1), general formula (1-2), and general formula (1) -4) and at least one of the compounds represented by the formula (1-7). 14 u.doc
201030060 (所述通式中,R13及RM分別表示碳數1〜30的烷基 或碳數1〜30的烷氧基)。 [8]根據[1]〜[7]中任一項所述的液晶配向劑,其特徵 在於:所述二胺進一步包含以下述通式(III)〜通式(X)、通 式(N)以及通式(a)所表示的不具有侧鏈結構的二胺。201030060 (In the above formula, R13 and RM each represent an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms). The liquid crystal alignment agent according to any one of [1] to [7] wherein the diamine further comprises the following general formula (III) to general formula (X), and general formula (N) And a diamine having no side chain structure represented by the formula (a).
15 201030060,doc [化8] h2n—x-nh2 (III)15 201030060,doc [化8] h2n—x-nh2 (III)
16 201030060 Hc _____ ^ir.doc (通式(III)中’ X表示_(CH2)m-(m表示1〜6的整數), 通式(V)及通式(VII)〜通式(IX)中,γ獨立地表示單鍵、 _〇_、-S-、_S_S-、-S02-、-CO-、-CONH_、-NHCO-、-NH-、 -N(CH3)-(CH2)m-N(CH3)-、_C(CH3)2-、-C(CF3)2-、-(CH2)m-、 -0-(CH2)m-0-、-S-(CH2)m-S-(m 表示 1〜6 的整數),通式(vil) 中,Z表示單鍵或不存在,通式(χ)中,R〗9&R2〇分別獨立 地表示碳數1〜3的烷基或苯基,A11獨立地表示亞甲基、 次本基或經烧基取代的次本基。i表示1〜6的整數,j表 ® 示1〜10的整數’通式(IV)〜通式(IX)中,鍵結於環己烷環 或苯環上可獨立地被-F、-CH3、-CF3、-OH、-COOH、、 -ΡΟ#2所取代,通式(VI)中的苯環上所鍵結的氫可以被节 基所取代。通式(Ν)中,Α1獨立地表示碳數為1〜4的烷基、 碳數為1〜4的烧氧基、乙醯胺、氟、氯或溴,a2獨立地 表示碳數為1〜3的烧基,m表示0〜3的整數,η表示〇 〜4的整數。通式(a)中’ L1表示氫、碳數1〜4的烷基、笨 基或节基)。 ❹ [9]根據[8]所述的液晶配向劑,其特徵在於··所述不具 有侧鏈結構的二胺是選自以下述結構式(VP〗)、結構式 (VI-2)、結構式(VI-15)〜結構式(VI-17)、結構式(vn_i)〜 結構式(VII-13)、結構式(VII-32)、結構式(νπ·34)〜結構式 (VII-36)、結構式(χι_2)、結構式(Χ-3)、結構式(ν)。、結構 式(Ν)-2、結構式(ν)- 14以及結構式(a-1)所表示的化合物中 的至少一種。 17 201030060 [化9] h2n16 201030060 Hc _____ ^ir.doc (In the general formula (III), 'X represents _(CH2)m- (m represents an integer of 1 to 6), and the general formula (V) and the general formula (VII) to the general formula (IX) Wherein γ independently represents a single bond, _〇_, -S-, _S_S-, -S02-, -CO-, -CONH_, -NHCO-, -NH-, -N(CH3)-(CH2)mN (CH3)-, _C(CH3)2-, -C(CF3)2-, -(CH2)m-, -0-(CH2)m-0-, -S-(CH2)mS-(m denotes 1 In the formula (vil), Z represents a single bond or does not exist, and in the formula (χ), R 9&R2〇 independently represents an alkyl group or a phenyl group having 1 to 3 carbon atoms, A11 independently represents a methylene group, a sub-base group or a sub-group substituted by a mercapto group. i represents an integer of 1 to 6, and j represents an integer of 1 to 10 'general formula (IV) to formula (IX) Wherein, the bond to the cyclohexane ring or the benzene ring may be independently substituted by -F, -CH3, -CF3, -OH, -COOH, - -#2, on the benzene ring in the formula (VI) The bonded hydrogen may be substituted by a benzyl group. In the formula (Ν), Α1 independently represents an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, acetamide, fluorine, Chlorine or bromine, a2 independently represents a burning group having a carbon number of 1 to 3, m represents an integer of 0 to 3, and η represents 〇 An integer of ~4. In the formula (a), 'L1 represents hydrogen, an alkyl group having 1 to 4 carbon atoms, a styl group or a benzyl group). [9] The liquid crystal alignment agent according to [8], wherein the diamine having no side chain structure is selected from the following structural formula (VP), structural formula (VI-2), Structural formula (VI-15)~Structure formula (VI-17), Structural formula (vn_i)~Structure formula (VII-13), Structural formula (VII-32), Structural formula (νπ·34)~Structure formula (VII -36), structural formula (χι_2), structural formula (Χ-3), structural formula (ν). At least one of the compounds represented by the structural formula (Ν)-2, the structural formula (ν)-14, and the structural formula (a-1). 17 201030060 [化9] h2n
H2N—nh2 (VI-1)H2N-nh2 (VI-1)
(VII-4) (VII-5) (VII-6)(VII-4) (VII-5) (VII-6)
HO OH (VII-32) 18 201030060 , I,i^i.doc [化 10] l_〇^NH2 h2n—n-H^^-nh2 h2n-^^—n^v^n (VII-35) (VI1-34)HO OH (VII-32) 18 201030060 , I,i^i.doc [化10] l_〇^NH2 h2n-nH^^-nh2 h2n-^^-n^v^n (VII-35) (VI1 -34)
NH, ch3 ch3 H2N-C3H6-Si-〇-Si-C3H6-NH2 CH3 ch3NH, ch3 ch3 H2N-C3H6-Si-〇-Si-C3H6-NH2 CH3 ch3
〇 (X-3) ❿ )n_O~nh2〇 (X-3) ❿ )n_O~nh2
H2N—^ y-H^ ,N—^ >-nh2 (N)-2 (N)-1H2N—^ y-H^ , N—^ >-nh2 (N)-2 (N)-1
(a-1) [10]根據[6]〜[9]中任一項所述的液晶配向劑,其特徵 在於: 所述聚醯胺酸或其衍生物包含兩種聚醯胺酸或其衍 生物A及B, 所述聚醯胺酸或其衍生物A包含所述二胺中以所述 19 201030060, 通式(I)及通式(II)所表示的具有側鏈結構的二胺的一種或 一種以上,且所述聚醯胺酸或其衍生物A及B的四羧酸二 酐的一方或雙方包含以所述通式(TC-1)〜通式(TC-14)所 表示的四叛酸二野的一種或一種以上與其他四叛酸二針。 [11] 根據[1]〜[10]中任一項所述的液晶配向劑,其特 徵在於:其進一步含有選自被烯基取代的納迪克醯亞胺化 合物、具有自由基聚合性不飽和雙鍵的化合物、惡嗪化合 物、惡唑啉化合物以及環氧化合物中的一種或一種以上。 [12] —種液晶配向膜,其特徵在於:其是對根據[〗]〜 ❹ [11]中任一項所述的液晶配向劑的塗膜進行加熱而形成。 [13] —種液晶顯示元件,其具有:一對基板;液晶層, 含有液晶分子,並形成於所述一對基板之間;電極,對液 晶層施加電壓;以及液晶配向膜,使所述液晶分子配向在 預定的方向上;所述液晶顯示元件的特徵在於: 所述液晶配向膜是根據[12]所述的液晶配向膜。 根據本發明,可以提供一種在延遲與流動配向方面, 具有延遲得到提升且不產生流動配向等所需性能的液晶帛 示元件。 醫 為讓本發明之上述特徵和優點能更明顯易懂,下文特 舉實施例,並配合所附圖式作詳細說明如下。 【實施方式】 本發明的液晶配向劑含有作為四羧酸二酐與二胺的 =產物的聚醯胺酸或其衍生物。所述聚醯胺酸的衍生物 曰在製成3有溶劑的後述的液晶向劑時溶解于溶劑中 20 20103006(^ dn _____ ^n.doc 的成分、且在將該液晶配向劑製成後述的液晶配向膜時可 以形成以聚醯亞胺為主成分的液晶配向膜的成分。作為此 種聚醯胺酸的衍生物,例如可以列舉:可溶性聚醯亞胺、 聚醯胺酸酯(polyamic acid ester)以及聚酿胺酸酿胺 (polyamicacidamide)等,更具體而言,可以列舉1)聚醯胺 酸的所有氨基與羧基(carboxyl)進行脫水閉環反應而成的 聚醯亞胺、2)部分地進行脫水閉環反應而成的部分聚醯亞 胺、3)將聚醯胺酸的羧基轉變為酯而成的聚醯胺酸酯、句 ® 將四竣酸二酐化合物所含的酸二酐的一部分替換為有機二 羧酸來進行反應而獲得的聚醯胺酸-聚醯胺共聚物,進一步 可以列舉5)使該聚醯胺酸-聚醯胺共聚物的一部分或者全 部進行脫水閉環反應而成的聚醯胺醯亞胺 (polyamide-imide)。所述聚醯胺酸或其衍生物可以是一種 化合物’也可以是兩種或兩種以上的化合物。另外,所述 聚醯胺酸或其衍生物只要是具有四羧酸二酐與二胺的反應 生成物的結構的化合物即可,也可以是使用其他原料,通 〇 過四羧酸二酐與二胺的反應以外的其他反應所獲得的反應 生成物。 < 1.本發明中所使用的四羧酸二酐> 本發明中所使用的四羧酸二酐(以下也簡稱為酸二酑) 包含以所述通式(TC-1)〜通式(TC-14)所表示的四羧酸二 酐的一種或一種以上。 作為以通式(TC-1)所表示的四魏酸二針,優選在通式 中’ X的作為主鏈的烷烯基的碳數為〇〜20,例如可以列 21 doc 201030060 舉以下述結構式所表示的酸二酐。 [化η][10] The liquid crystal alignment agent according to any one of [6], wherein the polyamic acid or a derivative thereof comprises two polylysine or Derivatives A and B, wherein the polyaminic acid or derivative A thereof comprises the diamine having a side chain structure represented by the above-mentioned 19 201030060, the general formula (I) and the general formula (II) One or more of the polyamic acid or derivatives A and B of the tetracarboxylic dianhydride include one or both of the formula (TC-1) to the formula (TC-14) One or more of the four rebel acides of the wilderness are represented by two other needles with the other four. [11] The liquid crystal alignment agent according to any one of [1], which further comprises a nadic ylidene compound selected from an alkenyl group, having a radical polymerizable unsaturated group. One or more of a compound of a double bond, an oxazine compound, an oxazoline compound, and an epoxy compound. [12] A liquid crystal alignment film which is formed by heating a coating film of the liquid crystal alignment agent according to any one of [1] to [11]. [13] A liquid crystal display element having: a pair of substrates; a liquid crystal layer containing liquid crystal molecules and formed between the pair of substrates; an electrode applying a voltage to the liquid crystal layer; and a liquid crystal alignment film to cause the The liquid crystal molecules are aligned in a predetermined direction; the liquid crystal display element is characterized in that: the liquid crystal alignment film is the liquid crystal alignment film according to [12]. According to the present invention, it is possible to provide a liquid crystal display element having a desired property such as retardation and flow alignment in terms of retardation and flow alignment. The above-described features and advantages of the present invention will become more apparent from the following detailed description. [Embodiment] The liquid crystal alignment agent of the present invention contains polyamine or a derivative thereof as a product of tetracarboxylic dianhydride and diamine. The derivative of the poly-proline is dissolved in a solvent in a liquid crystal-forming agent (3) which is described later as a solvent, and is a component of the composition of the liquid crystal alignment agent. In the case of the liquid crystal alignment film, a component of a liquid crystal alignment film containing polyiminoimine as a main component can be formed. Examples of such a derivative of polyglycine are soluble polyimine and polyamic acid ester (polyamic). The acid ester) and the polyamic acidamide, etc., more specifically, 1) polyimine which is obtained by dehydration ring-closing reaction of all amino groups of a poly-proline and a carboxyl group, 2) Partial polyimine which is obtained by dehydration ring-closure reaction, 3) polyglycolate which converts carboxyl group of polyproline into ester, and acid 2 contained in tetracarboxylic acid dianhydride compound A poly-proline-polyamine copolymer obtained by replacing a part of the anhydride with an organic dicarboxylic acid, and further, 5) performing a dehydration ring closure of a part or all of the polyamido-polyamide copolymer Polyamidamine (polyami) De-imide). The polyaminic acid or a derivative thereof may be a compound ' or a compound of two or more kinds. Further, the polyamic acid or a derivative thereof may be a compound having a structure of a reaction product of a tetracarboxylic dianhydride and a diamine, and may be a tetracarboxylic dianhydride by using another raw material. A reaction product obtained by a reaction other than the reaction of a diamine. < 1. Tetracarboxylic dianhydride used in the present invention> The tetracarboxylic dianhydride (hereinafter also simply referred to as diterpenoid) used in the present invention contains the above formula (TC-1) to One or more kinds of tetracarboxylic dianhydride represented by the formula (TC-14). As the two needles of the tetracarboxylic acid represented by the formula (TC-1), it is preferred that the carbon number of the alkenyl group as the main chain of 'X in the formula is 〇 20 20, for example, it can be listed as 21 doc 201030060. The acid dianhydride represented by the structural formula. [ηη]
作為以通式(TC-2)所表示的四羧酸二酐,優選在通式 中,R1的作為主鏈的烷烯基的碳數為0〜10,例如可以列 舉以下述結構式所表示的酸二酐。 [化 12]In the general formula, the number of carbon atoms of the alkenyl group as a main chain of R1 is preferably from 0 to 10, and is represented by the following structural formula, for example, as the tetracarboxylic dianhydride represented by the formula (TC-2). Acid dianhydride. [化 12]
作為以通式(TC-3)所表示的四羧酸二酐,優選在通式 中,R1的作為主鏈的烷烯基的碳數為0〜10,例如可以列 舉以下述結構式所表示的酸二酐。 22 201030060 [化 13]The tetracarboxylic dianhydride represented by the formula (TC-3) is preferably a compound in which the number of carbon atoms of the alkenyl group as a main chain of R1 is from 0 to 10, and examples thereof include the following structural formulas. Acid dianhydride. 22 201030060 [Chem. 13]
作為以通式(TC-4)所表示的四羧酸二酐,優選在通式 中,R1的作為主鏈的烷烯基的碳數為0〜10,例如可以列 舉以下述結構式所表示的酸二酐。 23 201030060doc [化 14]In the general formula, the number of carbon atoms of the alkenyl group as the main chain of R1 is preferably from 0 to 10, and is represented by the following structural formula, for example, as the tetracarboxylic dianhydride represented by the formula (TC-4). Acid dianhydride. 23 201030060doc [Chem. 14]
作為以通式(TC-5)所表示的四羧酸二酐,優選在通式 中,R1的作為主鏈的烷烯基的碳數為0〜10,例如可以列 舉以下述結構式所表示的酸二酐。 [化 15]The tetracarboxylic dianhydride represented by the formula (TC-5) is preferably a compound in which the number of carbon atoms of the alkenyl group as a main chain of R1 is from 0 to 10, and examples thereof include the following structural formulas. Acid dianhydride. [化15]
24 201030060 [化 16]24 201030060 [Chem. 16]
φ 作為以通式(TC-6)所表示的四羧酸二酐,優選在通式 中,R1的作為主鏈的烷烯基的碳數為0〜10,例如可以列 舉以下述結構式所表示的酸二酐。 25 201030060, _____ ^ __.doc [化π]φ is a tetracarboxylic dianhydride represented by the formula (TC-6), and in the formula, the number of carbon atoms of the alkenyl group as a main chain of R1 is preferably from 0 to 10, and examples thereof include the following structural formula. Indicated acid dianhydride. 25 201030060, _____ ^ __.doc [化π]
作為以通式(TC-7)所表示的四羧酸二酐,優選在通式 中,R1的作為主鏈的烷烯基的碳數為0〜10,例如可以列 舉以下述結構式所表示的酸二酐。 [化 18]The tetracarboxylic dianhydride represented by the formula (TC-7) is preferably a compound in which the number of carbon atoms of the alkenyl group as a main chain of R1 is from 0 to 10, and examples thereof include the following structural formula. Acid dianhydride. [Chem. 18]
26 201030060iTd _____^ir.doc 作為以通式(TC-8)所表示的四羧酸二酐,優選在通式 中,R1的作為主鏈的烷烯基的碳數為0〜10,例如可以列 舉以下述結構式所表示的酸二酐。 [化 19]26 201030060iTd _____^ir.doc As the tetracarboxylic dianhydride represented by the formula (TC-8), it is preferred that in the formula, the carbon number of the alkenyl group as a main chain of R1 is 0 to 10, for example, The acid dianhydride represented by the following structural formula is listed. [Chem. 19]
27 .i.doc 201030060 [化 20]27 .i.doc 201030060 [Chem. 20]
作為以通式(TC-9)所表示的四羧酸二酐,例如可以列 舉以下述結構式所表示的酸二酐。 [化 21] ch3 ch3 N—CaHe—Si—O—Si—CgHe—N / CH3 0¾ 、 28The tetracarboxylic dianhydride represented by the formula (TC-9) may, for example, be an acid dianhydride represented by the following structural formula. [Chem. 21] ch3 ch3 N—CaHe—Si—O—Si—CgHe—N / CH3 03⁄4 , 28
201030060 H .(±,it.doc 作為以通式(TC-10)所表示的四羧酸二酐,例如可以列 舉以下述通式或結構式所表示的酸二酐。 [化 22]201030060 H. (±, it. doc) The tetracarboxylic dianhydride represented by the formula (TC-10) may, for example, be an acid dianhydride represented by the following formula or structural formula.
29 .doc 201030060 [化 23] 201030060 ii.doc29 .doc 201030060 [Chem. 23] 201030060 ii.doc
31 201030060,oc (在所述通式中,R23、R24、R25、R26分別表示碳數1 〜30的烷基或碳數1〜30的烷氧基)。 作為以通式(TC-11)所表示的四羧酸二酐,例如可以列 舉以下述結構式所表示的酸二酐。 [化 25]31 201030060, oc (In the above formula, R23, R24, R25, and R26 each represent an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms). The tetracarboxylic dianhydride represented by the formula (TC-11) may, for example, be an acid dianhydride represented by the following structural formula. [Chem. 25]
作為以通式(TC-12)所表示的四羧酸二酐,例如可以列 舉以下述結構式所表示的酸二酐。The tetracarboxylic dianhydride represented by the formula (TC-12) may, for example, be an acid dianhydride represented by the following structural formula.
32 lt^doc 201030060 [化 26]32 lt^doc 201030060 [Chem. 26]
33 201030060, _____ £.doc [化 27]33 201030060, _____ £.doc [Chem. 27]
作為以通式(TC-13)所表示的四羧酸二酐,例如可以列 舉以下述通式所表示的酸二酐。The tetracarboxylic dianhydride represented by the formula (TC-13) may, for example, be an acid dianhydride represented by the following formula.
34 201030060 d 1 ii.doc [化 28]34 201030060 d 1 ii.doc [Chem. 28]
R29R29
35 _.doc 201030060 (R29表示-Η、碳數1〜30的烷基或碳數1〜30的烷氧 基,更優選表示礙數3〜30的烧基或碳數3〜30的烧氧基)。 作為以通式(TC-14)所表示的四羧酸二酐,例如可以列 舉以下述通式所表示的酸二酐。35 _.doc 201030060 (R29 represents - an anthracene, an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms, more preferably an alkyl group having a hindrance of 3 to 30 or a burning oxygen having a carbon number of 3 to 30 base). The tetracarboxylic dianhydride represented by the formula (TC-14) may, for example, be an acid dianhydride represented by the following formula.
(R29表示碳數6〜22的烷基,更優選表示碳數6〜10 的烷基。R3()表示-Η或碳數1〜22的烷基,更優選表示-Η 或碳數1〜10的烷基)。 作為其他四羧酸二酐,例如可以列舉以下述通式所表 示的酸二酐。 36 if.doc(R29 represents an alkyl group having 6 to 22 carbon atoms, more preferably an alkyl group having 6 to 10 carbon atoms. R3() represents an anthracene or an alkyl group having 1 to 22 carbon atoms, and more preferably represents -? or a carbon number of 1~ 10 alkyl). Examples of the other tetracarboxylic dianhydride include acid dianhydride represented by the following formula. 36 if.doc
201030060 (R35及R36分別獨立地表示碳數3〜30的烷基)。 特別適用于本發明的四羧酸二酐是以通式(TC-1)〜通 式(TC-7)所表示的四羧酸二酐,其中,特別優選由以下的 結構式所表示的四羧酸二酐。201030060 (R35 and R36 each independently represent an alkyl group having 3 to 30 carbon atoms). The tetracarboxylic dianhydride which is particularly suitable for use in the present invention is a tetracarboxylic dianhydride represented by the general formula (TC-1) to the general formula (TC-7), and among them, particularly preferably represented by the following structural formula Carboxylic dianhydride.
37 201030060, [化 31]37 201030060, [Chem. 31]
Ο 另外’就在液晶顯示元件中顯現所需的延遲,並且抑 制液晶顯示元件的流動配向的觀點而言,優選在構成本發 明的液晶配向劑中的聚醯胺酸的酸二酐中含有以莫耳比計 為10%〜99.5%的以所述(TC-1)〜所述(TC-14)所表示的四 羧酸二酐,更優選含有20%〜95%的以所述(TC-1)〜所述 (TC-14)所表示的四羧酸二酐。 在本發明中,作為所述四羧酸二酐,除以所述通式 (TC-1)〜通式(TC-14)所表示的四羧酸二酐以外,進一步使 用其他四羧酸二酐。以所述通式(TC-1)〜通式(TC-14)所表 38Ο In addition, from the viewpoint of exhibiting a desired retardation in the liquid crystal display element and suppressing the flow alignment of the liquid crystal display element, it is preferably contained in the acid dianhydride of the poly-proline which constitutes the liquid crystal alignment agent of the present invention. The molar ratio is from 10% to 99.5%, and the tetracarboxylic dianhydride represented by the above (TC-1) to the above (TC-14), more preferably contains 20% to 95% of the (TC) -1) ~ The tetracarboxylic dianhydride represented by (TC-14). In the present invention, as the tetracarboxylic dianhydride, in addition to the tetracarboxylic dianhydride represented by the above formula (TC-1) to formula (TC-14), other tetracarboxylic acid II is further used. anhydride. It is represented by the above formula (TC-1) to formula (TC-14).
Jtdoc 201030060 示的四羧酸二酐以外的四羧酸二酐可以是一種,也可以是 兩種或兩種以上、就使本發财的聚酿胺酸或其衍生物成 為可溶於溶_形㈣觀祕言,優選適絲 通式(似)〜通式(似4)所表示的四_ 述四羧酸二酐。汁的所 作為以所述通式(TC-1)〜通式(TCM 酸二酐以外的所述四㈣二酐,例如可以列舉::巷:叛 羧酸二酐、脂肪族四羧酸二酐以及脂環式酸:族四 此,使用以所述通式(T(M)〜通式(Τ(Μ 二野°如 二酐與該四紐二料外的四舰二酐作為本發明 配向劑中所含有的聚醯胺酸或其衍生物的原料,由此县文明 該液晶配向賴延遲的提升與流動配㈣抑制。Θ現 作為所述芳香族四羧酸二酐,例如可以 構式(1)〜結構式(14)所表示的化合物。 下迷結 ❿ 39 :.doc 201030060 [化 32]Jtdoc 201030060 The tetracarboxylic dianhydride other than the tetracarboxylic dianhydride may be one type, or two or more types may be used to make the present poly-tantoic acid or its derivative soluble. In the case of the shape (4), it is preferable to use a tetracarboxylic dianhydride represented by the formula (like) to the formula (like 4). The juice is represented by the above-mentioned formula (TC-1) to the formula (the tetrakis(tetra) dianhydride other than the TCM acid dianhydride, and examples thereof include: lane: carboxylic acid dianhydride, aliphatic tetracarboxylic acid II Anhydride and an alicyclic acid: a family of four, using the above formula (T(M) to the formula (Τ(Μ二野° such as dianhydride and the four-cylinder dianhydride as the invention) The raw material of the poly-proline or the derivative thereof contained in the alignment agent, thereby increasing the retardation of the liquid crystal alignment and the flow distribution (4) suppression by the county civilization. As the aromatic tetracarboxylic dianhydride, for example, it is possible to The compound represented by the formula (1) to the structural formula (14). The underlying knot 39 :.doc 201030060 [Chem. 32]
(13) 所述芳香族四羧酸二酐優選以所述結構式(1)、結構式 (2)、結構式(5)〜結構式(7)、結構式(10)、結構式(13)及結 構式(14)所表示的化合物,更優選以所述結構式(1)所表示 的均苯四甲酸二酐(pyromellitic dianhydride)。 作為所述脂肪族四羧酸二酐及脂環式四羧酸二酐,例 如可以列舉以下述結構式(15)〜結構式(64)所表示的化合 201030060 H _____ ^xt.doc [化 33](13) The aromatic tetracarboxylic dianhydride preferably has the structural formula (1), the structural formula (2), the structural formula (5) to the structural formula (7), the structural formula (10), and the structural formula (13). And a compound represented by the structural formula (14), and pyromellitic dianhydride represented by the structural formula (1) is more preferable. Examples of the aliphatic tetracarboxylic dianhydride and the alicyclic tetracarboxylic dianhydride include the compounds represented by the following structural formulae (15) to (64): 201030060 H _____ ^xt.doc [Chem. 33 ]
(24) (25) (26) (27)(24) (25) (26) (27)
(28) (29) (30)(28) (29) (30)
(34) (35) (36) (37) 41 201030060 doc(34) (35) (36) (37) 41 201030060 doc
4242
201030060tH201030060tH
^ ^ y % I ^/IX.CLOC^ ^ y % I ^/IX.CLOC
[化 35][化35]
所述脂肪族四鲮酸二酐及脂環式四羧酸二酐優選以 所述結構式(15)、結構式(16)、結構式(21)〜結構式(25)以 及結構式(29)〜結構式(31)所表示的化合物,更優選以結構 式(15)所表示的 12,3,4-環丁烷四甲酸二酐 (l,2,3,4-cyclobutane tetracarboxylic dianhydride)。 Φ 另外,就使本發明中的聚醯胺酸或其衍生物成為可溶 於滲媒的聚醯亞胺的觀點而言,所述脂肪族四羧酸二酐及 脂瓖式四羧酸二酐優選以所述結構式(15)〜結構式(18)、結 構式(21)〜結構式(25)、結構式(28)〜結構式(3〇)以及結構 式(44)〜結構式(47)所表示的化合物。 另外,所述四羧酸二酐也可以含有具有侧鏈結構的四 羧酸二酐。具有侧鏈結構的四羧酸二酐可以增大液晶顯示 201030060, —….ri.doc 元件中的預傾角(pretilt angle) °作為具有侧鍵結構的四叛 酸二酐,例如可以列舉以下述結構式(65)及結構式(66)所表 示的具有類固醇骨架的化合物。 [化 36]The aliphatic tetraphthalic acid dianhydride and the alicyclic tetracarboxylic dianhydride preferably have the structural formula (15), the structural formula (16), the structural formula (21) to the structural formula (25), and the structural formula (29). The compound represented by the structural formula (31) is more preferably 12,3,4-cyclobutane tetracarboxylic dianhydride represented by the structural formula (15). Φ Further, in view of the fact that the poly-proline or the derivative thereof in the present invention is a polyimine which is soluble in a vehicle, the aliphatic tetracarboxylic dianhydride and the lipid bismuth tetracarboxylic acid The anhydride preferably has the structural formula (15) to the structural formula (18), the structural formula (21) to the structural formula (25), the structural formula (28) to the structural formula (3〇), and the structural formula (44) to the structural formula. (47) The compound represented. Further, the tetracarboxylic dianhydride may also contain a tetracarboxylic dianhydride having a side chain structure. The tetracarboxylic dianhydride having a side chain structure can increase the pretilt angle in the liquid crystal display 201030060, ..... ri. doc element. As the tetrareic acid dianhydride having a side bond structure, for example, the following A compound having a steroid skeleton represented by the structural formula (65) and the structural formula (66). [化36]
就減少液晶顯示元件中的殘留電壓的觀點而& ’所述 © 四羧酸二酐優選含有所述芳香族四羧酸二酐、脂肪族四羧 酸二酐以及脂環式四羧酸二酐的一方或雙方。 所述四羧酸二酐也包含其他各種形態的四叛酸二 酐,並不限定於所述的四鲮酸二酐。所述四羧酸二酐可以 在達成本發明目的的範圍内使用其他各種形態的四竣酸二 酐。 也可以將所述四羧酸二酐的一部分替換成羧酸酐 44 201030060 ---.· rll.doc (carboxylic anhydride)。將四羧酸二酐的一部分替換成羧酸 軒會引起生成所述聚醯胺酸或其衍生物的聚合反應的終止 (termination) ’從而抑制反應的進一步進行,因此,就容易 地控制聚酿胺酸或其衍生物的分子量的觀點而言優選。羧 酸酐相對於所述四羧酸二酐的比率只要在不損及本發明效 果的範圍内即可,作為基準,優選為小於等於所述四羧酸 二酐的10莫耳%。 就提高延遲的值與抑制流動配向的觀點而言,在構成 Φ 液晶配向劑中的聚醯胺酸的酸二酐中,以所述通式(TC-1) 〜通式(TC-14)所表示的四羧酸二酐以外的所述四羧酸二 針的含量以莫耳比計優選為1〇%〜9〇%,更優選為1〇%〜 80% ’進一步優選為30%〜70%。 另外’在構成液晶配向劑中的聚醯胺酸的酸二酐中, 所述芳香族四羧酸二酐的含量以莫耳比計優選為〇%〜 80% ’更優選為〇%〜60%,進一步優選為〜5〇%。 <2.本發明中所使用的二胺> 作為本發明中所使用的二胺,可以優選使用以下述通 式(I)〜通式(II)所表示的具有侧鏈結構的二胺(以下也稱為 側鍵型二胺)。 45 201030060* [化 37] R12From the viewpoint of reducing the residual voltage in the liquid crystal display element, the above-mentioned tetracarboxylic dianhydride preferably contains the aromatic tetracarboxylic dianhydride, aliphatic tetracarboxylic dianhydride, and alicyclic tetracarboxylic acid One or both of the anhydrides. The tetracarboxylic dianhydride also contains tetrahedoic dianhydride in various other forms, and is not limited to the tetraphthalic acid dianhydride. The tetracarboxylic dianhydride may use other various forms of tetradecanoic dianhydride within the scope of achieving the object of the present invention. It is also possible to replace a part of the tetracarboxylic dianhydride with a carboxylic anhydride 44 201030060 ---.. rll.doc (carboxylic anhydride). Replacing a part of the tetracarboxylic dianhydride with a carboxylic acid causes a termination of the polymerization reaction of the polyamic acid or its derivative, thereby suppressing further progress of the reaction, and therefore, it is easy to control the brewing. From the viewpoint of the molecular weight of the amine acid or its derivative, it is preferred. The ratio of the carboxylic acid anhydride to the tetracarboxylic dianhydride may be within a range not detracting from the effects of the present invention, and is preferably equal to or less than 10 mol% of the tetracarboxylic dianhydride. From the viewpoint of increasing the retardation value and suppressing the flow alignment, in the acid dianhydride constituting the poly-proline in the Φ liquid crystal alignment agent, the above formula (TC-1) to the formula (TC-14) The content of the tetracarboxylic acid two needles other than the tetracarboxylic dianhydride represented is preferably from 1% by weight to 9% by mole based on the molar ratio, more preferably from 1% by weight to 80% by weight, and further preferably 30% by weight. 70%. Further, the content of the aromatic tetracarboxylic dianhydride in the acid dianhydride constituting the polyamic acid in the liquid crystal alignment agent is preferably from 〇% to 80% by the molar ratio, and more preferably 〇% to 60%. % is further preferably 〜5% by weight. <2. Diamine used in the present invention> As the diamine used in the present invention, a diamine having a side chain structure represented by the following general formula (I) to formula (II) can be preferably used. (hereinafter also referred to as a side bond type diamine). 45 201030060* [化37] R12
nh2 nh2 (I)Nh2 nh2 (I)
(ID 通式(I)中’ R12表示-H或碳數1〜30的烷基。該烷基 中’碳數2〜3〇的烷基的任意的-CH2-可獨立地被-0-、 -CH-CH-或所取代。其中,在該烷基中不相鄰。 通式®及通式®)中,A9獨立地表示-〇-或碳數1〜6的烧稀 基。通式(I)中,Αι〇表示單鍵或碳數i〜3的烧稀基。環了 表示M-人笨基或1,4-環己稀。h表示〇或卜通式⑼中, R15表示缝6〜22的錄H示·H或碳數丨〜22的烧 基0 例如 另外,作為以所述通式(I)所表示的側鏈型二胺 可以列舉以下述通式屮1)〜通式(1-9)所表示的二胺‘(ID) In the formula (I), 'R12 represents -H or an alkyl group having 1 to 30 carbon atoms. Any -CH2- of the alkyl group having a carbon number of 2 to 3 Å in the alkyl group may be independently -0- And -CH-CH- or substituted, wherein, in the alkyl group, it is not adjacent. In the formula ® and the formula ®), A9 independently represents -〇- or a carbon number of 1 to 6. In the formula (I), Αι〇 represents a single bond or a sintered group having a carbon number of i to 3. Ring represents M-human stupid or 1,4-cyclohexene. h represents 〇 or 通式 in the formula (9), R15 represents the H shown in the slits 6 to 22, H or the carbon number 丨 22 22, for example, in addition, as a side chain type represented by the above formula (I) Examples of the diamine include diamines represented by the following formulas 屮1) to (1-9).
4747
201030060rH _所述通式(Ι·1)及(1-2)中,R13表示_H或碳數1〜30的 烷基’所述通式(1_4)及(1_5)中,rU表示_H或碳數1〜3〇 的烷基。另外,所述通式(1_3)中,表示_H或碳數1〜3〇 的烧基所述通式(1-6)〜通式(1-9)中,R14表示-H或碳數1 〜20的烧基。 作為以所述通式(I)所表示的二胺,例如可以優選使用 輯述通式(1_ 1 )、通式(1-2)、通式(1-4)及通式(1-7)所表示的 二胺。 以所述通式(II)所表示的侧鏈型二胺優選分別鍵結於 鏐 兩個笨基上的兩個氨基相對於A9鍵結在間位或對位。 作為以所述通式(Π)所表示的侧鏈型二胺,例如可以列 舉以下述通式(II-1)〜通式(11_3)所表示的二胺。 [化 39]201030060rH _ In the above formulas (Ι·1) and (1-2), R13 represents _H or an alkyl group having 1 to 30 carbon atoms. In the above formulas (1_4) and (1_5), rU represents _H. Or an alkyl group having a carbon number of 1 to 3 Å. Further, in the above formula (1_3), a group represented by _H or a carbon number of 1 to 3 Å is represented by the formula (1-6) to the formula (1-9), and R14 represents -H or a carbon number. 1 to 20 burnt base. As the diamine represented by the above formula (I), for example, a formula (1_1), a formula (1-2), a formula (1-4) and a formula (1-7) can be preferably used. ) the diamine represented. The side chain type diamine represented by the above formula (II) is preferably bonded to the two base groups of 镠, respectively, and the two amino groups are bonded to the meta or para position with respect to A9. The side chain type diamine represented by the above formula (Π) may, for example, be a diamine represented by the following formula (II-1) to formula (11_3). [化39]
Rt7 R18Rt7 R18
(H-2) R1J R1® (11-1) R1〈 R18 H^O^O^〇sy^-NH2 @ (H-3) 所述通式中,R17表示碳數6〜2〇的烷基,表示_H 或碳數l〜的燒基。 就獲得製成液晶顯示元件時的適#的配向性的觀點 而言,所述具有舰結構的二_對于構成本發明的液晶 配向劑中的聚醯胺酸的二胺的莫耳比在面内切換(In_plane 48 201030060 ,(H-2) R1J R1® (11-1) R1 < R18 H^O^O^〇sy^-NH2 @ (H-3) In the above formula, R17 represents an alkyl group having 6 to 2 carbon atoms , indicating _H or a carbon number of l~. From the viewpoint of obtaining the alignment property of the liquid crystal display element, the second structure having the ship structure is in the form of a molar ratio of the diamine constituting the polyamic acid in the liquid crystal alignment agent of the present invention. Internal switching (In_plane 48 201030060,
Switching,IPS)中優選為〇%〜5〇%’更優選為0%〜20%, 在扭曲向列(Twisted Nematic,TN)及STN中優選為〇〇/〇〜 90%,更優選為3%〜70%。 作為以所述通式(I)及通式(II)所表示的二胺以外的其 他二胺,也可以優選例示進一步包含以下述通式(ΠΙ)〜^ 式(X)、通式(Ν)以及通式(a)所㈣的不具有侧鍵結構的二 胺(以下也稱為直鏈型二胺)。不具有侧鏈結構的二胺可以 是一種,也可以是兩種或兩種以上。 ❹In Switching, IPS), 〇%~5〇%' is more preferably 0%~20%, and in twisted nematic (TN) and STN, it is preferably 〇〇/〇~90%, more preferably 3 %~70%. Further, other diamines other than the diamines represented by the above formula (I) and formula (II) may be preferably further exemplified by the following formula (ΠΙ)~^ formula (X), formula (Ν) And a diamine (hereinafter also referred to as a linear diamine) having no side bond structure of (4) of the formula (a). The diamine having no side chain structure may be one type or two or more types. ❹
49 201030060 [化 40] h2n—x-nh2 (III)49 201030060 [化40] h2n—x-nh2 (III)
50 ii.doc 201030060 (通式(III)中,X表示-(CH2)m-(m表示1〜6的整數), 通式(V)及通式(VII)〜通式(IX)中,Y獨立地表示單鍵、 -〇-、-S-、-S-S-、-S02-、-CO-、-CONH-、-NHC0-、-NH-、 -N(CH3HCH2)m-N(CH3)-、-C(CH3)2-、-C(CF3)2-、-(CH2)m-、 -0-(CH2)m-〇-、-S-(CH2)m-S-(m表示 1〜6 的整數),通式(VII) 中,Z表示單鍵或不存在,通式(X)中,R19及R2〇分別獨立 地表示碳數1〜3的烷基或苯基,A11獨立地表示亞甲基、 次笨基或被院基取代的次苯基。i表示1〜6的整數,j表 示1〜10的整數,通式(IV)〜通式(IX)中,鍵結於環己烷環 或苯環上的氫獨立,且可以被-F、-CH3、-CF3、-0H、 -C00H、-SOsH、-P〇3H2所取代,通式(vi)中的笨環上所 鍵結的氫可以被苄基所取代。通式(N)中,V獨立地表示 碳數為1〜4的烷基、碳數為1〜4的烷氧基、乙醯胺、氣、 氯或溴,A2獨立地表示碳數為i〜3的烷基,m表示〇〜3 的整數’ η表示0〜4的整數。通式(a)中,Ll表示氫、 1〜4的烷基、苯基或苄基)。 ^ ❿ 作為以通式(III)所表示的直鍵型二胺,例如可以 以結構式(III-1)〜結構式(III-3 )所表示的二胺。 [化 41]50 ii.doc 201030060 (In the formula (III), X represents -(CH2)m- (m represents an integer of 1 to 6), in the formula (V) and the formula (VII) to the formula (IX), Y independently represents a single bond, -〇-, -S-, -SS-, -S02-, -CO-, -CONH-, -NHC0-, -NH-, -N(CH3HCH2)mN(CH3)-, -C(CH3)2-, -C(CF3)2-, -(CH2)m-, -0-(CH2)m-〇-, -S-(CH2)mS- (m represents an integer of 1 to 6 In the formula (VII), Z represents a single bond or does not exist, and in the formula (X), R19 and R2〇 each independently represent an alkyl group or a phenyl group having 1 to 3 carbon atoms, and A11 independently represents a sub-group. a sub-phenyl group substituted with a subgroup or a substituent group. i represents an integer of 1 to 6, and j represents an integer of 1 to 10, and is bonded to cyclohexane in the formula (IV) to formula (IX). The hydrogen on the ring or benzene ring is independent and can be substituted by -F, -CH3, -CF3, -0H, -C00H, -SOsH, -P〇3H2, and the ring on the ring in the formula (vi) The hydrogen may be substituted by a benzyl group. In the formula (N), V independently represents an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, acetamidine, gas, chlorine or bromine. , A2 independently represents an alkyl group having a carbon number of i to 3, and m represents an integer of 〇~3' η represents 0 to 4 In the formula (a), L1 represents hydrogen, an alkyl group of 1 to 4, a phenyl group or a benzyl group. ^ ❿ As the direct bond type diamine represented by the formula (III), for example, a diamine represented by the formula (III-1) to the formula (III-3) can be used. [化41]
H2hT ,NH2 (川-1) Η2Ν^^^ΝΗ2 (1ΙΙ-2) Η2Ν^—s^-NHj (HI-3) 作為以通式(IV)所表示的直鍵型二胺,例如可以列舉 51H2hT, NH2 (Chuan-1) Η2Ν^^^ΝΗ2 (1ΙΙ-2) Η2Ν^-s^-NHj (HI-3) As the direct bond type diamine represented by the formula (IV), for example, 51
d〇C 201030060 以結構式(IV-1)及結構式(I V-2)所表示的二胺 [化 42] H2N—NH2 (IV-2) h2n -〇 nh2 (IV-1)D〇C 201030060 Diamine represented by structural formula (IV-1) and structural formula (I V-2) H2N-NH2 (IV-2) h2n -〇 nh2 (IV-1)
作為以通式(V)所表示的直鏈型二胺,例如可以列舉以 結構式(V-1)〜結構式(V-3)所表示的二胺。 QThe linear diamine represented by the formula (V) may, for example, be a diamine represented by the structural formula (V-1) to the structural formula (V-3). Q
[化 43][化43]
作為以通式(VI)所表示的直鏈型二胺,例如可以列舉 以結構式(VI-1)〜結構式(VI-17)所表示的二胺。The linear diamine represented by the formula (VI) may, for example, be a diamine represented by the structural formula (VI-1) to the structural formula (VI-17).
52 .i.doc 201030060 [化 44]h2n_〇^' (VI-1) •nh252 .i.doc 201030060 [化 44]h2n_〇^' (VI-1) •nh2
HzN-〇rNH H2N—nh2 (VI-3)HzN-〇rNH H2N-nh2 (VI-3)
COOHCOOH
(VI-2) OH(VI-2) OH
HOOC (VI-9) -nh2 H2N v NH2 (VI-6)HOOC (VI-9) -nh2 H2N v NH2 (VI-6)
H2N-^)-NH2 (VI-7)H2N-^)-NH2 (VI-7)
Λ h2n-^:^vnh2 (VI-8)Λ h2n-^:^vnh2 (VI-8)
,cf3 H2N~^ ^~NH2 (VI-17) 參 作為以通式(VII)所表示的直鏈型二胺,例如可以列舉 以結構式(VII-1)〜結構式(VII-3 6)所表示的二胺。 53 .doc 201030060 [化 45], cf3 H2N~^ ^~NH2 (VI-17) The linear diamine represented by the formula (VII), for example, may be exemplified by the structural formula (VII-1) to the structural formula (VII-3 6). The diamine represented. 53 .doc 201030060 [Chem. 45]
%-nh2 H2N-~J^~m2 H2N—^ (VI1-1) (VII-2) 丨丫 NH2 H2N^j| (VII-3)%-nh2 H2N-~J^~m2 H2N—^ (VI1-1) (VII-2) 丨丫 NH2 H2N^j| (VII-3)
J-^2 H2N-^^〇N^j)-NH2J-^2 H2N-^^〇N^j)-NH2
(VI1-12) (VII-13) h^°XXNH2 (VI1-14)(VI1-12) (VII-13) h^°XXNH2 (VI1-14)
h2nm〇^0v^〇n0^nH2 H2N^Ok〇n^〇^Oknh2 (VI1-16) (VII-17) (VII-18) H2N-^^°\^n^〇^^-NH2 H2N-^^C (VII-19) (VII-20) h2N-^~^S~~v^~^—NH2 H2N-h^^K~S、s^~^)—nh2 (Vll-21) (VII-22) ❹ '〇、 nh2 54 201030060 ii.doc [化 46] H2N^0^S^Sx<Q^NH2 H2N-^0rS'^s^〇KNH2 (VII-23) (VI1-24) 、s ^〇^ΝΗζ HzN_hO^ ❹ h2n-0t-£ (VI1-25) (VI1-26) NH,H2nm〇^0v^〇n0^nH2 H2N^Ok〇n^〇^Oknh2 (VI1-16) (VII-17) (VII-18) H2N-^^°\^n^〇^^-NH2 H2N-^ ^C (VII-19) (VII-20) h2N-^~^S~~v^~^-NH2 H2N-h^^K~S, s^~^)-nh2 (Vll-21) (VII- 22) ❹ '〇, nh2 54 201030060 ii.doc [Chem. 46] H2N^0^S^Sx<Q^NH2 H2N-^0rS'^s^〇KNH2 (VII-23) (VI1-24), s ^ 〇^ΝΗζ HzN_hO^ ❹ h2n-0t-£ (VI1-25) (VI1-26) NH,
^~NH2 H2N-《》-N-《》-NH2 H2N—^》-N^V-N-《》—NH2^~NH2 H2N-""-N-"--NH2 H2N-^"-N^V-N-""-NH2
OH OHOH OH
(VI1-33) (VI1-34) I (VII-35)(VI1-33) (VI1-34) I (VII-35)
NH, 參 作為以通式(VIII)所表示的直鏈型二胺,例如可以列 舉以結構式(VIII-1)〜結構式(VIII-6)所表示的二胺。 55 201030060, ___ .r__.doc [化 47]NH, the linear diamine represented by the formula (VIII), for example, a diamine represented by the structural formula (VIII-1) to the structural formula (VIII-6). 55 201030060, ___ .r__.doc [Chem. 47]
(VIII-5) (VIII-6) ® 作為以通式(IX)所表示的直鏈型二胺,例如可以列舉 以結構式(IX-1)〜結構式(IX-16)所表示的二胺。(VIII-5) (VIII-6) ® As the linear diamine represented by the formula (IX), for example, two represented by the structural formula (IX-1) to the structural formula (IX-16) amine.
56 201030060 d x u.doc56 201030060 d x u.doc
nh2h2n- (IX-1) (Xi-2) H2n-Ok^^j^ch2)tO^HI)_nH2 HzN'H0/v^3^CH2)r0^0~NH2 (IX-3) (IX-4) h3c .ch3 (IX-5) (IX-6) _f3c、;f3 — — 9 — -S'Nh2h2n- (IX-1) (Xi-2) H2n-Ok^^j^ch2)tO^HI)_nH2 HzN'H0/v^3^CH2)r0^0~NH2 (IX-3) (IX-4 ) h3c .ch3 (IX-5) (IX-6) _f3c,;f3 — — 9 — -S'
/-NH2 (IX-8) NH2 H2N^r〇-Q-(cH2)rQ^〇-<Q^NH2 ❹ (IX*7)/-NH2 (IX-8) NH2 H2N^r〇-Q-(cH2)rQ^〇-<Q^NH2 ❹ (IX*7)
(IX-10)(IX-10)
-NHZ H2N-〇^°^Q^-(CH2)j^-〇-QkNH2 H2N-Q-°^Qh-(cH2^, 0Χ-Ί1) (1X-12) h3c ch3 η2ν^Ο^ (IX-13) J3C. >CF3 (IX-14) —^3G CF3^ 〇㈣令 h2N_q^k!令 (IX-15) (IX-16) 這些二胺中,作為更優選的直鏈型二胺,可以列舉以 戶斤述結構式(VI-1)、結構式(VI_2)、結構式(VI_15)〜結構式 (VI-17)、結構式(VII-1)〜結構式(VII-13)、結構式(VII-32)、 結媾式(VII-34)〜結構式(VII_36)以及結構式(ιχ_2)所表示 的>胺’作為進一步優選的直鏈型二胺’可以列舉以所述 结耩式(vi-i)、結構式(VI_15)、結構式(VI_16)、結構式(vw) 以及結構式(VII-7)所表示的二胺。 57-NHZ H2N-〇^°^Q^-(CH2)j^-〇-QkNH2 H2N-Q-°^Qh-(cH2^, 0Χ-Ί1) (1X-12) h3c ch3 η2ν^Ο^ (IX- 13) J3C. >CF3 (IX-14) - ^3G CF3^ 〇 (4) Let h2N_q^k! Order (IX-15) (IX-16) Among these diamines, as a more preferable linear diamine, The formula (VI-1), the structural formula (VI_2), the structural formula (VI_15) to the structural formula (VI-17), the structural formula (VII-1) to the structural formula (VII-13), The formula (VII-32), the crucible formula (VII-34) to the structural formula (VII_36), and the amine (represented by the structural formula (ι__2)) are further preferred as the linear amine diamine. The diamine represented by the formula (vi-i), the structural formula (VI-15), the structural formula (VI_16), the structural formula (vw), and the structural formula (VII-7). 57
201030060H 作為以所述通式(x)所表示的二胺,例如可以列舉以下 述結構式(X-1)〜結構式(X-7)所表示的二胺。這些二胺中, 特別優選使用以下述結構式(X-3)所表示的二胺。 [化 49] CH3 ch3 H2N-CH2-Si-〇-Si-CH2-NH2 CH3 ch3 (X-1) ch3 ch3 H2N-C3H6-Si-〇-Si—C3H6-NH2 ch3 ch3 ch3 ch3 l. !. H2N—C2H4—0 卜 〇-由一C2H4一ΝΗ2 ch3 ch3 (X-2) ch3 ch3 H2N-C4H8-Si-〇-Si-C4H8-NH2 CH3 ch3201030060H The diamine represented by the above formula (X) is, for example, a diamine represented by the following structural formula (X-1) to structural formula (X-7). Among these diamines, a diamine represented by the following structural formula (X-3) is particularly preferably used. CH3 ch3 H2N-CH2-Si-〇-Si-CH2-NH2 CH3 ch3 (X-1) ch3 ch3 H2N-C3H6-Si-〇-Si-C3H6-NH2 ch3 ch3 ch3 ch3 l. !. H2N —C2H4—0 〇—from C2H4—ΝΗ2 ch3 ch3 (X-2) ch3 ch3 H2N-C4H8-Si-〇-Si-C4H8-NH2 CH3 ch3
(X-3) CH3 CH3 CH3 H2N-C3H6-Si-〇-S卜〇-Si-C3H6-NH2 CH3 ch3 ch3 (X-4) C2H5 c2h5 H2N-C3He~Si~0-Si—C3H6—NH2 C2H5 c2h5 (X-5) O3H7 C3H7 (X-6) H2N-C3H6-Si-0-Si—C3H6-NH2 C3H7 C3H7 (X-7) 作為以所述通式(N)所表示的二胺,例如可以列舉以下 述結構式(N)-l、結構式(N)-2、結構式(Ν)·5〜結構式(N)-7、 結構式(N)-9、結構式(N)-10、結構式(N)-14、結構式(N)-17、 結構式(N)-18、結構式(N)-21〜結構式(N)-23、結構式 (N)-26、結構式(N)-28所表示的二胺。這些二胺中,特別 優選使用以下述結構式(N)-l、結構式(N)-2以及結構式 (N)-14所表示的二胺。 58 u.doc 201030060 Λ.(X-3) CH3 CH3 CH3 H2N-C3H6-Si-〇-S 〇-Si-C3H6-NH2 CH3 ch3 ch3 (X-4) C2H5 c2h5 H2N-C3He~Si~0-Si-C3H6-NH2 C2H5 c2h5 (X-5) O3H7 C3H7 (X-6) H2N-C3H6-Si-0-Si-C3H6-NH2 C3H7 C3H7 (X-7) As the diamine represented by the above formula (N), for example, The following structural formula (N)-1, structural formula (N)-2, structural formula (Ν)·5~ structural formula (N)-7, structural formula (N)-9, structural formula (N)-10, Structural formula (N)-14, structural formula (N)-17, structural formula (N)-18, structural formula (N)-21~structural formula (N)-23, structural formula (N)-26, structural formula The diamine represented by (N)-28. Among these diamines, a diamine represented by the following structural formula (N)-1, structural formula (N)-2, and structural formula (N)-14 is particularly preferably used. 58 u.doc 201030060 Λ.
[化 50][化 50]
(N)-1(N)-1
(N)-6(N)-6
(N)-10 (N)-14(N)-10 (N)-14
(N)-21 (N)-22(N)-21 (N)-22
(N)-23(N)-23
(N)-26(N)-26
(N)-28 作為以所述通式(a)所表示的二胺,例如可以列舉以下 述結構式(a-Ι)〜結構式(a-3)所表示的二胺。這些二胺中, 特別優選使用以下述結構式(a-Ι)所表示的二胺。 59 _i.doc 201030060 [化 51](N)-28 The diamine represented by the above formula (a) may, for example, be a diamine represented by the following structural formula (a-Ι) to structural formula (a-3). Among these diamines, a diamine represented by the following structural formula (a-Ι) is particularly preferably used. 59 _i.doc 201030060 [Chem. 51]
就獲得製成液晶顯示元件時的適當的配向性的觀點 而言,所述直鏈型二胺相對于構成本發_液晶配向射 的聚醯胺酸的二胺的莫耳比在〗ps中優選為5〇%〜1〇〇%, 更優選為80%〜100% ’在TN及STN中優選為1〇%〜 100°/。,更優選為30%〜97%。 另外,作為所述其他二胺,並無特別限定,例如可以 列舉以下述通式(丨,)〜通式(8,)所表示的二胺。 [化 52]From the viewpoint of obtaining an appropriate orientation when the liquid crystal display element is formed, the molar ratio of the linear diamine to the diamine constituting the poly-proline of the present invention is in 〖ps It is preferably from 5% to 1% by weight, more preferably from 80% to 100%. It is preferably from 1% to 100% in TN and STN. More preferably, it is 30% to 97%. In addition, the other diamine is not particularly limited, and examples thereof include diamines represented by the following formula (丨) to (8). [化52]
60 n.doc 201030060 / 獨立地表示碳數3〜30的絲1 通通式(4)、(6)以及(8,)中,R22表示碳數3〜30的燒基。 在構成本發明的液晶配向劑中的聚酿 1 在不損及本發明效果的程度的範_使用所= 對於所述二絲說,可以於各二胺中 (m〇n〇amine)相對於二胺的比率小於等於* =60 n.doc 201030060 / Wire 1 independently showing carbon number 3 to 30 In the general formulas (4), (6) and (8,), R22 represents a carbon group having a carbon number of 3 to 30. In the liquid crystal alignment agent constituting the present invention, the degree of the effect of the present invention is not detrimental to the extent of the effect of the present invention. For the second filament, it can be compared with each of the diamines (m〇n〇amine). The ratio of diamine is less than or equal to * =
内’將二胺的-部分替換成單胺。此 可 ^ 進-步進行。因此,通過此種替換, 應的 得的聚合(聚醯胺酸或其衍生物)的分子量,:如;以$ 及本發明的絲而改善液晶的塗布特性。 = 及本發明的效果’那麼替換成單胺的二胺可以是二種^ 可以是兩種或兩種以上。作為所述單胺,例如可 ^ ^ (aniline) (4-hydroxyaniline) (cyclohexylamine)、正丁胺(n_butylam 胺、正庚胺、正辛胺、正壬胺、正癸胺、正二= -胺、正十二胺、正十四胺、正十五胺、正十六胺、正 七胺、正十八胺以及正二十胺。 所述聚醢胺酸或其衍生物的單體中(_〇贿)也可以 進-步包含單異氣酸醋(monoisocyanate)化合物。通過 體中包含單異氰_旨化合物,峨得的聚醯贿或其衍生 物的末端被修飾,分子量得_節。通過使_末端修舞 型聚醢胺酸或其衍生物,例如可以不損及本發明的效果而The inner portion replaces the -diamine moiety with a monoamine. This can be done in step-by-step. Therefore, by such substitution, the molecular weight of the desired polymerization (polylysine or its derivative), such as; and the coating of the present invention, improves the coating properties of the liquid crystal. = and the effect of the present invention 'The diamines which are then substituted with a monoamine may be two kinds, and may be two or more kinds. As the monoamine, for example, aniline (4-hydroxyaniline) (cyclohexylamine), n-butylamine (n-butylamamine, n-heptylamine, n-octylamine, n-decylamine, n-nonylamine, n-di-amine, n-Dodecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptaamine, n-octadecylamine, and n-dodecylamine. Among the monomers of polylysine or its derivatives (_〇 Bribes can also include a monoisoocyanate compound. The mono-ocyanate compound is contained in the body, and the end of the polypyrene or its derivative is obtained, and the molecular weight is obtained. The _ terminal dance type polyaminic acid or a derivative thereof can be used, for example, without impairing the effects of the present invention.
201030060.J〇C 改善液晶配向劑的塗布特性。就所述的觀點而言,單體中 的單異氰酸醋化合物的含量優選相對於單體中的二胺及四 麵二肝的總量為i莫耳%〜10莫耳%。作為所述單異氰 酸酯化合物,例如可以列舉異氰酸笨酯(phenylis〇cyanate) 及異氰酸萘醋(naphthyl isocyanate卜 、于本發明中,在不損及本發明效果的範圍内,以所述 通式(III)〜通式(X)以及通式(N)所表示的二胺以外的其他 二胺也可以使用如下所示的具有側鍵結構的二胺(以下也 稱為側鏈型二胺)。作為此種具有側鏈結構的二胺,例如可 〇 以列舉以下述通式(XD、通式(xm)以及通式(χιν)所表示 的具有側鏈結構的二胺。具有侧鏈結構的二胺可以是一 種,也可以是兩種或兩種以上。 [化 53] R27 Λ (Χ0 h2nt^J-nh2 ❹ 通式(XI)中,A12 表示單鍵、_〇_、_c〇〇…〇c〇-、-CO-、 -C0NH_4-(CH2)m-(m表示1〜ό的整數),R27表示具有類 固醇骨架的基、以下述通式(XII)所表示的基,另外,當鍵 結於笨環上的兩個氨基的位置關係為對位時,R27進一步包 含碳數1〜30的烷基,當其位置關係為間位時,R27進一步 包含碳數1〜30的烷基或苯基。於該烷基中,任意的‘氏一 獨立且可以被-CFr、-CHF-、-〇-(但不連續)、_CH=CH-或 62 201030060u.doc ^«斤取代,_CH3可以被-CH#、-CHF2或-CF3所取代。 ,另外,該苯基的氫獨立,且可以被_F、_CH3、_0CH3、 -OCH2F、-〇CHF2 或-ocf3 所取代。201030060.J〇C Improves the coating properties of liquid crystal alignment agents. From the above viewpoints, the content of the monoisocyanate compound in the monomer is preferably i mole % to 10 mol% relative to the total amount of the diamine and the tetrahedral liver in the monomer. Examples of the monoisocyanate compound include phenylis〇cyanate and naphthyl isocyanate. In the present invention, in the range which does not impair the effects of the present invention, The diamine other than the diamine represented by the general formula (III) to the general formula (X) and the general formula (N) may be a diamine having a side bond structure as described below (hereinafter also referred to as a side chain type II). (Amine). As such a diamine having a side chain structure, for example, a diamine having a side chain structure represented by the following general formula (XD, general formula (xm), and general formula (χιν)) may be mentioned. The diamine of the chain structure may be one type or two or more types. [Chem. 53] R27 Λ (Χ0 h2nt^J-nh2 ❹ In the formula (XI), A12 represents a single bond, _〇_, _c 〇〇...〇c〇-, -CO-, -C0NH_4-(CH2)m- (m represents an integer of 1 to )), and R27 represents a group having a steroid skeleton, and a group represented by the following formula (XII), In addition, when the positional relationship of the two amino groups bonded to the stupid ring is para-position, R27 further contains an alkyl group having a carbon number of 1 to 30, when the positional relationship is between In the case of R27, R27 further contains an alkyl group having 1 to 30 carbon atoms or a phenyl group. In the alkyl group, any 'independent' can be -CFr, -CHF-, -〇- (but not continuous), _CH =CH- or 62 201030060u.doc ^«Just substituted, _CH3 can be substituted by -CH#, -CHF2 or -CF3. In addition, the hydrogen of the phenyl group is independent and can be _F, _CH3, _0CH3, -OCH2F , -〇CHF2 or -ocf3 is replaced.
通式(XII)中’ A13及A14分別獨立地表示單鍵、-0_(但 不連續)、-COO-、-0C0-、-CONH-、-CH=CH-或碳數 1 〜 12的烷烯基’ r3〇及r31分別獨立地表示-F或-CH3,環S 獨立地表示M-次苯基、M-環己烯、二惡烧-2,5-二基、 嘧啶-2,5-二基、吡啶-Μ-二基、萘_1,5-二基、萘-2,7-二基 或蒽-9,l〇-二基,R32表示-H、_F、碳數1〜30的烷基、碳 數1〜30的被氟取代的烷基、碳數1〜30的烷氧基、-C=N、 •OCH2F、_〇CHF2或_OCF3,a及b分別表示0〜4的整數, c、d及e分別表示0〜3的整數’ f及g分別獨立地表示0 〜2的整數,且c + d+eg卜另外,當c + d+e=l時,R4 表示碳數1〜30的烷基、碳數1〜30的被氟取代的烷基或 碳數1〜30的烧氧基。 63 201030060-In the general formula (XII), 'A13 and A14 each independently represent a single bond, -0_ (but not continuous), -COO-, -0C0-, -CONH-, -CH=CH- or an alkane having 1 to 12 carbon atoms. Alkenyl 'r3〇 and r31 each independently represent -F or -CH3, and ring S independently represents M-phenylene, M-cyclohexene, dioxo-2,5-diyl, pyrimidine-2,5 -diyl, pyridine-fluorene-diyl, naphthalene-1,5-diyl, naphthalene-2,7-diyl or fluoren-9,l-diyl, R32 represents -H, _F, carbon number 1~ An alkyl group of 30, an alkyl group substituted with fluorine having 1 to 30 carbon atoms, an alkoxy group having 1 to 30 carbon atoms, -C=N, •OCH2F, _〇CHF2 or _OCF3, a and b respectively represent 0~ An integer of 4, c, d, and e respectively represent integers 0 to 3 'f and g respectively represent integers of 0 to 2, respectively, and c + d + eg Bu. In addition, when c + d + e = 1, R4 An alkyl group having 1 to 30 carbon atoms, a fluorine-substituted alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms. 63 201030060-
(ΧΠΙ) (XIV) 通式(XIII)中,鍵結于形成類固醇骨架的碳上的氫獨 立且可以被_ch3所取代。通式(xm)及通式(χιν)中,R37 分別獨立地表示-H或-CH3 ’ R38表示-H或者碳數1〜20的 烧基或碳數2〜20的烯基。A15分別獨立地表示單鍵、_c〇_ 或-CHr·。通式(XIV)中’ R39&R4g分別獨立地表示丑、碳 數1〜20的烷基或苯基。 氨某Hr斤述通式(XI)所表示的侧鍵型二胺來說,兩個 :時與5:氨基的鍵二置_選= 乂所述通式(XI)所表示的二胺,例如可以列舉以 201〇3〇〇6〇“.加 下述通式(XI-l)〜通式(XI-9)所表示的二胺 ❹ [化 56](ΧΠΙ) (XIV) In the formula (XIII), hydrogen bonded to the carbon forming the steroid skeleton is independent and can be substituted by _ch3. In the formula (xm) and the formula (?), R37 each independently represents -H or -CH3'. R38 represents -H or a carbon group of 1 to 20 or an alkenyl group having 2 to 20 carbon atoms. A15 independently represents a single bond, _c〇_ or -CHr·. In the formula (XIV), 'R39&R4g each independently represents an ugly, alkyl group having 1 to 20 carbon atoms or a phenyl group. In the case of a side-chain type diamine represented by the formula (XI), two kinds of diamines represented by the formula (XI), For example, a diamine oxime represented by the following formula (XI-1) to formula (XI-9) can be cited as 201〇3〇〇6〇".
(XM) (XI-3) (XI-2) h2n 明 h2n(XM) (XI-3) (XI-2) h2n Ming h2n
(XI-9) 所述通式(XI-1)、通式(XI-2)、通式(XI-5)以及通式 (XI-6)中’ R41表示碳數1〜30的烷基或碳數1〜30的烷氧 ❹ 基,優選為碳數3〜30的烷基或碳數3〜30的烷氧基,更 優選為碳數5〜25的烷基或碳數5〜25的烷氧基。另外, 所述通式(XI-3)、通式(XI-4)以及通式(XI-7)〜通式(XI-9) 中’R42表示碳數1〜30的烷基或碳數1〜30的烷氧基,更 優選為碳數3〜25的烷基或碳數3〜25的烷氧基。 另外,作為以所述通式(XI)所表示的侧鏈型二胺,例 如可以列舉以下述通式(XI_10)〜通式(XH5)所表 胺。 '、的一 65 20103 0060.a〇c [化 57](XI-9) In the above formula (XI-1), formula (XI-2), formula (XI-5) and formula (XI-6), 'R41 represents an alkyl group having 1 to 30 carbon atoms. Or an alkoxy fluorenyl group having 1 to 30 carbon atoms, preferably an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms, more preferably an alkyl group having 5 to 25 carbon atoms or a carbon number of 5 to 25 Alkoxy group. Further, in the above formula (XI-3), formula (XI-4), and formula (XI-7) to formula (XI-9), 'R42 represents an alkyl group or a carbon number of 1 to 30 carbon atoms. The alkoxy group of 1 to 30 is more preferably an alkyl group having 3 to 25 carbon atoms or an alkoxy group having 3 to 25 carbon atoms. In addition, examples of the side chain type diamine represented by the above formula (XI) include the amines represented by the following formula (XI_10) to (XH5). ', one of 65 20103 0060.a〇c [57]
(XI-14) (XI-15) 所述通式(XI-10)〜通式(XI-13)中,R43表示碳數4〜 30的烷基,優選為碳數6〜25的烷基。所述通式(XI-14) 及通式(XI-15)中,R44表示碳數6〜30的烷基,優選為碳 數8〜25的烷基。 另外,作為以所述通式(XI)所表示的側鏈型二胺,例 如可以列舉以下述通式(XI-16)〜通式(XI-36)所表示的二 胺。(XI-14) (XI-15) In the above formula (XI-10) to formula (XI-13), R43 represents an alkyl group having 4 to 30 carbon atoms, preferably an alkyl group having 6 to 25 carbon atoms. . In the above formula (XI-14) and formula (XI-15), R44 represents an alkyl group having 6 to 30 carbon atoms, preferably an alkyl group having 8 to 25 carbon atoms. In addition, examples of the side chain type diamine represented by the above formula (XI) include diamines represented by the following formula (XI-16) to formula (XI-36).
66 201030060 i.doc [化 58]66 201030060 i.doc [Chem. 58]
h2n h2n^^ h2n H2N νι H2N /V| h«7\ H2N (XI-16) h2n h2n (XM7) h2n h2n (XI-18) h2n h2^ h2n ^0^r45 0^°^OR45 ^°^^-R46 h2n /V1 h2n ,V1 h2n ,VI OH, h2n h2n (XI-19) ❹ h2n h2nH2n h2n^^ h2n H2N νι H2N /V| h«7\ H2N (XI-16) h2n h2n (XM7) h2n h2n (XI-18) h2n h2^ h2n ^0^r45 0^°^OR45 ^°^^ -R46 h2n /V1 h2n , V1 h2n , VI OH, h2n h2n (XI-19) ❹ h2n h2n
(XI-20) h2n r°^>' o (XI-22)(XI-20) h2n r°^>' o (XI-22)
R45 h2n h2n (XI-23) (XI-21) -R45 r46R45 h2n h2n (XI-23) (XI-21) -R45 r46
h2n (XI-24) (XI-25) NH2n (XI-24) (XI-25) N
(XI-28) (XI-29) ❹ 67 201030060idoc [化 59](XI-28) (XI-29) ❹ 67 201030060idoc [Chem. 59]
所述通式(XI-16)、通式(XI-17)、通式(χι_2〇)、通式 (ΧΙ-22)、通式(ΧΙ-23)、通式(ΧΙ-26)、通式(χι_28)、通式 (ΧΙ-29)、通式(ΧΙ-34)以及通式(XI-35)中,R45表示碳數i 〜30的炫基或碳數1〜30的烧氧基,更優選為碳數3〜25 的烷基或碳數3〜25的烷氧基。 所述通式(XI-18)、通式(XI-19)、通式(XI-21)、通式 (XI-24)、通式(XI-25)、通式(XI-27)、通式(χι_30)〜通式 ❹ (XI-33)以及通式(XU6)中’ R46表示-H、-F、碳數1〜30 的烷基、破數1〜3〇的烷氧基、-ON、-〇CH2F、-〇CHF2 或-〇CF3,優選為碳數3〜25的烷基或碳數3〜25的烷氧 基。所述通式(XI-31)及通式(XI-32)中,A16表示碳數1〜20 的烷烯基。 另外’作為以所述通式(X〗)所表示的側鏈型二胺,例 如可以列舉以下述結構式(XI-37)〜結構式(ΧΙ·46)所表示 68 20103006(Ldoc 的二胺。The general formula (XI-16), the general formula (XI-17), the general formula (χι_2〇), the general formula (ΧΙ-22), the general formula (ΧΙ-23), the general formula (ΧΙ-26), In the formula (χι_28), the formula (ΧΙ-29), the formula (ΧΙ-34), and the formula (XI-35), R45 represents a thio group having a carbon number of i to 30 or an alkoxy group having a carbon number of from 1 to 30. More preferably, it is an alkyl group having 3 to 25 carbon atoms or an alkoxy group having 3 to 25 carbon atoms. The general formula (XI-18), the general formula (XI-19), the general formula (XI-21), the general formula (XI-24), the general formula (XI-25), the general formula (XI-27), In the formula (χι_30) to the formula XI (XI-33) and the formula (XU6), 'R46 represents -H, -F, an alkyl group having 1 to 30 carbon atoms, an alkoxy group having a number of 1 to 3 Å, -ON, -〇CH2F, -〇CHF2 or -〇CF3, preferably an alkyl group having 3 to 25 carbon atoms or an alkoxy group having 3 to 25 carbon atoms. In the above formula (XI-31) and formula (XI-32), A16 represents an alkenyl group having 1 to 20 carbon atoms. In addition, as the side chain type diamine represented by the above formula (X), for example, 68 20103006 (Ldoc diamine) represented by the following structural formula (XI-37) to structural formula (ΧΙ·46) can be used. .
[化 60][60]
69 201030060^ [化 61]69 201030060^ [Chem. 61]
h2nH2n
(XI-45)(XI-45)
以 優選為以通式 或通式ρα.4)絲_二胺Γ枝私⑽式_ 以所^通式(xm)所表示的侧鍵型二胺優選兩個 NH^Ph-A1 的一方鍵結於類固醇核的3位,另一方鍵 結於6位。另外’分別鍵結於兩個笨基上的兩個氨基優選 相對於A15的鍵結位置而鍵結於間位或對位。 作為以所述通式(ΧΙΠ)所表示的側鏈型二胺’例如可 以列舉以下述結構式(ΧΠΙ-1)〜結構式(ΧΙΙΙ-4)所表示的二 胺。 70 201030060iidoc [化 62]Preferably, the one-bonded diamine represented by the formula or the general formula ρα.4) is a one-bonded diamine represented by the formula (xm), preferably one of the two NH^Ph-A1 It is attached to the 3 position of the steroid core, and the other is bonded to the 6 position. Further, the two amino groups respectively bonded to the two stupid groups are preferably bonded to the meta or para position with respect to the bonding position of A15. The side chain type diamine represented by the above formula (ΧΙΠ) may, for example, be a diamine represented by the following structural formula (ΧΠΙ-1) to structural formula (ΧΙΙΙ-4). 70 201030060iidoc [Chem. 62]
κϋί 表示賴鏈型二胺的兩個 鲁 野於麟於苯基的碳上,但優選相 叫核所鍵結的苯基t的碳而鍵結於間位 ,分難結麵個苯基上㈣純基優軸對於A〗5 的鏠結位置而鍵結於間位或對位。 、 作為以所述通式(XIV)所表示的侧鏈型二胺,例如可 以列舉以下述結構式(XIV-1)〜結構式(XIV-8)所表示的_ 71Κϋί means that two of the lysine-type diamines are on the phenyl carbon, but it is preferred that the carbon of the phenyl t bonded by the nucleus is bonded to the meta position, and the phenyl group is difficult to bond. (4) The pure base axis is bonded to the meta or para position for the 鏠 junction position of A 〖5. Examples of the side chain type diamine represented by the above formula (XIV) include _71 represented by the following structural formula (XIV-1) to structural formula (XIV-8).
20103 0060JOC20103 0060JOC
[化 63][化63]
(XIV-1) ο(XIV-1) ο
(XlV-2) 0 NH2(XlV-2) 0 NH2
nh2Nh2
(XIV-5) 0(XIV-5) 0
nh2Nh2
(XIV-8) ^CS0-NH2 ❹ 就獲得製成液晶顯示元件時的適當的配向性的觀點 而言,所述二胺中以所述通式(XI)、通式(XIII)以及通式 (XIV)所表示的具有侧鏈結構的二胺相對于構成本發明的 72 201030060idoc 液曰曰向劑中的聚it胺酸的所有二胺的莫耳比在奶中優 選為0%〜50%,更優選為〇%〜篇,在tn及st 選為0%〜90%,更優選為3%〜7〇%。 、所述聚醯胺酸或其衍生物,除使用輯式(TC-1)〜通 式(TC 14)所表示的四羧酸二酐與其他四叛酸二酐以外,能 夠以與聚醯亞賴_形成巾所使㈣眾所周知的聚酿胺 酸或其衍生物同樣地進行製造。讀酸二酐的總添加量優(XIV-8) ^CS0-NH2 ❹ From the viewpoint of obtaining an appropriate alignment property in forming a liquid crystal display element, the above-mentioned diamine has the above formula (XI), formula (XIII) and formula The molar ratio of the diamine having a side chain structure represented by (XIV) to all the diamines constituting the polyalkenic acid in the 72 201030060idoc liquid turbidity agent of the present invention is preferably 0% to 50% in milk. More preferably, it is 〇%~, and it is selected from 0% to 90% in tn and st, and more preferably 3% to 7%. The poly-proline or a derivative thereof can be used in combination with the tetracarboxylic dianhydride represented by the formula (TC-1) to the formula (TC 14) and other tetrahydro acid dianhydrides. (A) The well-known polyacrylic acid or a derivative thereof is produced in the same manner. Excellent total addition of acid dianhydride
選與二胺的總莫耳數大致料莫耳(莫耳比為Q9〜n左 右)〇 所述聚醯胺酸或其衍生物的分子量以聚苯乙烯 (polystyrene)換算的重量平均分子量(Mw)計,優選為 10,000〜500,000,更優選為20,000〜200,〇〇〇。所述聚醯胺 酸或其衍生物的分子量可以通過利用凝膠滲透色譜(GelThe total number of moles selected from the diamine is approximately mol (the molar ratio is about Q9 to n), and the molecular weight of the polyamic acid or its derivative is a polystyrene-reduced weight average molecular weight (Mw Preferably, it is from 10,000 to 500,000, more preferably from 20,000 to 200, 〇〇〇. The molecular weight of the polyaminic acid or its derivative can be determined by using gel permeation chromatography (Gel)
Permeation Chromatography,GPC)法進行測定而求出。 所述聚醯胺酸或其衍生物可以通過如下方式來確認 其存在’即通過紅外光譜(Infrared Spectr0SC0py,IR)、核磁 共振(Nuclear Magnetic Resonance,NMR)對利用大量的不 良溶劑進行沉澱所獲得的固體成分進行分析。另外,可以 通過對用KOH或NaOH等強驗的水溶液對所述聚醯胺酸 或其衍生物的分解物的有機溶劑的萃取物進行氣相色譜 (Gas Chromatography,GC)、高效液相色譜(High Performance Liquid Chromatography,HPLC)或氣相色譜-質譜(Gas Chromatograph-Mass Spectrometer,GC-MS)分 析,來確認所使用的單體。 73 201030060.doc 本發明的液晶配向劑可以進一步含有所述聚醯胺酸 或其衍生物以外的其他成分。其他成分可以是一種,也可 以是兩種或兩種以上。 例如’就使液晶顯示元件的電性能長期穩定的觀點而 言’本發明的液晶配向劑可以進一步含有被烯基取代的納 迪克酿亞胺化合物。所述被烯基取代的納迪克醯亞胺化合 物可以是一種化合物,也可以是兩種或兩種以上的化合 物。就所述的觀點而言’所述被烯基取代的納迪克酿亞胺 化合物的含量以相對于液晶配向劑中的聚酿胺酸或其衍生 ⑩ 物的重量比計’優選為0.01〜1.00,更優選為0.01〜0.70, 進一步優選為0.01〜0.50。 所述被烯基取代的納迪克醯亞胺化合物優選可以在 溶解本發明中所使用的聚醯胺酸或其衍生物的溶劑中溶解 的化合物。此種被烯基取代的納迪克醯亞胺化合物的例子 可以列舉以下述通式(Ina)所表示的化合物。 [化 64] 修正通式。The Permeation Chromatography (GPC) method was measured and determined. The polyaminic acid or a derivative thereof can be confirmed by the following method: that is, by infrared spectroscopy (IR), nuclear magnetic resonance (NMR), and precipitation using a large amount of poor solvent. The solid components were analyzed. In addition, gas chromatography (GC), high performance liquid chromatography (Gas Chromatography, GC) can be performed on an extract of an organic solvent of a decomposition product of the polyaminic acid or a derivative thereof with a strong aqueous solution such as KOH or NaOH. High Performance Liquid Chromatography (HPLC) or Gas Chromatograph-Mass Spectrometer (GC-MS) analysis was performed to confirm the monomers used. 73 201030060.doc The liquid crystal alignment agent of the present invention may further contain other components than the polyamic acid or a derivative thereof. The other ingredients may be one type or two or more types. For example, the liquid crystal alignment agent of the present invention may further contain an alkenyl substituted imine compound substituted with an alkenyl group from the viewpoint of stabilizing the electrical properties of the liquid crystal display device for a long period of time. The alkenyl iodide compound substituted with an alkenyl group may be one compound or a combination of two or more compounds. From the viewpoint of the above, the content of the alkenyl substituted imine compound substituted by the alkenyl group is preferably 0.01 to 1.00 by weight based on the weight ratio of the poly-artisic acid or the derivative thereof in the liquid crystal alignment agent. More preferably, it is 0.01 to 0.70, and further preferably 0.01 to 0.50. The naphthylamine compound substituted with an alkenyl group is preferably a compound which can be dissolved in a solvent which dissolves the polyaminic acid or a derivative thereof used in the present invention. Examples of such an alkenylimine compound substituted with an alkenyl group include compounds represented by the following formula (Ina). [Chem. 64] Corrected the general formula.
的烷基、碳數 通式(Ina)中,L〗及L2分別獨立地表示氫、碳數丨〜^ 基、碳數3〜6的烯基、碳數5〜8的環烷基 74 201030060士 (cycloalkyl)、芳基(aryi)或苄基,n表示1或2。 當1時’ W表示碳數1〜12的烷基、碳數2〜6的 烯基、碳數5〜8的環烷基、碳數6〜12的芳基、节基、以 •ζ^ονβονζ3·!^1、Z2及Z3獨立地表示碳數二6的 烧稀基,q表示0或1,而且Γ表示1〜3〇的整數)所表示 的基、以-(Z4)S-B-Z5-H(Z4及Z5獨立地表示碳數i〜4的烷 稀基或碳數5〜8的壞烧稀基,B表示次苯基,而且s表示 〇或1)所表示的基、以表示次苯基,而且τ表 0 示-CH2_、-C(CH3)2-、-0-、-CO-、-S-或 S02-)所表示的基、 或者這些基的1個〜3個氳被羥基取代的基。 此時,優選的W是碳數1〜8的烧基、碳數3〜4的 烯基、環己基(cyclohexyl)、苯基、f基、碳數4〜1〇的聚 (乙稀氧基)乙基(poly(ethyleneoxy)ethyl)、笨氧基笨基 (phenyloxy phenyl)、苯基甲基苯基(phenyl methyi phenyl)、 苯基異亞丙基苯基(phenyl isopropylidene phenyl)、以及這 些基的1個或2個氫被羥基取代的基。 ❹ 當通式(Ina)中的n=2時,W表示碳數2〜20的统稀 基、碳數5〜8的環烷烯基、碳數6〜12的亞芳基(aryiene)、 以-zLcKzhvz^z1〜Z3以及r的含義如上所述)所表示 的基、以-Z4-B-Z -(Z、Z及B的含義如上所述)所表示的 基、以-B-(0-B)s-T_(B-0)s-B-(B表示次苯基,τ表示碳數1 〜3的烧婦基、-0-或-SCV ’ s表示〇或1)所表示的基、或 者這些基的1個〜3個氳被經基取代的基。 此時,優選的W是碳數2〜12的烷烯基、環己婦、 75 201030060.a〇c 次苯基、甲代次苯基(tolylene)、笨二甲基㈣加e)、以 〇3Η6-0-(Ζ2·〇)γ-〇·(:3Η6-(Ζ2 表示碳數 2〜6 的烧烯基、Γ 表 不1或2)所表示的基、以_Β·Τ-Β_(Β表示次苯基 、而且Τ 表示-CHr、_〇-或-S(V)所表示的基以 -b-o-b-C3H6_b-o-b_(b表示次笨基)所表示的基、以及這些 基的1個或2個氫被經基取代的基。 •此種被烯基取代的納迪克醯亞胺化合物例如可以使 用.如日本專利第2729565號公報中所記載那樣,通過將 被烯基取代的納迪克酸酐衍生物與二胺在8〇。(:〜22〇。(:的 ❹ 溫度下保持G.5小時〜2G小時進行合成而獲得的化合物、 或者市售的化合物。作為被稀基取代的納迪克酿亞胺化合 物的具體例,可以列舉以下所示的化合物。 N-甲基婦丙基雙環[2.2.lm_542,3_二緩基酿亞胺 (N-methyl-allylbicyclo[2.2j]hept-5-ene-2,3-dicarboxyimide) 、N-甲基烯丙基曱基雙環[2 2 ·_5|2,3-二叛基醯亞 胺、Ν_甲基·甲基烯丙基雙環[2 21]庚_5_烯'3_二羧基醯亞 胺、Ν_曱基-曱基稀丙基甲基雙環[2 2]]庚_5_烤_2,3_二絲 醯亞胺、Ν-(2-乙基己基)-缔丙基雙環[2 2庚·5_婦_2,3_二 ❹ 羧基醯亞胺、 ’一 Ν·(2-乙基己基)-烯丙基(甲基)雙環[2 21]庚_5_烯_2,3_ 二羧基醯亞胺、Ν-烯丙基-烯丙基雙環[2·2 η庚_5_烯义弘 一羧基醯亞胺、Ν-烯丙基-烯丙基甲基雙環[2 2…庚-^烯 -2,3-二羧基醯亞胺、Ν-烯丙基-曱基烯丙基雙環[2·2^庚。· 烯-2,3-二羧基醯亞胺、異丙烯基-烯丙基雙環Ρ·2·η庚_5_ 76 u.doc 201030060 烯—緩基醯亞胺、N-異丙稀基-烯丙基(甲基)雙環pH] 庚-5-烯-2,3-二羧基醯亞胺、N_異丙烯基_甲基烯丙基雙環 [2.2.1]庚-5-烯-2,3·二羧基醯亞胺' N_環己基_烯丙基雙環 [2.2^]庚-5-稀-2,3-二羧基醯亞胺、N_環己基_烯丙基(甲基) 雙%P.2.1]庚-5-烯-2,3-二羧基醯亞胺、N-環己基-曱基烯丙 基雙環[2.2.1]庚-5·稀_2,3-二羧基酸亞胺、ν·苯基-烯丙㈣ 環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺、 〇 m N-苯基-烯丙基(甲基)雙環ρ.2.1]庚-5-烯-2,3-二羧基 亞胺、N-节基·烤丙基雙環[2 21]庚_5_稀_2,3_ 雙肌曜领办二縣= N今基呷基稀丙基雙環[2 21]庚·5_烯 ST叫稀丙基雙環[2.2.1]庚卿 Μ胺(2_經基乙基)_烯丙基(甲基)雙環[Z2.1]庚_5-烯 ^)歸丙基雙觀2.lm_5.m絲亞胺、邮3丙 ^===甲基__]庚_5命2,3-二竣基 _(3_羥基-1-丙烯基)-烯丙基雙環Ρ·2·1]庚_5_烯 [如]庚·5-稀幾基酿亞胺、 峨環 队(4-經基苯基)_烯丙基雙環[221]庚_5_稀-2,3_二絲 77 jt.doc 201030060 酿亞胺、N~(4-羥基苯基)-稀丙基(甲基)雙環[2.2.1]庚_5-稀 _2,3_—幾基醜亞胺、N-(4-經基苯基)-甲基埽兩基雙環[2 2 1] 庚-5-烯-2,3-二羧基醯亞胺、N_(4_羥基苯基)_曱基烯丙基甲 基雙環[2.2.1]庚_5_烯-2,3-二叛基醯亞胺、N-(3-經基苯基)_ 烯丙基雙環[2.2.1]庚-5-烯·2,3-二羧基醯亞胺、N_(3_羥基苯 基)-烯丙基(甲基)雙環[2.2·_5鲁2,3_二縣醯亞ς、 Ν-(對經基节基)_稀丙基雙環p21]庚j稀_2,3_二縣酿亞 胺、則吵經基乙氧基)乙基}_稀聽雙環似项--2,3-二緩基醜亞胺、 η :故基乙氧基)乙基}_稀丙基(曱基)雙環(2.2.1] 庚-5鲁,3·二縣醯亞胺、N_{2_(2嚷基 ㈣丙庚傾·2,3•讀驗m 甲基稀丙基甲基雙雜2.1]庚二 4坡r备坡、庚烯-2,3-二叛基酿亞胺、队[2-{2-(2-H氧基}乙_丙基(曱基)雙環[2.2.1]庚^ 〇 、鄉(2·織乙氧基)乙竭乙 基異亞两基)笨基基雙二 .T N_{4-(4-經基笨基異亞丙基二 N- {4-(4-羥心Λ異:.2.1 ]庚-5·烯·2,3·二羧基醢亞胺、 NN,i亞胺、以及它們的寡聚物、 , 基·雙咖基雙卵·2.η庚·5·烯_2,3.二絲 78 201030060iidoc ^)(N,N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicar boxyimide))、N,N’-次乙基-雙(稀丙基曱基雙環[2 2 ^庚·5_ 烯-2,3-一幾·基醯亞胺)、N,N’-次乙基-雙(甲基稀丙基雙環 [2.2.1] 庚-5-烯-2,3-二叛基醯亞胺)、ν,Ν’-王亞曱基-雙(稀丙 基雙環[2.2.1]庚-5-烯-2,3-二缓基醯亞胺)、ν,ν'-六亞甲基_ 雙(稀丙基雙環[2.2.1]庚-5-婦-2,3·二羧基醯亞胺)、ν,ν,α 亞甲基-雙(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二緩基酿亞 © 胺)、Ν,Ν·-十二亞甲基-雙(稀丙基雙環[2.2.lm_5_烯_1,3_二 幾基酿亞胺)、N,N’-十一亞甲基-雙(稀丙基曱基雙環[22 1] 庚-5-烯-2,3-二羧基酿亞胺)、N,N’-環己烯_雙(烯丙基雙環 [2.2.1] 庚-5-稀-2,3-—叛基酿亞胺)、N,N’·環己稀-雙(稀丙基 曱基雙環[2.2.1]庚·5·烯二羧基醯亞胺)、 1,2-雙{3’·烤丙基雙環[2.2.1]庚-5-烯·2,3_二羧基醯亞 胺) 丙氧基 } 乙烷 (l,2-bis{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimid φ e)propoxy } ethane)、 1,2_雙{3'_稀丙基曱基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧基}乙烷、1,2-雙{3,··曱基稀丙基 雙被[2.2.1]庚-5-稀-2,3-二叛基酿亞胺)丙氧基}乙院、雙 [2'·{3'_烯丙基雙環P.2.1]庚-5-烯-2,3-二羥基醯亞胺)丙氧 基 } 乙 基 ] 醚 (bis[2'-{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide )propoxy}ethyl]ether)、雙[2'-{3'_烯丙基甲基雙環[2.2.1]庚 -5-烯-2,3-二羧基醯亞胺)丙氧基}乙基]醚、1,4-雙{3'-稀丙基 79 201030060 _____Γ—·α<χ; 雙環[2.2.1]庚-5-烯-2,3-二叛基酿亞胺)丙氧基} 丁院 (1,4-bis{3 -(allylbicyclo[2.2.1 ]hept-5-ene-2,3-dicarboxyimid e)propoxy}butane)、1,4-雙{3'-烯丙基甲基雙環[2.2.1]庚-5- 烯-2,3-二羧基醯亞胺)丙氧基} 丁烷、 N,N’-對次苯基-雙(烯丙基雙環p.2.1]庚_5_烯_2,3-二羧 基酿亞 胺 XNW-p-phenylene-bisQllylbicyclol^ll^ept-S-eneJj-dicarboxyimide;)) 、 Ν,Ν’-對次苯 基-雙(烯 丙基甲 基雙環 [2.2.1] 庚-5-烯-2,3-二羧基醯亞胺)、Ν,Ν’-間次苯基-雙(烯丙基雙環 ® [2.2.1] 庚 -5- 烯 -2,3- 二羧基醢亞 胺)(N,N’_m-phenylene_bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide))、N,N'-間次苯基-雙(稀丙基甲基雙環[2.2.1] 庚-5_烯-2,3-二羧基醯亞胺)、风1^-{(1-甲基)-2,4-次苯基}-雙(烯丙基雙環P.2.1]庚-5-烯-2,3-二羧基醯亞 胺)(N,N'-{(l-methyl)-2,4-phenylene}-_bis(allylbicyclo[2.2.1] hept-5-ene-2,3-dicarboxyimide))、N,N’-對二曱苯基-雙(烯丙 基雙環[2.2.1]庚-5-烯-2,3-二羧基醢亞 ❹ 胺 XN’N'-p-xylylene-bisfallylbicycloP.〗. l]hept,5-ene-2,3-di carboxyimide))、N,N·-對二曱苯基-雙(烯丙基甲基雙環[2·2.1] 庚_5-烯-2,3-二羧基醯亞胺)、Ν,Ν'-間苯二曱基-雙(烯丙基雙 環 [2.2.1] 庚 -5- 烯 -2,3- 二羧基醯亞 胺)(N,N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-di carboxyimide))、N,NL間苯二曱基-雙(烯丙基曱基雙環[2.2.1] 庚-5-烯-2,3-二羧基醯亞胺)、 80 201030060idoc 2,2_雙[4·{4·(婦丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯 亞胺)苯氧基}苯基]丙院 (2,2-bis(4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyim ide)phenoxy}phenyl]propane)、2,2·雙[4-{4-(烯丙基甲基雙 環[2.2.1]庚烯·2,3-二羧基醯亞胺)笨氧基}苯基]丙烷、 2,2-雙[4-{4-(曱基稀丙基雙環[2.2.1]庚-5-烯-2,3-二叛基醢 亞胺)苯氧基}苯基]丙烧、雙{4-(稀丙基雙環[2.2.1]庚-5-烯 _2,3_二叛基醯亞胺)笨基}曱烧 © (bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)ph enyl}methane)、雙{4-(烯丙基曱基雙環[2.2.1]庚·5_稀_2,3_ 二羧基醯亞胺)苯基}甲烷、 雙{4-(曱基稀丙基雙環[2.2.1]庚-5-稀-2,3-二缓基醯亞 胺)苯基}甲烷、雙{4-(曱基烯丙基甲基雙環[2.2.1]庚_5-烯 •2,3-二叛基酿亞胺)苯基}曱烧、雙{4-(烯丙基雙環[2.2.1]庚 -5-烯-2,3-二羧基醯亞胺)苯基}醚 (bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)ph ❹ enyl}ether)、雙{4_(烯丙基曱基雙環[2.2.1]庚-5-稀-2,3-二叛 基醯亞胺)苯基}醚、雙{4-(甲基烯丙基雙環[2.2,1]庚烯 2,3_二羧基醯亞胺)苯基}喊、雙{4_(稀丙基雙環[221]庚·5_ 烯-2,3-二羧基醯亞胺)苯基}碌 (bis{4-(allylbicycl〇t2.2.1]hept-5-ene-2,3-dicarboxyimide)ph enyl}sulfone)、雙{4-(烯丙基甲基雙環[m]庚_5_婦_2,3_二 羧基醯亞胺)苯基}碾、 雙{4-(曱基烯丙基雙環[2.2.1]庚-5-稀-2,3-二繞基酿亞 81 201030060 Joc 胺)苯基}颯、1,6·雙(烯丙基雙環[2.2.1]庚_5_稀_2,3_二叛基 酿亞胺 )-3- 經基 -己炫 (l,6-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)-3 -hydroxy-hexane)、1,12-雙(甲基烯丙基雙環[2 2 ^庚:烯 2,3·二叛基酿亞胺)-3,6-二經基-十二燒、1,3_雙(婦丙基雙 環[2.2.1]庚-5-稀-2,3-二羧基酿亞胺)_5-經基_環己燒、1,5· 雙{3’-烯丙基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)丙氧 基}-3-羥基-戊烷、1,4-雙(烯丙基雙環[2.2.1]庚_5_烯_2,3·二 羧基醯亞胺)-2-羥基_苯、 ’ M-雙(烯丙基甲基雙環P.2.1]庚-5-烯_2,3-二竣基醯亞 胺)-2,5-二羥基-苯、N,N’-對(2-羥基)苯二曱基_雙(烯丙基雙 環[2.2.1]庚-5-烯_2,3-二羧基醯亞 ^ )C^,N p-(2~hydroxy)xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide))、N,N’-對(2-羥基)苯二曱基-雙 (烯丙基甲基環[2.2.1]庚-5-烯-2,3-二緩基醯亞胺)、n,N'-間 (2-羥基)苯二曱基·雙(烯丙基雙環ρ.2 η庚_5_烯'孓二羧 基醯亞胺)、Ν,Ν,-間(2·羥基)笨二甲基_雙(曱基烯丙基雙環 [2.2.1] 庚-5-烯-2,3-二羧基醯亞胺)、]^,:^,_對(2,3_二羥基)苯 一甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3_二護基醯亞胺)、 2,2-雙[4-{4-(烯丙基雙環[2 21]庚_5_烯_2,3_二羧基醯 亞胺)-2-羥基-苯氧基}苯基]丙烷、雙{4_(烯丙基甲基雙環 [2.2.1] 庚-5-烯-2,3-二羧基醯亞胺)_2_羥基_苯基丨曱烷、雙 {3-(烯丙基雙環[2.2.1]庚-5-烯·2,3_二叛基酿亞胺)斗經基_ 苯基}醚、雙{Η甲基烯丙基雙環[2.2 η庚d鲁2,3_二竣基 82 201030060^ 醯亞胺)-5-羥基-苯基}颯、三{4-(烯丙基甲基雙環 [2.2.1]庚-5-烯-2,3-二欸基醯亞胺)}苯氧基甲基丙烧、 N,N',N”s(次乙基甲基烯丙基雙環[2.2.1]庚_5_烯-2,3-二叛 基醯亞胺)異氰尿酸酯、以及它們的寡聚物等。 另外,本發明中所使用的被烯基取代的納迪克醯亞胺 化合物也可以是非對稱的含有烷烯基、次苯基的以下述結 構式所表示的化合物。 ❹ [化65]In the alkyl group and the carbon number formula (Ina), L and L2 each independently represent hydrogen, carbon number ^~^ group, carbon number 3 to 6 alkenyl group, and carbon number 5 to 8 cycloalkyl group 74 201030060 Cycloalkyl, aryi or benzyl, n represents 1 or 2. When 1 o', W represents an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, an aryl group having 6 to 12 carbon atoms, a sulfhydryl group, and a ruthenium group. Ννβονζ3·!^1, Z2 and Z3 independently represent a carbon number of 6 sinter, q represents 0 or 1, and Γ represents an integer represented by 1 to 3 )), and -(Z4)SB-Z5 -H (Z4 and Z5 independently represent an alkylene group having a carbon number of i to 4 or a badly burned base having a carbon number of 5 to 8, B represents a subphenyl group, and s represents a group represented by hydrazine or 1), and is represented by a phenyl group, and τ represents a group represented by -CH2_, -C(CH3)2-, -0-, -CO-, -S- or S02-), or one to three of these groups. A group substituted by a hydroxyl group. In this case, preferred W is a carbon group having 1 to 8 carbon atoms, an alkenyl group having 3 to 4 carbon atoms, a cyclohexyl group, a phenyl group, a group having an alkyl group, and a poly(ethyleneoxy group) having a carbon number of 4 to 1 Å. Ethyl (poly(ethyleneoxy)ethyl), phenyloxy phenyl, phenyl methyi phenyl, phenyl isopropylidene phenyl, and these groups One or two hydrogen-substituted groups. n When n=2 in the general formula (Ina), W represents a basic group having 2 to 20 carbon atoms, a cycloalkenyl group having 5 to 8 carbon atoms, and an arylene group having 6 to 12 carbon atoms. a group represented by -zLcKzhvz^z1 to Z3 and r as described above), a group represented by -Z4-BZ - (the meanings of Z, Z, and B are as described above), and -B-(0- B) s-T_(B-0)sB-(B represents a subphenyl group, τ represents a base of carbon number 1 to 3, -0- or -SCV 's represents a group represented by hydrazine or 1), or One to three quinones of these groups are substituted by a radical. In this case, preferred W is an alkenyl group having 2 to 12 carbon atoms, cyclohexanyl, 75 201030060.a〇c phenyl, tolylene, stupid dimethyl (tetra) plus e), 〇3Η6-0-(Ζ2·〇)γ-〇·(:3Η6-(Ζ2 represents an alkyl group having 2 to 6 carbon atoms, Γ is not 1 or 2), and _Β·Τ-Β_ (Β represents a subphenyl group, and Τ represents a group represented by -CHr, _〇- or -S(V), and a group represented by -bob-C3H6_b-o-b_(b represents a substitutable group), and these groups One or two hydrogen-substituted groups are substituted by a group. • Such a nadic-ylidene compound substituted with an alkenyl group can be used, for example, as described in Japanese Patent No. 2729565, by being substituted by an alkenyl group. The nadic anhydride derivative and the diamine are obtained by synthesizing a compound obtained by synthesizing G. 5 hours to 2 Gh at a temperature of ❹ at a temperature of 8 〜. Specific examples of the substituted Nadick-bromide compound include the compounds shown below. N-methylpropylpropyl bicyclo [2.2.lm_542, 3_di-supplemental enamine (N-methyl-allylbicyclo[2.2j] ]hept-5-ene-2,3-dicarbox Yimide), N-methylallylhydrazinobicyclo[2 2 ·_5|2,3-di-restrobinium imine, Ν-methyl·methallylbicyclo[2 21]hept-5-ene '3_Dicarboxy quinone imine, Ν_曱-yl-hydrazinylpropylbicyclo[2 2]]heptane-5_ roasted_2,3_di-filariaimine, Ν-(2-ethyl Hexyl)-propylidene bicyclo[2 2 hept·5_wo-2,3_diindole carboxy quinone imine, 'mono-(2-ethylhexyl)-allyl (methyl)bicyclo[2 21 Geng_5_ene_2,3_dicarboxy quinone imine, Ν-allyl-allyl bicyclo[2·2 ηhept_5_enyihong carboxy quinone imine, Ν-allyl-ene Propylmethylbicyclo[2 2...heptyl- 2,3-dicarboxyindenine, fluorenyl-allyl-mercaptopropylbicyclo[2·2^hept.·ene-2,3- Dicarboxy quinone imine, isopropenyl-allyl bicyclo quinone·2· η g _5_ 76 u.doc 201030060 olefin-sodium sulfoximine, N-isopropyl-allyl (methyl) bicyclic ring pH]hept-5-ene-2,3-dicarboxyarminemine, N_isopropenyl-methylallylbicyclo[2.2.1]hept-5-ene-2,3·dicarboxyarmine 'N_Cyclohexyl-allylbicyclo[2.2^]hept-5-rare-2,3-dicarboxyindolimine, N_cyclohexyl-allyl (methyl) double %P.2.1]g- 5-ene-2,3 -Dicarboxy quinone imine, N-cyclohexyl-mercaptopropyl bicyclo [2.2.1] hept-5 · dilute 2,3-dicarboxy acid imide, ν·phenyl-allyl (tetra) ring [2.2 .1]hept-5-ene-2,3-dicarboxy quinone imine, 〇m N-phenyl-allyl (methyl)bicyclo ρ.2.1]hept-5-ene-2,3-dicarboxyl Imine, N-nodal, propyl propyl bicyclo [2 21] g _5 _ _2, 3 _ double tendon lead two counts = N 呷 呷 稀 稀 dipropyl bicyclo [2 21] G · 5_ Alkene ST is called dipropyl bicyclo [2.2.1] gemylamine (2_ylidylethyl)-allyl (methyl)bicyclo[Z2.1]hept-5-ene^) 2.lm_5.m silk imine, post 3 propyl ^===methyl __] g _ 5 life 2,3-dimercapto _ (3 hydroxy-1-propenyl)-allyl bicyclo fluorene 2·1]g _5_ene [such as] G. 5 - Rare aryl iranine, anthracycline (4-phenylphenyl) _allyl bicyclo [221] G _ 5 _ -2, 3_二丝77 jt.doc 201030060 Imine imine, N~(4-hydroxyphenyl)-dilyl (methyl)bicyclo[2.2.1]g _5-diluted _2,3_- Amine, N-(4-p-phenylphenyl)-methylindolediylbicyclo[2 2 1]hept-5-ene-2,3-dicarboxyindenine, N_(4-hydroxyphenyl)_曱Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-di-resinimide, N-(3-carbyl) ()) allyl bicyclo [2.2.1] hept-5-ene · 2,3-dicarboxy quinone imine, N_(3-hydroxyphenyl)-allyl (methyl) bicyclo [2.2·_5 Lu 2,3_二县醯亚ς, Ν-(to the base group) _ propyl propyl p21] g y _2, 3 _ _ _ _ _ _ _ _ _ _ _ _ }_稀稀双环似---2,3-二缓基丑胺胺, η:故基ethoxy)ethyl}_propyl (indenyl)bicyclo (2.2.1) g-5-ru 3· 二县醯iimine, N_{2_(2嚷基(四)丙庚倾·2,3•Reading m Methyl propylmethyl double dimer 2.1] Geng 2 4 slope r preparatory slope, heptene-2 , 3-di-rebelletic imine, team [2-{2-(2-Hoxy}ethyl-propyl(indenyl)bicyclo[2.2.1]heptyl], township (2·woven ethoxylate) Ethyl diethylidene diyl) stupyl bis. T N_{4-(4-pyridyl isopropylidene di N- {4-(4-hydroxyxin: 2. -5· olefin·2,3·dicarboxy quinone imine, NN,i imine, and their oligomers, bis-di-gly-bis-bis. 2.η-g- 5·ene-2,3.二丝78 201030060iidoc ^)(N,N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicar boxyimide)), N,N'-ethylidene-bis(phosphorus Bismuthyl double ring [2 2 ^g·5_ ene-2,3- a few醯imino), N,N'-ethylidene-bis(methyldipylbicyclo[2.2.1]hept-5-ene-2,3-di-redecylimine), ν,Ν'- Wang 曱 --bis (dilyl bis-bicyclo[2.2.1]hept-5-ene-2,3-disulfhydrylimine), ν, ν'-hexamethylene _ bis (dilyl propyl bicyclic [2.2 .1]hept-5-female-2,3·dicarboxyindolimine), ν,ν,α methylene-bis(allylhydrazinobicyclo[2.2.1]hept-5-ene-2, 3-di-supplemental-based amines, anthracene, oxime--dodecyl-bis(dipropylbicyclo[2.2.lm_5_ene_1,3-diaminofuranimine), N,N '-Eleven methylene-bis(l-propyldecylbicyclo[22 1]hept-5-ene-2,3-dicarboxyanimine), N,N'-cyclohexene_bis(allyl Bicyclo[2.2.1] hept-5-rare-2,3--rebornyl imine), N,N'·cyclohexene-bis(l-propyl decylbicyclo[2.2.1]g·5 · enedicarboxyimine), 1,2-bis{3'·bromopropylbicyclo[2.2.1]hept-5-ene·2,3-dicarboxyarenimine) propoxy}ethane l,2-bis{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimid φ e)propoxy } ethane), 1,2_double {3'-dilyl fluorenyl double ring [2.2.1]hept-5-ene-2,3-dicarboxy quinone imine) propoxy } ethane, 1,2-double {3,···yl propyl propyl bis-[2.2.1]hept-5-lean-2,3-di-rebasic imine) propoxy} Bis[2'·{3'-allylbicyclic P.2.1]hept-5-ene-2,3-dihydroxyinlimine)propoxy}ethyl]ether (bis[2'-{3' -(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide )propoxy}ethyl]ether), bis[2'-{3'-allylmethylbicyclo[2.2.1]hept-5 -ene-2,3-dicarboxy quinone imine) propoxy}ethyl]ether, 1,4-double {3'-dilylpropyl 79 201030060 _____Γ—·α<χ; bicyclo[2.2.1]g -5-ene-2,3-di-reactive iodide)propoxy} butyl (1,4-bis{3 -(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimid e )propoxy}butane), 1,4-bis{3'-allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindolimine)propoxy}butane, N , N'-p-phenylene-bis(allylbicyclop.2.1)hept-5-ene-2,3-dicarboxyanimine XNW-p-phenylene-bisQllylbicyclol^ll^ept-S-eneJj- Dicarboxyimide;)), Ν, Ν'-p-phenyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyarmine), Ν,Ν'- Meta-phenyl-bis(allylbicyclo® [2.2.1] H,5-ene-2,3-dicarboxyimine) (N,N'_m-phenylene_bis (allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)), N,N'- Meta-phenyl-bis(distypropylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), wind 1^-{(1-methyl)-2,4 -N-phenyl}-bis(allylbicyclo P.2.1]hept-5-ene-2,3-dicarboxyindolimine)(N,N'-{(l-methyl)-2,4-phenylene }-_bis(allylbicyclo[2.2.1] hept-5-ene-2,3-dicarboxyimide), N,N'-p-diphenylene-bis(allylbicyclo[2.2.1]hept-5- Alkenyl-2,3-dicarboxyindenylamine XN'N'-p-xylylene-bisfallylbicycloP.〗 l]hept,5-ene-2,3-di carboxyimide)), N,N·-pair Phenyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), hydrazine, Ν'-m-phenylenedifluoryl-bis(allylbicyclo) [2.2.1] H-5-ene-2,3-dicarboxy quinone imine) (N,N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-di Carboximide)), N, NL meta-benzoic acid-bis(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), 80 201030060idoc 2,2_double [4·{4·(propylpropyl bicyclo[2.2.1]hept-5-ene-2,3-di 2,2-bis(4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyim ide)phenoxy}phenyl] Propane), 2,2·bis[4-{4-(allylmethylbicyclo[2.2.1]heptene·2,3-dicarboxyindolimide) phenyloxy}phenyl]propane, 2, 2-Bis[4-{4-(decyl-dipylbicyclo[2.2.1]hept-5-ene-2,3-dioxalimine)phenoxy}phenyl]propane, double { 4-(Dilyl-propylbicyclo[2.2.1]hept-5-ene-2,3-bis-destrobin iodide) stupid base}曱(©(bisl4-(allylbicyclo[2.2.1]hept-5) -ene-2,3-dicarboxyimide)ph enyl}methane), bis{4-(allylhydrazinobicyclo[2.2.1]hept-5-diluted_2,3-dicarboxyarmineimine)phenyl}methane , double {4-(mercaptopropylidene bicyclo[2.2.1]hept-5-lean-2,3-disulfhydrylimine)phenyl}methane, double {4-(mercaptopropylallyl) Bicyclo[2.2.1]hept-5-ene•2,3-di-rebasic imine)phenyl}zepine, bis{4-(allylbicyclo[2.2.1]hept-5-ene- 2,3-dicarboxy quinone imine) bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)ph ❹ enyl}ether), double {4_(ene Propyl fluorenylbicyclo[2.2.1]hept-5-thin-2,3-di-resinimide)phenyl}ether Double {4-(methylallylbicyclo[2.2,1]heptene 2,3-dicarboxyindolimine)phenyl} shouting, double {4_(dilylpropylcyclo[221]hept-5-ene-2 , 3-dicarboxy quinoid imine) bis{4-(allylbicycl〇t2.2.1]hept-5-ene-2,3-dicarboxyimide)ph enyl}sulfone), double {4-(allyl Methylbicyclo[m]hepta-5-indenyl-2,3-dicarboxyarsenazo)phenyl}milled, double {4-(mercaptopropylbicyclo[2.2.1]hept-5-thin- 2,3-two-wound base Ya 81 201030060 Joc amine) phenyl} 飒, 1,6 bis (allyl bicyclo [2.2.1] g _5 _ _2, 3 _ bis ribitol )-3-,6-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide)-3-hydroxy-hexane), 1,12-bis(methyl) Allyl bicyclo [2 2 ^heptene:ene 2,3·di-rebasic imine)-3,6-di-perylene-dodecyl, 1,3_bis (propylpropyl bicyclo [2.2.1] Hg-5-rare-2,3-dicarboxy-bromoimine)_5-radio-cyclohexene, 1,5·bis{3'-allylbicyclo[2.2.1]hept-5-ene-2 ,3-dicarboxyindolimine)propoxy}-3-hydroxy-pentane, 1,4-bis(allylbicyclo[2.2.1]hept-5-ene-2,3.dicarboxyfluorene Amine)-2-hydroxy-benzene, 'M-bis(allylmethylbicyclic P.2.1)hept-5-ene_2,3- Dimercaptopurine)-2,5-dihydroxy-benzene, N,N'-p-(2-hydroxy)benzodiazepine_bis(allylbicyclo[2.2.1]hept-5-ene_ 2,3-Dicarboxy 醯 ^ ^ ) C ^, N p-(2~hydroxy) xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyimide), N,N'- (2-hydroxy)benzodiazepine-bis(allylmethylcyclo[2.2.1]hept-5-ene-2,3-disulfhydrylimine), n,N'-inter (2 -hydroxy)phenylenedonyl·bis(allylbicyclo ρ.2 ηhept-5-ene'孓dicarboxy quinazomine), hydrazine, hydrazine, -m-(2.hydroxyl)-p-dimethyl- _ Mercaptopropyl bicyclo [2.2.1] hept-5-ene-2,3-dicarboxy quinone imine), ]^, :^, _ p-(2,3-dihydroxy)benzene-methyl-double (allylbicyclo[2.2.1]hept-5-ene-2,3-di-protective imine), 2,2-bis[4-{4-(allylbicyclo[2 21]hept_ 5-ene-2-,3-dicarboxyarsenine)-2-hydroxy-phenoxy}phenyl]propane, bis{4_(allylmethylbicyclo[2.2.1]hept-5-ene-2 , 3-dicarboxy quinoid imine) 2 -hydroxy-phenyl decane, bis {3-(allylbicyclo[2.2.1]hept-5-ene·2,3_di-rebasic imine) Bucket base _ phenyl} ether, double {Η methallyl double ring [2.2 η g du d 2,3_ dimercapto 82 201 030060^ 醯imino)-5-hydroxy-phenyl}indole, tris{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diindenylimine)} Phenoxymethylpropane, N,N',N"s (hypoethyl methallylbicyclo[2.2.1]hept-5-ene-2,3-dioxalimine) isocyanide Uric acid esters, and oligomers thereof and the like. Further, the alkenylimine compound substituted with an alkenyl group used in the present invention may be an asymmetric compound containing an alkenyl group or a phenylene group represented by the following structural formula. ❹ [Chem. 65]
83 •doc 201030060 中優ΐΧΓίΓ述被稀基取代的納迪克醯亞胺化合物之 N,N’-次乙基雙(稀丙基雙 醢亞胺)、料乙基,⑽丙基上 3:叛5基嫌酿2亞广職,-次乙基,甲基稀丙基雙環 ❹ 雙(稀丙基雙環叫庚^瘦^亞致胺)、N,N,_六亞曱基_ 亞甲基-雙(稀丙基甲基雙二:絲酿亞胺)、N,N,·六 ^其n,n,-十二亞甲基_雙(婦 羧基醯亞胺)、N,N,-十二亞甲其.1]庚_5务2,3-二 庚娜2,3·二縣酿甲^^丙^基雙卵圳 ^2·2.1,2,3-二羧基 ^ ,對次本基-雙(婦丙d 9 n g < 基醯亞胺),對次苯 1^=·^似3-二羧 ❹ [2.2·υ庚-5养2,3_二縣酿悉雙(席两基雙環 ㈣雙彻..5==:_基_雙(稀丙 雙(烯丙 :亞胺)、Ν,π對二子苯基,(烯丙 =j 亞胺)、取,·對二甲笨基 丙A雙产l^-2,3-二幾基酿亞胺)、N,N,-間苯4美土譬J 基雙雖2.购·㈣·:絲醯蝴 84 201030060iidoc 基-雙(稀丙基曱基雙環P.2.1]庚-5-烯-2,3-二羧基醯亞胺)、 2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二綾基醯亞胺) 本氧基}本基]丙烧、2,2-雙[4-{4-(烤丙基曱基雙環[22 1]庚 •5-烯-2,3-二羧基醯亞胺)苯氧基}笨基]丙烷、2,2_雙 [4-{4-(甲基烯丙基雙環ρ·2.1]庚-5-烯-2,3-二羧基醯亞胺) 苯氧基}苯基]丙烷、雙{4_(烯丙基雙環[2.2.1]庚_5_稀_23_ 二羧基醯亞胺)苯基}曱烷、雙{4-(烯丙基甲基雙環[22 q 庚-5·稀-2,3-二羧基醯亞胺)苯基}甲烷、 ·. ® 雙{4·(甲基烯丙基雙環P.2.1]庚-5-烯-2,3-二羧基醯亞 胺)苯基}曱烷、雙{4-(甲基烯丙基甲基雙環卩21]^_5_烯 _2,3-二羧基醯亞胺)苯基}甲烷、雙{4-(稀丙基雙環[2.2.1]庚 -5-婦_2,3-二竣基醯亞胺)苯基}醚、雙(烯丙基甲基雙環 [2.2.1]庚5-稀-2,3-一緩基醒亞胺)苯基}謎、雙_j4_(曱基歸丙 基雙壞[2.2.1]庚_5-埽_2,3-二羧基醯亞胺)苯基}趟、雙{4_(稀 丙基雙環[2.2.1]庚-5·烯-2,3_二緩基酿亞胺)苯基冰、雙 {心(烯丙基甲基雙環叫收士稀办工緩基酿亞胺详基} ❹ 颯二雙{4·(甲基烯丙基雙環[2.2.1]庚-5-烯·2,3_二羧基醯亞 胺)本基}艰。 乂下列舉更優選的被稀基取代的納迪克醯亞胺化合 物0 Ν,Ν'_次乙基-雙(烯丙基雙環Ρ.2.1]庚-5-烯·2,3_二羧基 醯亞胺)、Ν,Ν,·次乙基-雙(烯丙基曱基雙環[2.2.1]庚-5-婦 錢亞胺)、N,NL次乙基_雙(甲基稀丙基雙環 P.2.1]庚-5·烯-2,3-二羧基醯亞胺)、N,N,_三亞甲基-雙(稀丙 85 l.Joc 201030060 基雙環[2.2.1]庚-5-稀-2,3-二缓基醯亞胺)、n,n,_六亞甲基-雙(稀丙基雙環[2·2.1]庚_5_稀_2,3-二綾基醯亞胺)、N,N,_六 亞甲基-雙(稀丙基甲基雙環[2.2.1]庚_5_埽_2,3-二羧基醢亞 胺)、N,N,-十二亞甲基·雙(稀丙基雙環[2 2 ^庚士稀^一 羧基醯亞胺)、N,N,-十二亞甲基•雙(烯丙基甲基雙環[2.2.1] 庚-5-烯-2,3-二羧基醯亞胺)、N,N,-環己烯_雙(烯丙基雙環 [2.2.1] 庚-5-烯-2,3-工羧基醯亞胺)、N,N,-環己烯-雙(稀丙基 甲基雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、 N,N’_對次苯基-雙(烯丙基雙環[2.2.1]庚-5-稀-2,3-二羧 基醯亞胺)、N,Nf-對次苯基-雙(烯丙基甲基雙環 烯-2,3-二羧基醯亞胺)、N,N,_間次苯基_雙(烯丙基雙環 [2.2.1] 庚_5-烯_2,3-二羧基醯亞胺)、N,n,4b1次苯基-雙(烯丙 基甲基雙環[2·2.1]庚-5-烯_2,3_二綾基醯亞胺)、N,N'-{(1-甲 基)-2,4-次苯基卜雙(烯丙基雙環p.2 l]庚_5_烯_2,’3_二羧 酿亞胺)、N,N,-對二甲苯基-雙(婦丙基雙環[2.2.1]庚_5_缚 -2,3-二羧基酿亞胺)、N,N’_對二甲苯基_雙(婦丙基甲基雙環 [2.2.1] 庚-5_稀_2,3_二絲醯亞胺)、取,_間苯二甲基: 丙基雙環[2.2.1]庚_5_埽_2,3-二叛基醯亞胺)、;^界間苯二甲 基-雙(稀丙基甲基雙環P.2.1]庚-5-蝉-2,3-二絲醯亞 2,2-雙[4-{4-(烯丙基雙環刚庚娜2,3_二 =)苯氧基}笨基]丙燒、2,2_雙[4♦(烯丙基曱基雙環 .2.1]庚-5-烯_2,3-二羧基醯亞胺)苯氧基丨苯基]丙烷、 基雙環刚 表氧基}苯基]丙⑥、雙{4_(稀丙基雙環[22^庚士燦-^ 86 201030060idoc 二緩基酿亞胺)苯基}甲烧、雙{4_(稀丙基甲基雙環[2 2 j] 庚-5-稀-2,3-一緩基醯亞胺)苯基}甲燒、雙{4-(曱基稀丙美 雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)笨基}甲燒、雙{4_(甲 基烯丙基甲基雙環[2.2.1]庚-5參2,3·二緩基酿亞胺)苯基} 甲烧。 而且,作為特別優選的被缔基取代的納迪克釀亞胺化 合物,可以列舉如下所示的以結構式(^^丨)所表示的雙 {4-(烯丙基雙環[2.2.1]庚-5-烯_2,3-二羧基醢亞胺)苯基}曱 烷、以結構式(Ina-2)所表示的ν,ν,-間苯二甲基-雙(烯丙基 雙環[2.2.1]庚-5-烯-2,3-二羧基醯亞胺)、以及以結構式 (Ina-3)所表示的ν,Ν'-六亞甲基_雙(烯丙基雙環[2 2丨]庚_5_ 烯-2,3-二羧基醯亞胺)。 [化 66]83 • doc 201030060 中优ΐΧΓ Γ N 被 被 被 被 被 被 被 被 N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N N 5 base susceptor 2 Yaguang, -ethylidene, methyl propyl bicyclo guanidine bis (dilyl propyl ring called Geng ^ thin ^ sub-amine), N, N, _ hexamethylene _ methylene - bis (dilylmethyl bis-bis-silk imine), N, N, · six ^, n, n, - dodecamethylene _ bis (female carboxy quinone imine), N, N, - Twelve Asians. 1] Geng _5 2, 3- 2 Gina 2, 3 · 2 County Stuffed A ^ ^ C ^ base double egg Zhen ^ 2 · 2.1, 2, 3- dicarboxy ^, the second Benji-double (female c 9 ng < quinone imine), p-benzene benzene 1 ^ = · ^ like 3- dicarboxy hydrazine [2.2 · υ -5 -5 养 2, 3 _ Two-base bicyclic (four) double-ruple..5==:_yl_double (sweet propylene (allyl:imine), hydrazine, π-diphenylene, (allyc = j imine), take, · pair Dimethyl stupyl-propyl A double-produced l^-2,3-di-succinimide), N,N,-m-phenylene smectite 基J base double though 2. purchase · (four) ·: silk 醯 butterfly 84 201030060iidoc Base-bis (l-propyl decyl bicyclic P.2.1] hept-5-ene-2,3-dicarboxy quinone imine), 2,2-double [4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-diindenylimine) oxy}benzin]propane, 2,2-bis[4- {4-(Baked propyl fluorenylbicyclo[22 1]hept-5-ene-2,3-dicarboxy quinazomine)phenoxy} stupyl]propane, 2,2_bis[4-{4- (Methylallylbicyclo ρ·2.1]hept-5-ene-2,3-dicarboxy quinone imine) phenoxy}phenyl]propane, bis{4_(allylbicyclo[2.2.1]g _5_稀_23_ Dicarboxy quinone imine) phenyl} decane, bis {4-(allylmethyl bicyclo [22 q hept-5 · dilute-2,3-dicarboxy quinone imine) phenyl }methane, ·. ® double {4·(methylallylbicyclo P.2.1]hept-5-ene-2,3-dicarboxy quinone imine)phenyl}decane, double {4-(methyl Allylmethylbicyclic hydrazone 21]^_5-ene 2,3-dicarboxy quinone imine) phenyl}methane, double {4-(dipropyl biscyclo[2.2.1]hept-5-women_2 , 3-dimercaptoindole) phenyl}ether, bis(allylmethylbicyclo[2.2.1]hept-5-lean-2,3-a sulphonyl imine)phenyl} mystery, double _j4_(曱基归propyl double bad [2.2.1]g _5-埽_2,3-dicarboxy quinone imine) phenyl} 趟, double {4_(dilyl bisbicyclo[2.2.1]g -5·ene-2,3_di-supplemental imine)phenyl ice, double {heart (allyl methyl double ring called士 办 办 酿 酿 酿 酿 酿 酿 { 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 difficult. The more preferred dipyridinium compound substituted by a dilute group, Ν'_ethylidene-bis(allylbicycloindole.2.1)hept-5-ene·2,3_dicarboxyindole Imine), hydrazine, hydrazine, · ethethyl-bis(allylhydrylbicyclo[2.2.1]hept-5-phetamine), N, NL-ethylidene-bis (methyl propyl) Bicyclic P.2.1]hept-5-ene-2,3-dicarboxyindolimine), N,N,_trimethylene-bis(slightly propyl 85 l.Joc 201030060 bisbicyclo[2.2.1]hept-5 - dilute-2,3-disyl iodide), n, n, hexamethylene-bis (dilyl propyl bicyclo [2·2.1] g _5_ dilute _2,3-didecyl fluorene Amine, N,N,_hexamethylene-bis(trimylmethylbicyclo[2.2.1]hept-5_埽_2,3-dicarboxyindenine), N,N,-Twelve Methylene bis (dipropyl bicyclo [2 2 ^heptyl] carboxy quinone imine), N, N, - dodecamethylene bis (allyl methyl bicyclo [2.2.1] g -5-ene-2,3-dicarboxy quinone imine), N,N,-cyclohexene_bis(allylbicyclo[2.2.1]hept-5-ene-2,3-indole carboxy fluorene Amine, N,N,-cyclohexene-bis(distypropylmethylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,N'_p-phenylene Base-double Propylbicyclo[2.2.1]hept-5-rare-2,3-dicarboxyindolimine), N,Nf-p-phenylene-bis(allylmethylbiscycloalkenene-2,3-dicarboxyl醯imino), N,N,_m-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboxyindenine), N,n,4b1 benzene Base-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-didecylimine), N,N'-{(1-methyl)-2,4-time Phenyl bis(allylbicyclop.2 l)hept-5-ene-2, '3-dicarboxyanimine), N,N,-p-xylyl-bis(propylpropyl bicyclo[2.2 .1]g_5_Bound-2,3-dicarboxyanimine), N,N'_p-xylylene_bis(propylpropylmethylbicyclo[2.2.1]g-5-dilution_2 , 3_dextrin imine), taken, _m-xylylene: propyl bicyclo [2.2.1] g _5_埽_2,3-di-reindolimine); Dimethyl-bis(trimylmethylbicyclic P.2.1]hept-5-indole-2,3-dioxazolidine 2,2-bis[4-{4-(allyl bicycloglycone 2 , 3_2 =) phenoxy} stupyl] propane, 2,2_bis[4♦(allylhydrylbicyclo.2.1)hept-5-ene_2,3-dicarboxyarlimine) Phenoxyindole phenyl]propane, bis-cyclobutanosyloxy}phenyl]propane 6, double {4_(dilyl propyl double [22^庚士灿-^ 86 201030060idoc II slow-base brewed imine) phenyl} methyl, double {4_(dilylmethylbicyclo[2 2 j] hept-5-rare-2,3- a slow Phenylimine) phenyl}methyl, double {4-(nonyl propyl propyl bicyclo [2.2.1] hept-5-ene-2,3-dicarboxy quinone imine) {4_(Methylallylmethylbicyclo[2.2.1]hept-5-resin 2,3·di-succinyl iodide)phenyl}-methyl. Further, as a particularly preferred nadicyl imine compound substituted with a hydrazide, a bis(4-(allylbicyclo[2.2.1]g) represented by the structural formula (^^) can be cited as shown below. -5-ene-2,3-dicarboxy quinone imine)phenyl}decane, ν,ν,-m-xylylene-bis(allylbicyclo) represented by the structural formula (Ina-2) 2.2.1] hept-5-ene-2,3-dicarboxyindenine), and ν,Ν'-hexamethylene-bis(allylbicyclo) represented by the structural formula (Ina-3) 2 2 丨]g _5_ ene-2,3-dicarboxy quinone imine). [化66]
(I na— 3) 87 20103 0060.ioc 另外,例如就使液晶顯示元件的電性能長期穩定的觀 點而言,本發明的液晶配向劑可以進一步含有具有自由基 聚合性不飽和雙鍵的化合物。所述具有自由基聚合性不飽 和雙鍵的化合物可以是一種化合物,也可以是兩種或兩種 以上的化合物。此外,所述具有自由基聚合性不飽和雙鍵 的化合物中不包括所述被烯基取代的納迪克醯亞胺化合 物。就所述的觀點而言,所述具有自由基聚合性不飽和雙 鍵的化合物的含量以相對於聚醯胺酸或其衍生物的重量比 計優選為0.01〜1.00,更優選為0.01〜0.70,進一步優選 ❹ 為 0.01 〜0.50。 此外,就降低液晶顯示元件的離子密度(ion density), 抑制離子密度隨時間增加,進一步抑制殘像的觀點而言, 具有自由基聚合性不飽和雙鍵的化合物相對於被烯基取代 的納迪克醯亞胺化合物的比率以重量比計優選為〇1〜 10,更優選為0.5〜5。 作為所述具有自由基聚合性不飽和雙鍵的化合物,可 以列舉:(甲基)丙烯酸g旨((meth)acryiic acid ester)、(甲基) 丙烯醯胺((meth)acrylic acid amide)等(甲基)丙烯酸衍生物 © 以及雙馬來醯亞胺(bismaleimide)。所述具有自由基聚合性 不飽和雙鍵的化合物更優選具有兩個或兩個以上自由基聚 合性不飽和雙鍵的(曱基)丙烯酸衍生物。 作為(甲基)丙婦酸醋的具體例,例如可以列舉.(甲基) 丙烯酸環己酯、(曱基)丙烯酸-2-曱基環己酯、(曱基)丙烯 酸二環戊酯、(甲基)丙烯酸二環戊氧基乙酯、(甲基)丙烯酸 88 201030060^ 異冰片酯、(甲基)丙烯酸苯酯、(曱基)丙烯酸苄酯、(甲基) 丙烯酸-2-羥基乙酯以及(甲基)丙烯酸-2-羥基丙酯。 作為雙官能(曱基)丙烯酸酯的具體例,例如可以列 舉:雙丙烯酸乙二酯,東亞合成(股)的產品AronixM-210、 Aronix M-240及Aronix M-6200,日本化藥(股)的產品 KAYARAD HDDA、KAYARAD HX-220、KAYARAD R-604 及KAYARAD R-684,大阪有機化學工業(股)的產品 V260、V312及V335HP,以及共榮社化學(股)的產品Light ® Acrylate BA-4EA、Light Acrylate BP-4PA 及 Light Acrylate BP-2PA。 作為三官能或三官能以上的多官能(甲基)丙烯酸酯的 具體例,例如可以列舉:4,4'-亞甲基雙(N,N-二羥基次乙基 丙烯酸酯苯胺)、Aronix M-400、Aronix M-405、Aronix M-450、Aronix M-7100、Aronix M-8030、Aronix M-8060、 KAYARAD TMPTA、KAYARAD DPCA-20、KAYARAD DPCA-30、KAYARAD DPCA-60、KAYARAD DPCA-120 φ 以及大阪有機化學工業(股)的產品VGPT。 作為(曱基)丙烯醯胺衍生物的具體例,例如可以列 舉:N-異丙基丙烯酿胺(N-isopropyl acrylamide)、N-異丙基 曱基丙烯醢胺、N-正丙基丙婦醯胺、N-正丙基甲基丙烯醯 胺、N-環丙基丙烯醯胺、N-環丙基甲基丙烯醯胺、N-乙氧 基乙基丙烯醯胺、N-乙氧基乙基曱基丙稀醯胺、N-四氫糠 基丙烯醯胺、N-四氫糠基曱基丙烯醯胺、N-乙基丙烯醯 胺、N-乙基-N-甲基丙烯醯胺、N,N-二乙基丙烯醢胺、N- 89 201030060u〇c 曱基_N•正丙基丙烯醯胺、N-甲基-N-異丙基丙烯醯胺、N_ 丙稀酿基吸咬、N丙稀醯基吡咯烧、N,N,-亞曱基雙丙埽酿 胺、n,n’-次乙基雙丙烯醯胺、N,N,_:羥基次乙基雙丙烯醯 胺、N-(4-羥基苯基)甲基丙烯醯胺、N_苯基甲基丙烯醯胺、 N-丁基甲基丙烯醯胺、N_(異丁氧基甲基)甲基丙烯醯胺、 Ν_[2-(Ν,Ν·二甲基氨基)乙基]甲基丙烯醯胺、风队二甲基甲 基丙烯酿胺、Ν-[3-(二甲基氨基)丙基]曱基丙烯醯胺、Ν_(曱 氧基甲基)甲基丙烯醯胺、Ν_(羥基甲基)_2_曱基丙烯醯胺、 Ν-苄基-2-甲基丙烯醯胺以及Ν,Ν,-亞甲基雙甲基丙烯醯 胺。 所述的(曱基)丙稀酸衍生物中,特別優選Ν,Ν,-亞曱基 雙丙烯醯胺、Ν,Ν’-二羥基次乙基-雙丙烯醯胺、雙丙烯酸 乙二酯以及4,4’-亞甲基雙(Ν,Ν-二羥基次乙基丙烯酸酯苯 胺)。 作為雙馬來醯亞胺,例如可以列舉:ΚΙ CHEMICAL INDUSTRY(股)製造的BMI-70及BMI-80,以及大和化成 工業(股)製造的 BMI-1000、BMI-3000、BMI-4000、 BMI-5000 及 BMI-7000。 另外’例如就液晶顯示元件中的電性能的長期穩定性 的觀點而言’本發明的液晶配向劑可以進一步含有惡嗪化 合物。所述惡唤化合物可以是一種化合物,.也可以是兩種 或兩種以上的化合物。就所述的觀點而言,所述惡嗪化合 物的含量相對於所述聚醯胺酸或其衍生物優選為〇.1 wt%(重量百分比)〜50 wt°/〇,更優選為1 wt%〜40 wt%,進 201030060udoc 步優選為1 wt%〜20 wt%。 所述惡嗪化合物優選可溶於溶解聚醯胺酸或其衍生 物的溶媒中’並且具有開環聚合性的惡嗪化合物。〃 另外’所述惡嗪化合物中的惡嗪結構的數量並無特 限定。 …'、 惡嗪的結構已知有各種結構。于本發明中,惡嗪的結 構並無特別限定,所述惡嗪化合物中的惡嗪結構可以列舉 苯並惡嗪(benzoxazine)或萘並惡嗪(naphthoxazine)等具有 包含縮合多環芳香族基的芳香族基的惡嗪的結構。' 作為所述惡嗪化合物’例如可以列舉下述通式(a)〜通 式(ί)所表示的化合物。此外,下述通式中,朝向環的中心 ^顯示的鍵表示鍵結於構成環並且可以鍵結取代基的任— [化 67](I na-3) 87 20103 0060.ioc Further, for example, in order to stabilize the electrical properties of the liquid crystal display element for a long period of time, the liquid crystal alignment agent of the present invention may further contain a compound having a radical polymerizable unsaturated double bond. The compound having a radical polymerizable unsaturated double bond may be one compound or two or more compounds. Further, the naphthylamine compound substituted with an alkenyl group is not included in the compound having a radical polymerizable unsaturated double bond. From the viewpoint of the above, the content of the compound having a radical polymerizable unsaturated double bond is preferably 0.01 to 1.00, more preferably 0.01 to 0.70 by weight based on the weight ratio of the polyaminic acid or its derivative. Further preferably, ❹ is from 0.01 to 0.50. Further, in terms of reducing the ion density of the liquid crystal display element, suppressing an increase in ion density with time, and further suppressing the afterimage, a compound having a radical polymerizable unsaturated double bond is substituted with an alkenyl group. The ratio of the diclosan compound is preferably from 1 to 10, more preferably from 0.5 to 5, by weight. Examples of the compound having a radically polymerizable unsaturated double bond include (meth)acrylic acid (meth)acrylic acid ester (meth)acrylic acid amide, (meth)acrylic acid amide, and the like. (Meth)acrylic acid derivative © and bismaleimide. The compound having a radical polymerizable unsaturated double bond is more preferably a (mercapto)acrylic acid derivative having two or more radically polymerizable unsaturated double bonds. Specific examples of the (meth) acetoacetate include, for example, cyclohexyl (meth)acrylate, 2-mercaptocyclohexyl (meth) acrylate, and dicyclopentanyl (mercapto) acrylate. Dicyclopentyloxyethyl (meth)acrylate, (meth)acrylic acid 88 201030060^ Isobornyl ester, phenyl (meth) acrylate, benzyl (meth) acrylate, 2-hydroxyl (meth) acrylate Ethyl ester and 2-hydroxypropyl (meth)acrylate. Specific examples of the difunctional (fluorenyl) acrylate include, for example, ethylene diacrylate, East Asian synthetic products Aronix M-210, Aronix M-240, and Aronix M-6200, Nippon Chemical Co., Ltd. Products KAYARAD HDDA, KAYARAD HX-220, KAYARAD R-604 and KAYARAD R-684, products of Osaka Organic Chemical Industry Co., Ltd. V260, V312 and V335HP, and products of Kyoritsu Chemical Co., Ltd. Light ® Acrylate BA- 4EA, Light Acrylate BP-4PA and Light Acrylate BP-2PA. Specific examples of the trifunctional or trifunctional or higher polyfunctional (meth) acrylate include, for example, 4,4'-methylenebis(N,N-dihydroxyethylene phenyl aniline), Aronix M -400, Aronix M-405, Aronix M-450, Aronix M-7100, Aronix M-8030, Aronix M-8060, KAYARAD TMPTA, KAYARAD DPCA-20, KAYARAD DPCA-30, KAYARAD DPCA-60, KAYARAD DPCA-120 φ and VGPT of Osaka Organic Chemical Industry Co., Ltd. Specific examples of the (fluorenyl) acrylamide derivative include, for example, N-isopropyl acrylamide, N-isopropyl decyl acrylamide, and N-n-propyl propyl. Glucosamine, N-n-propyl methacrylamide, N-cyclopropyl acrylamide, N-cyclopropyl methacrylamide, N-ethoxyethyl acrylamide, N-ethoxy Ethyl ethyl acrylamide, N-tetrahydrofurfuryl acrylamide, N-tetrahydrofurfuryl decyl acrylamide, N-ethyl acrylamide, N-ethyl-N-methyl propylene Indoleamine, N,N-diethyl acrylamide, N-89 201030060u〇c fluorenyl _N• n-propyl acrylamide, N-methyl-N-isopropyl acrylamide, N_ propylene Base absorbing, N-propyl thiopyrrolidone, N, N,- fluorenyl propylamine, n, n'-ethylidene bis decylamine, N, N, _: hydroxyethylidene double Acrylamide, N-(4-hydroxyphenyl)methacrylamide, N-phenylmethacrylamide, N-butylmethacrylamide, N_(isobutoxymethyl)methacrylate Amine, Ν_[2-(Ν,Ν·dimethylamino)ethyl]methacrylamide, wind dimethyl methacrylamide, Ν-[3-(Dimethylamino)propyl]decyl acrylamide, Ν_(decyloxymethyl)methacrylamide, Ν-(hydroxymethyl)_2-mercaptopropenylamine, hydrazine- Benzyl-2-methylpropenylamine and hydrazine, hydrazine, -methylene bis methacrylamide. Among the (mercapto)acrylic acid derivatives, particularly preferred are hydrazine, hydrazine, -merylene bis acrylamide, hydrazine, Ν'-dihydroxyethenyl-bispropenylamine, ethylene diacrylate. And 4,4'-methylenebis(indole, fluorene-dihydroxyethylene phenyl aniline). Examples of the bismaleimide include BMI-70 and BMI-80 manufactured by INDUSTRY CHEMICAL INDUSTRY, and BMI-1000, BMI-3000, BMI-4000, and BMI manufactured by Daiwa Kasei Kogyo Co., Ltd. -5000 and BMI-7000. Further, the liquid crystal alignment agent of the present invention may further contain an oxazine compound from the viewpoint of long-term stability of electrical properties in the liquid crystal display element. The agonizing compound may be a compound. It may also be a compound of two or more kinds. From the viewpoint of the above, the content of the oxazine compound is preferably 0.1% by weight to 50% by weight, more preferably 1%, based on the polyamic acid or a derivative thereof. %~40 wt%, step into 201030060udoc is preferably 1 wt% to 20 wt%. The oxazine compound is preferably soluble in a solvent which dissolves polylysine or a derivative thereof and has a ring-opening polymerizable oxazine compound. Further, the number of the oxazine structure in the oxazine compound is not particularly limited. ...', the structure of the oxazine is known to have various structures. In the present invention, the structure of the oxazine is not particularly limited, and the oxazine structure in the oxazine compound may include a benzoxazine or a naphthoxazine having a condensed polycyclic aromatic group. The structure of the aromatic-based oxazine. 'As the oxazine compound', for example, a compound represented by the following formula (a) to the formula (ί) can be mentioned. Further, in the following formula, a bond shown toward the center of the ring ^ represents a bond which is bonded to a constituent ring and which may bond a substituent - [Chem. 67]
201030060# 所述通式(a)〜通式(c)中,R1及R2表示碳數16〜如, 有機基。另外,所述通式⑷〜通式(0中,R3S R表不氮 或碳數1〜6的烴基。另外,所述通式(c)、通式(d)及通式 (f)中,X表示單鍵、-〇-、各、-8各、-8〇2-、七0-、七0·-、 -NHCO-、_C(CH3)2-、-C(CF3)2-、-(CH2)m、_〇_(CH2)m〇-、 -S-(CH2)mS-。此處,m為1〜6的整數。另外,所述通式(e) 及通式(f)中’ Y獨立地表示單鍵、-〇-、-S-、-CO-、 -C(CH3)2-、-C(CF3)2-或碳數1〜3的烷烯基。所述Y中的 鍵結於苯環、萘環上的氫獨立,且可以被、_CH3、_〇H、 -COOH、-S03H、-Ρ03Η2 所取代。 另外,所述惡嗪化合物包括侧鏈上具有惡嗪結構的寡 聚物或聚合物(一ymer)、主鍵中具有惡嗪結構的寡聚物或 聚合物。 作為以通式⑷所表示的惡嗪化合物’例如可以列舉以 下的惡嗪化合物。 [化 68]201030060# In the above formula (a) to formula (c), R1 and R2 represent a carbon number of 16 to, for example, an organic group. Further, in the above formula (4) to the formula (0, R3S R represents a nitrogen group or a hydrocarbon group having 1 to 6 carbon atoms. Further, in the above formula (c), formula (d) and formula (f) , X represents a single bond, -〇-, each, -8, -8〇2-, 七--, 七--, -NHCO-, _C(CH3)2-, -C(CF3)2-, -(CH2)m, _〇_(CH2)m〇-, -S-(CH2)mS-. Here, m is an integer of 1 to 6. Further, the above formula (e) and formula (f) Wherein 'Y independently represents a single bond, -〇-, -S-, -CO-, -C(CH3)2-, -C(CF3)2- or an alkenyl group having 1 to 3 carbon atoms. The bond in Y is independently bonded to the hydrogen on the benzene ring and the naphthalene ring, and may be substituted by _CH3, _〇H, -COOH, -S03H, -Ρ03Η2. In addition, the oxazine compound includes a side chain having a wickiness. An oligomer or a polymer having a azine structure (a ymer) or an oligomer or a polymer having an oxazine structure in the primary bond. The oxazine compound represented by the formula (4) is exemplified by the following oxazine compound. 68]
(a«1)(a«1)
(a-2)(a-2)
更優選碳數1〜2〇 式中,R1優選碳數1〜30的烷基, 的烧基。 92 201030060„.doc 作為以通式(b)所表示的惡唤化合物,例如可以列舉以 下的惡嗪化合物。 [化 69]More preferably, the carbon number is 1 to 2, and in the formula, R1 is preferably an alkyl group having 1 to 30 carbon atoms. 92 201030060 „.doc As the agonizing compound represented by the formula (b), for example, the following oxazine compounds can be exemplified.
Φ-9) (b-10) 93 201030060 icc 式中,R1優選碳數1〜30的烷基,更優選碳數1〜20 的烧基。 作為以通式(c)所表示的惡嗪化合物,可以列舉以下述 通式(c-I)所表示的惡喚化合物。 [化 70]Φ-9) (b-10) 93 201030060 icc In the formula, R1 is preferably an alkyl group having 1 to 30 carbon atoms, more preferably a carbon group having 1 to 20 carbon atoms. The oxazine compound represented by the formula (c) includes a agonizing compound represented by the following formula (c-I). [化70]
(c-I)(c-I)
所述通式(c-I)中,R1及R2表示碳數1〜30的有機基, R3至R6表示氩或碳數1〜6的烴基,X表示單鍵、-CH2-、 -C(CH3)2-、-CO-、-Ο-、-S02-或-C(CF3)2-。作為以所述通 式(c-I)所表示的惡喚化合物,例如可以列舉以下的惡嗓化 合物。In the above formula (cI), R1 and R2 represent an organic group having 1 to 30 carbon atoms, R3 to R6 represent an argon or a hydrocarbon group having 1 to 6 carbon atoms, and X represents a single bond, -CH2-, -C(CH3) 2-, -CO-, -Ο-, -S02- or -C(CF3)2-. As the agonizing compound represented by the above formula (c-I), for example, the following oxime compound can be mentioned.
94 201030060udoc [化 71] c94 201030060udoc [化71] c
95 201030060doc 72]95 201030060doc 72]
(c-15)(c-15)
式中,R1優選碳數1〜30的烷基,更優選碳數1〜20 的烧基。 作為以通式(d)所表示的惡嗓化合物,例如可以列舉以 96 ii.doc 201030060 下的惡嗪化合物。In the formula, R1 is preferably an alkyl group having 1 to 30 carbon atoms, more preferably an alkyl group having 1 to 20 carbon atoms. As the oxime compound represented by the formula (d), for example, an oxazine compound of 96 ii.doc 201030060 can be cited.
參 作為以通式(e)所表示的惡嗪化合物,例如可以列舉以 下的惡唤化合物。 97 20103 0060. Joc [化 74]The oxazine compound represented by the formula (e) is exemplified by the following acetonide compound. 97 20103 0060. Joc [化74]
作為以通式(f)所表示的惡嗪化合物,例如可以列舉以 ❹ 下的惡嗓化合物。 98 201030060* [化 75]The oxazine compound represented by the formula (f) may, for example, be an oxindole compound. 98 201030060* [化 75]
99 201030060ldoc [化 76]99 201030060ldoc [Chem. 76]
(M1)(M1)
這些惡嗪化合物中’更優選 (c-3)、式(c-5)、式(C-7)、式(匕9)、式 V )式(c ” 式 式㈣、綱〜離^ 所述惡嗪化合物可以利用與國際公開綱觸97〇 手冊、日本專利特開平1Μ2258號公報、日本專利特開 2004-3 52670號公報中所記載的方法相同的方法來製造。Among these oxazine compounds, '(3), (c-5), (C-7), (9), and V) are the formula (c), The oxazide compound can be produced by the same method as that described in the Japanese Patent Laid-Open Publication No. Hei. No. Hei.
例如以通式(a)所表示的惡嗪化合物可以通過使苯酚 (phenol)化合物、伯胺(primary amine)以及醛(aldehyde)反應 而獲得(參照國際公開2004/009708號手冊)。 〜For example, the oxazine compound represented by the formula (a) can be obtained by reacting a phenol compound, a primary amine, and an aldehyde (refer to International Publication No. 2004/009708). ~
另外,以通式(b)所表示的惡唤化合物可以通過如下方 式獲得,即利用將伯胺缓緩添加到甲搭(formaldehyde)中的 方法使其反應後’添加具有萘酚(naPhtho1)系羥基的化合物 進行反應(參照國際公開2004/009708號手冊V 另外,以通式(c)所表示的惡嗪化合物可以通過如下方 100 201030060* 式獲得’即在有機溶媒中,使1莫耳的苯酚化合物、相對 於其一個苯酚性羥基至少為2莫耳或2莫耳以上的醛、以 及1莫耳的伯胺于脂肪族仲胺(aliphatic secondary amines)、脂肪族叔胺(aUphatic tertiary amines)或驗性含氮 雜環化合物的存在下反應(參照國際公開2004/009708號手 冊及曰本專利特開平11-12258號公報)。 另外’以通式(d)〜通式(f)所表示的惡嗓化合物可以通 過如下方式獲得,即在正丁醇中,使4,4,-二氨基二苯基甲 〇 烷等具有多個苯環與鍵結這些苯環的有機基的二胺、福馬 林(formalin)等醛以及苯酚以901或90°c以上的溫度進行 脫水縮合反應(參照日本專利特開2004-352670號公報)。 另外’例如就液晶顯示元件中的電性能的長期穩定性 的觀點而言’本發明的液晶配向劑可以進一步含有惡吐琳 化合物。所述惡唑啉化合物是具有惡唑啉結構的化合物。 所述惡唑啉化合物可以是一種化合物,也可以是兩種或兩 種以上的化合物。就所述的觀點而言,所述惡唾琳化合物 的含量相對於所述聚醯胺酸或其衍生物優選為0.1 Wt〇/〇〜 擊 50 Wt%,更優選為1 wt%〜40 Wt%,進一步優選為1 wt% 〜20 wt%。或者,就所述的觀點而言,所述惡唑啉化合物 的含量優選於將惡唑啉化合物中的惡唑啉結構換算為惡唑 啉時’相對於所述聚醯胺酸或其衍生物為〇.丨^^%〜4〇 wt% 0 所述惡唾啉化合物可以在一個化合物中僅具有一種 惡唑啉結構,也可以在一個化合物中具有兩種或兩種以上 101 201030060 上 uoc 的惡唑啉結構。另外,所述惡唑啉化合物只要在一個化合 物中具有-個所述惡唾淋結構即可,但優選具有兩個或兩 個以上的惡唑啉結構。另外,所述惡唑啉化合物可以是侧 鏈上具有惡唑啉環結構的聚合物,也可以是共聚物。侧鏈 上具有惡唑啉結構的聚合物可以是侧鏈上具有惡唑啉結構 的單體的均聚物,也可以是側鏈上具有惡唑啉結構的單體 與不具有惡唑淋結構的單體的共聚物。侧鏈上具有惡。坐琳 結構的共聚物可以是侧鏈上具有惡唑啉結構的兩種或兩種 以上的單體的共聚物,也可以是侧鏈上具有惡唑啉結構的 @ 兩種或兩種以上的單體與不具有惡唑啉結構的單體的共聚 物。 所述惡唑啉結構優選以使惡唑啉結構中的氧及氮的 一方或雙方與聚酿胺酸的幾基(carb〇nyi)可以反應的方式 存在於惡唾琳化合物中的結構。 作為所述惡唑琳化合物,例如可以列舉:2,2f_雙(2-惡 唑啉)(2,2’-bis(2-oxazoline))、1,2,4-三-(2-惡唑啉基-2)-苯 (l,2,4-tris-(2-oxazolinyl-2)-benzene)、4-°夫味-2-基亞甲基-2· ❹ 苯基-4H-惡 唑-5-酮(4-furan-2-yl methylene-2-phenyl-4H,oxazole-5-one)、1,4-雙(4,5_二氫-2-惡唾基)苯(l,4-bis(4,5-dihydro-2-oxazolyl)benzene)、1,3,雙 (4,5·二氫-2-惡唑基)苯、2,3-雙(4_異丙烯基-2-惡唑啉-2-基) 丁烷、2,2’-雙-4-苄基-2-惡唑啉、2,6-雙(異丙基-2-惡唑淋-2-基)吡啶、2,2’-異亞丙基雙(4-叔丁基-2-惡唑啉)、2,2,-異亞 丙基雙(4-笨基-2-惡唑啉)、2,2’-亞甲基雙(4-叔丁基-2-惡唑 102 201030060 =)私及2,2-亞甲基雙(4-苯基-2-惡0坐琳)。除這些惡唾被仆 三=外,也可以列舉如Epocros(商品名,日本觸 物的具有,㈣基的聚合物或寡聚物。這些二 物中更優選1,3_雙(4,5_二氫_2_惡唑基)苯。 的觀二卜二例ΐ就液晶顯示元件中的電性能的長期穩定性Further, the oleophobic compound represented by the formula (b) can be obtained by adding a primary amine to the formaldehyde, and then adding the naphthol (naPhtho1) system after the reaction. The hydroxy compound is reacted (refer to International Publication No. 2004/009708, manual V. Further, the oxazine compound represented by the formula (c) can be obtained by the following formula 100 201030060*, that is, in an organic solvent, 1 mol a phenolic compound, an aldehyde of at least 2 moles or more with respect to one of its phenolic hydroxyl groups, and 1 mole of primary amine in an aliphatic secondary amines, auphatic tertiary amines The reaction is carried out in the presence of a nitrogen-containing heterocyclic compound (refer to the International Publication No. 2004/009708 and the Japanese Patent Laid-Open No. Hei 11-12258). Further, 'is represented by the general formula (d) to the general formula (f) The oxime compound can be obtained by using a diamine having a plurality of benzene rings and an organic group bonded to the benzene rings, such as 4,4,-diaminodiphenylmethane or the like, in n-butanol. Aldehydes such as formalin and Phenol is subjected to a dehydration condensation reaction at a temperature of 901 or 90 ° C or higher (refer to Japanese Laid-Open Patent Publication No. 2004-352670). Further, 'for example, from the viewpoint of long-term stability of electrical properties in a liquid crystal display element' The liquid crystal alignment agent may further contain a oxethin compound, which is a compound having an oxazoline structure. The oxazoline compound may be one compound or two or more compounds. In view of the above, the content of the smectite compound is preferably 0.1 Wt 〇 〇 50 W t%, more preferably 1 wt% 〜 40 Wt% with respect to the polyaminic acid or its derivative. Further, it is preferably from 1 wt% to 20 wt%. Or, from the viewpoint of the above, the content of the oxazoline compound is preferably when the oxazoline structure in the oxazoline compound is converted to an oxazoline. The oxaporphyrin compound may have only one oxazoline structure in one compound or may be in one compound, relative to the poly-proline or its derivative. 丨.丨^^%~4〇wt% 0 Have two or more types 1 01 201030060 The oxazoline structure of uoc. In addition, the oxazoline compound may have one or more of the oxazoline structures in one compound, but preferably has two or more oxazoline structures. Further, the oxazoline compound may be a polymer having an oxazoline ring structure in a side chain, or may be a copolymer. A polymer having an oxazoline structure in a side chain may have an oxazoline structure on a side chain. The homopolymer of the monomer may also be a copolymer of a monomer having an oxazoline structure in a side chain and a monomer having no oxazole structure. There is evil on the side chain. The copolymer of the pendant structure may be a copolymer of two or more kinds of monomers having an oxazoline structure in a side chain, or two or more kinds of oxazoline structures having a oxazoline structure in a side chain. a copolymer of a monomer and a monomer having no oxazoline structure. The oxazoline structure is preferably a structure in which one or both of oxygen and nitrogen in the oxazoline structure are allowed to react with a carbaryl group of the poly-aracine. Examples of the oxazoline compound include 2,2f-bis(2-oxazoline), 1,2,4-tri-(2-oxo). Isozoline-2)-benzene (1,2,4-tris-(2-oxazolinyl-2)-benzene), 4-°fusin-2-ylmethylene-2· phenylene-4H- 4-furan-2-yl methylene-2-phenyl-4H, oxazole-5-one, 1,4-bis(4,5-dihydro-2-oxasinyl)benzene , 4-bis(4,5-dihydro-2-oxazolyl)benzene, 1,3,bis(4,5-dihydro-2-oxazolyl)benzene, 2,3-bis(4-isopropenyl) -2-oxazolin-2-yl)butane, 2,2'-bis-4-benzyl-2-oxazoline, 2,6-bis(isopropyl-2-oxazole-15 Pyridine, 2,2'-isopropylidene bis(4-tert-butyl-2-oxazoline), 2,2,-isopropylidene bis(4-indolyl-2-oxazoline) 2,2'-methylenebis(4-tert-butyl-2-oxazole 102 201030060 =) private and 2,2-methylenebis(4-phenyl-2-oxo 0 sitting). In addition to these evil salivas, it is also possible to cite, for example, Epocros (trade name, Japanese touch, or (4)-based polymer or oligomer. These two are more preferably 1,3_double (4,5). _Dihydro-2-oxazolyl) benzene. The second example of the observation of the electrical properties of the liquid crystal display elements
發明的液晶配向劑可以進一步含有環氧化 ο物。所述環氧化合物可以是一種化合物,也可以是兩種 或兩種以上的化合物。就所述的觀點而言,所述環氧化合 物的含量相對於所述聚醢胺酸或其衍生物優選為al wt& 〜50 Wt〇/〇,更優選為1 wt%〜40 wt%,進-步優選為i wt% 作為環氧化合物,可以列舉分子内具有一個或者兩個 或兩個以上環氧環的各種化合物。作為分子内具有一個環 氧環的化合物,例如可以列舉:苯基縮水甘油醚(phenyl glycidyl ether)、丁基縮水甘油醚、3,3,3-三氟曱基環氧丙烷 (3,3,3-tnfluoro propylene oxide)、氧化苯乙烯(styrene oxide)、六IL環氧丙烧、環氧環己烧(cyclohexene oxide)、 3-縮水甘油氧基丙基三甲氧基砍燒(3_giyCid〇Xy propyl 以11^11(^丫3如1^)、2-(3,4-環氧環己基)乙基三曱氧基矽烷、 N-縮水甘油基鄰苯二曱醯亞胺(N-glycidyl phthalimide)、 (九氟-正丁基)環氧化物((nonafluoro-N-butyl)epoxide)、全氟 乙基縮水甘油謎、表氣酵(epichlorohydrin)、表溴醇 (epibromohydrin)、N,N-二縮水甘油基苯胺以及3-[2-(全氟 己基)乙氧基]-1,2-環氧丙烷。 103 201030060, A i.doc 為刀子内具有兩個環氧環的化合物,例如可以 举· · 乙二^醇二·输 U 4 glyco1 di^ 丙二醇二縮水甘油以=丙醚、三 二縮水甘油醚、U已醇二縮水甘_、新戊二醇 ㈣、2,2_二_戊二縮水甘⑽、甘油二縮水甘 :=曱氧環基^一-二縮水⑽ φ 舉的化合物,例如可以列 氧基]苯基)]乙基;f笨某…[4-[u-雙[4-([2,3-環氧丙 VG3101L”,三井^丙烧(商品名 “Techmore 作為分子内具有四個環氧 舉:U,5,6w縮水甘油基_24_H化^物,例如可以列 己烧、风耶,界四縮水甘油基_44,__ 一 丁丞砰 〇 及ΜΝ·烯丙基-N-縮水甘油基)氨基两基^^ = 除所述化合物以外,作為分子叫有環氧環的化合物 的例子’也可以解具有環氧_奸物 具有環氧環的單體,例如可以列舉: 油醋(glycidyl (meth)aCrylate)、(甲基化婦酸 3 4 環 酯以及(甲基)丙烯酸曱基縮水甘油醋。 ’ 作為與具有環氧環的單體進行共聚的其他單體,例如 可以列舉:(甲基)丙烯酸、(甲基)两稀酸甲醋(methyi 104 201030060 Η (meth)acrylate)、(曱基)丙烯酸乙酯、(甲基)丙烯酸異丙酯、 (甲基)丙烯酸丁酯、(甲基)丙烯酸異丁酯、(甲基)丙烯酸叔 丁酯、(曱基)丙烯酸環己酯、(甲基)丙烯酸节酯、(甲基)丙 烯酸2-羥基乙酯、(甲基)丙烯酸2-羥基丙酯、苯乙烯 (styrene)、甲基苯乙烯、氯甲基苯乙烯、(曱基)丙烯酸(3-乙基-3-環氧丙烷基)曱酯、N-環己基馬來醯亞胺以及N-苯 基馬來酿亞胺。 作為具有環氧環的單體的聚合物的優選的具體例,可 ® 以列舉聚甲基丙烯酸縮水甘油酯等。另外,作為具有環氧 環的單體與其他單體的共聚物的優選的具體例,可以列 舉:N-苯基馬來醯亞胺_甲基丙烯酸縮水甘油酯共聚物、 N-環己基馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、甲基 丙烯酸苄酯-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸丁 酯·甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸2_羥基乙酯 -曱基丙烯酸縮水甘油酯共聚物、曱基丙烯酸(3_乙基_3_環 氧丙烧基)曱醋甲基丙稀酸縮水甘油酯共聚物以及苯乙烤 ❿ ·曱基丙烯酸縮水甘油酯共聚物。 這些例子中,特別優選N,N,N,,N,_四縮水甘油基-間苯 二曱胺、1,3-雙(N,N-二縮水甘油基氨基曱基)環己烷、 N,N,N’,N’-四縮水甘油基_4,4,·二氨基二苯基曱烷、商品名 為“Techmore VG3101L”、3,4-環氧環己嫦基曱基_3,,4,-環氧 環己稀羧酸醋、N-苯基馬來醯亞胺_曱基丙烯酸縮水甘油酯 共聚物以及2-(3,4-環氧環己基)乙基三曱氧基矽院。 更加系統地來說’作為所述環氧化合物 ,例如可以列 105The liquid crystal alignment agent of the invention may further contain an epoxidized material. The epoxy compound may be one compound or two or more compounds. In view of the above, the content of the epoxy compound is preferably ag wt & 〜50 Wt 〇 / 〇, more preferably 1 wt% 〜 40 wt%, with respect to the polyamic acid or a derivative thereof. The further step is preferably i wt%. As the epoxy compound, various compounds having one or two or more epoxy rings in the molecule can be cited. Examples of the compound having an epoxy ring in the molecule include phenyl glycidyl ether, butyl glycidyl ether, and 3,3,3-trifluorodecyl propylene oxide (3, 3, 3-tnfluoro propylene oxide, styrene oxide, hexamethylene propylene oxide, cyclohexene oxide, 3-glycidoxypropyltrimethoxy chopping (3_giyCid〇Xy propyl) 11^11(^丫3 such as 1^), 2-(3,4-epoxycyclohexyl)ethyltrimethoxy decane, N-glycidyl phthalimide , (nonafluoro-N-butyl) epoxide, perfluoroethyl glycidol, epichlorohydrin, epibromohydrin, N, N- Diglycidyl aniline and 3-[2-(perfluorohexyl)ethoxy]-1,2-epoxypropane. 103 201030060, A i.doc is a compound having two epoxy rings in the knife, for example · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Equine Shrinking sweet (10), glycerol digoxime: = 曱 环 环 ^ 一 一 二 ( ( ( ( ( ( ( ( ( ( ( ( ( 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 化合物 [ [ [ [ [ [ [ [ [ [ 4-([2,3-epoxypropane VG3101L", Mitsui & Co., Ltd. (trade name "Techmore has four epoxy lifts in the molecule: U, 5, 6w glycidyl group _24_H chemical, for example, can be listed Baked, windy, tetraglycidyl _44, __ butyl hydrazine and hydrazyl allyl-N-glycidyl) amino two groups ^^ = In addition to the compound, as a molecule called a ring Examples of the compound of the oxygen ring ' can also be used to exemplify a monomer having an epoxy ring with an epoxy group, and examples thereof include: glycidyl (meth) a Crylate, (methylated 4 4 cyclic ester of women's acid and ( Methyl) decyl glycidol vinegar. 'As another monomer copolymerized with a monomer having an epoxy ring, for example, (meth)acrylic acid, (methyl) dicarboxylic acid methyl vinegar (methyi 104 201030060) Meth (meth)acrylate), (mercapto)ethyl acrylate, isopropyl (meth)acrylate, butyl (meth)acrylate, isobutyl (meth)acrylate Ester, tert-butyl (meth)acrylate, cyclohexyl (meth)acrylate, (meth)acrylate, 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, Styrene, methyl styrene, chloromethyl styrene, (3-ethyl-3-epoxypropenyl) decyl (meth) acrylate, N-cyclohexyl maleimide, and N- Phenyl maleate. Preferable specific examples of the polymer of the monomer having an epoxy ring include polyglycidyl methacrylate and the like. Further, preferred examples of the copolymer of the monomer having an epoxy ring and another monomer include N-phenylmaleimide-glycidyl methacrylate copolymer and N-cyclohexyl horse.醯imino-glycidyl methacrylate copolymer, benzyl methacrylate-glycidyl methacrylate copolymer, butyl methacrylate/glycidyl methacrylate copolymer, 2-hydroxyl methacrylate Ethyl ester-glycidyl methacrylate copolymer, methacrylic acid (3_ethyl_3_epoxypropenyl) phthalic acid methyl acrylate glycidyl ester copolymer and styrene bromide Glycidyl ester copolymer. Among these examples, N,N,N,,N,_tetraglycidyl-isophthalamide, 1,3-bis(N,N-diglycidylaminodecyl)cyclohexane, N is particularly preferred. , N, N', N'-tetraglycidyl_4,4, diaminodiphenyl decane, trade name "Techmore VG3101L", 3,4-epoxycyclohexyl fluorenyl _3, , 4,-epoxycyclohexanecarboxylic acid vinegar, N-phenylmaleimide-glycidyl methacrylate copolymer and 2-(3,4-epoxycyclohexyl)ethyltrimethoxyl Brothel. More systematically, as the epoxy compound, for example, it can be listed 105
,.d〇C 201030060 舉:縮水甘油謎、縮水甘油酯(glycidyl ester)、縮水甘油胺 (glycidyl amine)、含有環氧基的丙烯酸系樹脂、縮水甘油 醯胺(glycidyl amide)、縮水甘油基異氰尿酸酯(giycidyl isocyanurate)、鏈狀脂肪族型環氧化合物以及環狀脂肪族型 環氧化合物。此外’環氧化合物是指具有環氧基的化合物, 環氧樹脂是指具有環氧基的樹脂。 作為所述縮水甘油醚,例如可以列舉:雙盼 A(bisPhen〇l A)型環氧化合物、雙酚F型環氧化合物、雙酚 S型環氧化合物、雙酚型環氧化合物、氫化雙酚_A型環氧 化合物、氫化雙酚-F型環氧化合物、氫化雙酚_s型環氧化 合物、氫化雙酚型環氧化合物、溴化雙酚_A型環氧化合 物、溴化雙酚-F型環氧化合物、苯酚酚醛清漆(phen〇i η請㈣型環氧化合物、甲_駿清漆(c麵in〇v〇iac)型環 氧化合物、糾料祕清漆_氧化合物、溴化甲贿 〇 ΪΪίΐ環氧化合物、魏A _清漆型魏化合物、含 的環氧化合物、芳香族聚縮水甘油醚化合物、雙 環氧化合物、脂環式二縮水甘㈣化合物、 tit甘_化合物、多硫化物㈣祕e)型二缩 水甘油醚化合物以及聯苯酚型環氧化合物。 作為所述縮水甘油醋,例如可 合物及縮水甘油自旨環氧化合物。水甘油知化 合物 作為所述縮水甘油胺,例如 。 那了以列舉聚縮水甘油胺化 例如可以列 作為所述含有環氧絲化杨, 106 201030060 , x u.doc 舉具有環氧乙烷基(oxiranyl)的單體的均聚物及共聚物。 作為所述縮水甘油醯胺,例如可以列舉縮水甘油醯胺 型被氧化合物。 作為所述鏈狀脂肪族型環氧化合物,例如可以列舉將 烯烴(alkene)化合物的碳-碳雙鍵氧化而獲得的含有環 的化合物。 ^作為所述環狀脂肪族型環氧化合物,例如可以列舉將,.d〇C 201030060 举: glycidol mystery, glycidyl ester, glycidyl amine, epoxy-containing acrylic resin, glycidyl amide, glycidyl A giycidyl isocyanurate, a chain aliphatic epoxide, and a cyclic aliphatic epoxide. Further, the 'epoxy compound means a compound having an epoxy group, and the epoxy resin means a resin having an epoxy group. Examples of the glycidyl ether include a bisPhen〇l A type epoxy compound, a bisphenol F type epoxy compound, a bisphenol S type epoxy compound, a bisphenol type epoxy compound, and a hydrogenation double Phenol_A type epoxy compound, hydrogenated bisphenol-F type epoxy compound, hydrogenated bisphenol_s type epoxy compound, hydrogenated bisphenol type epoxy compound, brominated bisphenol type A epoxy compound, brominated double Phenol-F type epoxy compound, phenol novolac (phen 〇 η 请 (4) type epoxy compound, 甲 _ _ _ _ _ _ 面 〇 〇 〇 〇 环氧 环氧 环氧 、 、 _ _ _ _ _ _ _ _ 氧 氧 氧 氧甲甲〇ΪΪ 〇ΪΪ ΐ epoxy compound, Wei A _ varnish type Wei compound, epoxy compound, aromatic polyglycidyl ether compound, diepoxide, alicyclic dimethyl sulphate compound, titan _ compound, Polysulfide (iv) secret e) diglycidyl ether compound and biphenol type epoxy compound. As the glycidol vinegar, for example, a condensable compound and a glycidol-based epoxy compound. The glycidol compound is, for example, the glycidylamine. The amination of polyglycidyl glycerol, for example, can be listed as the homopolymer and copolymer of the monomer containing oxiranyl, 106. As the glycidylamine, for example, a glycidylamine type oxygenated compound can be mentioned. The chain aliphatic epoxy compound may, for example, be a ring-containing compound obtained by oxidizing a carbon-carbon double bond of an alkene compound. ^As the cyclic aliphatic epoxy compound, for example,
環烯烴化合物的碳-碳雙鍵氧化而獲得的含有環氧基的化 合物。 作為所述雙紛A型環氧化合物,例如可以列舉:828、 l〇(U、1002、1〇〇3、1〇〇4、1007、1〇1〇(均為日本環氧樹脂 (Japan Epoxy Resins)(股)製造),Ep〇t〇ht〇 YD128(東都化成 (股)製造)’ DER-331、DER-332、DER-324(均為 Dow Chemical Japan(股)製造),Epicl〇n840、Epicl〇n85〇、 EPicl〇nl〇5〇(均為 DIC(股)製造),Ep〇mic R_14〇、Ep〇mie R-301及Ep〇micR_3〇4(均為三井化學(股)製造)。 作為所述雙酚F型環氧化合物,例如可以列舉:8〇6、 8〇7、_4P(均為日本環氧樹脂(股)製造),Ep〇t〇ht〇 YDF-170、Epotohto YDF-175S、Epotohto YDF-2001(均為 東都化成(股)製造),DER-354(D〇w Chemical Japan(股)製 造),Epiclon830 及 Epiclon835(均為 DIC(股)製造)。 作為所述雙酚型環氧化合物,例如可以列舉2,2-雙(4-羥基笨基)-1,1,1,3,3,3_六氟丙烷的環氧化物。 作為所述氫化雙酚-A型環氧化合物,例如可以列舉: 107 201030060 JocAn epoxy group-containing compound obtained by oxidizing a carbon-carbon double bond of a cycloolefin compound. Examples of the double-type A-type epoxy compound include: 828, l〇 (U, 1002, 1〇〇3, 1〇〇4, 1007, 1〇1〇 (all Japanese epoxy resins (Japan Epoxy) Resins), Ep〇t〇ht〇YD128 (made by Toho Chemical Co., Ltd.) 'DER-331, DER-332, DER-324 (all manufactured by Dow Chemical Japan), Epicl〇n840 , Epicl〇n85〇, EPicl〇nl〇5〇 (all manufactured by DIC), Ep〇mic R_14〇, Ep〇mie R-301 and Ep〇micR_3〇4 (both manufactured by Mitsui Chemicals Co., Ltd.) Examples of the bisphenol F-type epoxy compound include: 8〇6, 8〇7, and _4P (all manufactured by Japan Epoxy Resin Co., Ltd.), Ep〇t〇ht〇YDF-170, and Epotohto YDF. -175S, Epotohto YDF-2001 (all manufactured by Tohto Kasei Co., Ltd.), DER-354 (manufactured by D〇w Chemical Japan Co., Ltd.), Epiclon 830 and Epiclon 835 (both manufactured by DIC). Examples of the phenol type epoxy compound include an epoxide of 2,2-bis(4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropane as the hydrogenated bisphenol-A. Examples of the epoxy compound include, for example: 107 201030060 Joc
Suntohto ST_3000(東都化成(股)製造)、脱⑽細 HBE-100(新日本理化(股)製造)以及以咖〇1 EX-252(Nagase chemtex(股)製造)。 作為所述虱化雙紛型環氧化合物,例如可以列舉氫化 2,2-雙(4-經基苯基氣丙烧的環氧化物。 作為所述溴化雙酚-A型環氧化合物,例如可以列舉: 5050、5051(均為日本環氧樹脂(股)製造),Ep〇t〇ht〇 YDB-360、Epotohto YDB-400(均為東都化成(股)製造), DER-530、DER-538(均為 Dow Chemical Japan(股)製造), 參 Epiclonl52 及 Epiclonl53(均為 DIC(股)製造)。 作為所述苯酚酚醛清漆型環氧化合物,例如可以列 舉:152、154(均為曰本環氧樹脂(股)製造)’ YDpN_638(東 都化成(股)製造)’ DEN431、DEN438(均為 Dow Chemical Japan(股)製造)’ Epiclon N_77〇(DIC(股)製造),EPPN-201 及EPPN-202(均為日本化藥(股)製造)。 作為所述曱酚酚醛清漆型環氧化合物,例如可以列 舉:180S75(日本環氧樹脂製造),yDCN_70丨、YDCN_7〇2(均 為東都化成(股)製造)’ EpiclonN-665、EpiclonN-695(均為 ❹ DIC(股)製造),EOCN-102S、EOCN-103S、EOCN-104S、 EOCN-1020、EOCN-1025 及 EOCN-1027(均為曰本化藥(股) 製造)。 作為所述雙驗A紛酸清漆型環氧化合物,例如可以列 舉157S70(曰本環氧樹脂(股)製造)以及Epicl〇n N-880(DIC(股)製造)。 108 201030060 i>doc 作為所述含有萘骨架的環氧化合物,例如可以列舉Suntohto ST_3000 (manufactured by Tohto Kasei Co., Ltd.), de-(10) fine HBE-100 (manufactured by Shin-Nihon Chemical Co., Ltd.), and curry 1 EX-252 (manufactured by Nagase Chemtex). Examples of the deuterated double-epelled epoxy compound include hydrogenated 2,2-bis(4-phenylphenyl alkoxylated epoxide. As the brominated bisphenol-A epoxy compound, For example, 5050, 5051 (all manufactured by Japan Epoxy Resin Co., Ltd.), Ep〇t〇ht〇YDB-360, Epotohto YDB-400 (both manufactured by Toho Chemical Co., Ltd.), DER-530, DER - 538 (all manufactured by Dow Chemical Japan Co., Ltd.), and Epiclonl 52 and Epiclon 53 (both manufactured by DIC). Examples of the phenol novolak type epoxy compound include 152 and 154 (both 曰). This epoxy resin (manufactured by Epoxy Resin Co., Ltd.) 'YDpN_638 (made by Toho Chemical Co., Ltd.)' DEN431, DEN438 (all manufactured by Dow Chemical Japan) Epiclon N_77〇 (manufactured by DIC), EPPN-201 and EPPN-202 (all manufactured by Nippon Kayaku Co., Ltd.) As the nonylphenol novolak type epoxy compound, for example, 180S75 (made by Nippon Epoxy Resin), yDCN_70丨, YDCN_7〇2 (both Dongdu) Chemical (share) manufacturing) 'Epiclon N-665, Epiclon N-695 (all manufactured by DIC DIC), EOCN-102 S, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025 and EOCN-1027 (all manufactured by Sakamoto Chemical Co., Ltd.). As the double-check A varnish-type epoxy compound, for example, 157S70 (manufactured by Epoxy Epoxy Resin Co., Ltd.) and Epicl Nn 880 (manufactured by DIC Co., Ltd.) 108 201030060 i>doc As the epoxy compound containing a naphthalene skeleton, for example,
Epiclon HP-4032、Epiclon HP-4700、Epiclon HP-4770(均為 DIC(股)製造)以及NC-7000(曰本化藥(股)製造)。 作為所述芳香族聚縮水甘油醚化合物,例如可以列 舉:對苯二紛二縮水甘油趟(hydroquinone diglycidyl ether)(下述結構式E101),鄰苯二酚二縮水甘油醚(catechol diglycidyl ether)(下述結構式E102),間苯二酚二縮水甘油 醚(resorcinol diglycidyl ether)(下述結構式 E103),三(4-縮 ❹ 水甘油基氧基苯基)甲烷(下述結構式E105),1031S、 1032H60(均為曰本環氧樹脂(股)製造),TACTIX-742(Dow Chemical Japan(股)製造),Denacol EX-20l(Nagase chemtex(股)製造),DPPN-503、DPPN-502H、DPPN-501H、 NC6000(均為日本化藥(股)製造),TechmoreVG3101L(三井 化學(股)製造),以下述結構式E106所表示的化合物以及 以下述結構式E107所表示的化合物。 ❹ 109 201030060, ___ A.. .aoc [化 77]Epiclon HP-4032, Epiclon HP-4700, Epiclon HP-4770 (both manufactured by DIC) and NC-7000 (manufactured by Sakamoto Chemical Co., Ltd.). As the aromatic polyglycidyl ether compound, for example, hydroquinone diglycidyl ether (the following structural formula E101), catechol diglycidyl ether ( The following structural formula E102), resorcinol diglycidyl ether (the following structural formula E103), tris(4-anthracene glycidyloxyphenyl)methane (the following structural formula E105) , 1031S, 1032H60 (all manufactured by Enamel Epoxy Co., Ltd.), TACTIX-742 (manufactured by Dow Chemical Japan), Denacol EX-20l (manufactured by Nagase Chemex), DPPN-503, DPPN- 502H, DPPN-501H, NC6000 (all manufactured by Nippon Kayaku Co., Ltd.), Techmore VG3101L (manufactured by Mitsui Chemicals Co., Ltd.), a compound represented by the following structural formula E106, and a compound represented by the following structural formula E107. ❹ 109 201030060, ___ A.. .aoc [化77]
作為所述雙環戊二烯酚型環氧化合物,例如可以, TACTIX-556(D〇w Chemical japan(股)製造)以及它列舉 HP-7200(DIC(股)製造)。 作為所述脂環式二縮水甘油謎化合物,例如 A」以列舉 環己烷二甲醇二縮水甘油醚化合物以及Rikaresin DME-100(新日本理化(股)製造)。 11〇 ii.doc 201030060As the dicyclopentadiene phenol type epoxy compound, for example, TACTIX-556 (manufactured by D〇w Chemical japan) and HP-7200 (manufactured by DIC) can be cited. Examples of the alicyclic diglycidyl mystery compound are, for example, A" cyclohexane dimethanol diglycidyl ether compound and Rikaresin DME-100 (manufactured by Shin Nippon Chemical and Chemical Co., Ltd.). 11〇 ii.doc 201030060
作為所述脂肪族聚縮水甘油醚化合物,例如可以列 舉:乙二醇二縮水甘油醚(下述結構式E108),二乙二醇一 縮水甘油醚(下述結構式E109),聚乙二醇二縮水甘油趟丁 丙二醇二縮水甘油醚(下述結構式E110),三丙二醇二縮水 甘油醚(下述結構式E111) ’聚丙二醇二縮水甘油喊,新戊 二醇二縮水甘油醚(下述結構式E112),1,4-丁二醇二縮水 甘油醚(下述結構式E113),1,6-己二醇二縮水甘油下述 結構式E114),二溴新戊二醇二縮水甘油醚(下述結構式 E115) > Denacol EX-810 ' Denacol EX-851 ^ Denacol EX-8301、Denacol EX-911、Denacol EX-920、Denacol EX-931 ' Denacol EX-211 ' Denacol EX-212 ' Denacol EX-313(均為 Nagase chemtex(股)製造), DD-503(ADEKA(股)製造),Rikaresin W-100(新日本理化 (股)製造)’ 1,3,5,6-四縮水甘油基-2,4-己二醇(下述結構式 E116) ’ 甘油聚縮水甘油鱗(giyCerinp〇iygiyCidyi ether),山 梨糖醇聚縮水甘油醚(sorbitol polyglycidyl ether),三經甲基 丙烧聚縮水甘油趟(trimethylolpropane polyglycidyl ether) ’ 季戊四醇聚縮水甘油醚(pentaerythritol polyglycidyl ether),Denacol EX-313、Denacol EX-611、Denacol EX-321 及 Denacol EX-411(均為 Nagase chemtex(股)製造)。 111 」.doc 201030060 [化 78]Examples of the aliphatic polyglycidyl ether compound include ethylene glycol diglycidyl ether (the following structural formula E108), diethylene glycol monoglycidyl ether (the following structural formula E109), and polyethylene glycol. Diglycidyl butane propylene glycol diglycidyl ether (structure E110 below), tripropylene glycol diglycidyl ether (structure E111 below) 'polypropylene glycol diglycidyl shunt, neopentyl glycol diglycidyl ether (described below Structural formula E112), 1,4-butanediol diglycidyl ether (Strong formula E113 below), 1,6-hexanediol diglycidyl, the following structural formula E114), dibromo neopentyl glycol diglycidyl Ether (Strong Formula E115 below) > Denacol EX-810 ' Denacol EX-851 ^ Denacol EX-8301, Denacol EX-911, Denacol EX-920, Denacol EX-931 ' Denacol EX-211 ' Denacol EX-212 ' Denacol EX-313 (both manufactured by Nagase Chemtex), DD-503 (made by ADEKA), Rikaresin W-100 (made by New Japan Physical and Chemical Co., Ltd.) 1,3,5,6-four shrinkage Glyceryl-2,4-hexanediol (Structure of Formula E116 below) 'GyryCerinp〇iygiyCidyi ether, sorbitol Sorbitol polyglycidyl ether, trimethylolpropane polyglycidyl ether 'pentaerythritol polyglycidyl ether, Denacol EX-313, Denacol EX-611, Denacol EX-321 And Denacol EX-411 (both manufactured by Nagase Chemtex). 111 ”.doc 201030060 [化78]
(E110) (E111)(E110) (E111)
(E113) ⑩ (E112)(E113) 10 (E112)
(E114) /Br(E114) /Br
(E115)(E115)
(E116) 作為所述多硫化物型二縮水甘油醚化合物, 列舉FLDP-5〇及FLDP顿均為加_(股)^以 作為所述聯苯酚型環氧化合物,例 γχ·4^顯(均為日本環氧‘(^ NC-3000P及NC_3000S(均為日本化藥(股)製造)。嶮)’ 作為所述二縮水甘油酯化合物,例如可以列舉.★ 二甲酸二縮水甘油酯(下述結構式117)、鄰笨二甲酸—對笨 112 201030060 , 甘油酯(下述結構式E118)、鄰苯二曱酸雙(2_曱基環氧乙烷 基曱基)酯(下述結構式E119)、以下述結構式E121所表示 的化合物、以下述結構式E122所表示的化合物以及以下 述結構式E123所表示的化合物。 [化 79](E116) As the polysulfide type diglycidyl ether compound, both FLDP-5〇 and FLDP are added as the bisphenol type epoxy compound, and γχ·4^ All of them are Japanese epoxy '(^ NC-3000P and NC_3000S (all manufactured by Nippon Kayaku Co., Ltd.). 崄)' As the diglycidyl ester compound, for example, dimethyl diglycidyl dicarboxylate can be cited. 117), o-p-dicarboxylic acid-pair stupid 112 201030060, glyceride (structure E118 below), bis(2- mercapto oxiranyl) phthalate (the following structure) The compound represented by the following structural formula E121, the compound represented by the following structural formula E122, and the compound represented by the following structural formula E123.
Ο 2 (E121)Ο 2 (E121)
(E123) 作為所述縮水甘油酯環氧化合物,例如可以列舉: 871 872(均為日本環氧樹脂(股)製造),Epiei〇n2〇〇、Epicl〇n 働(均為 DIC(股)製造),Denac〇1 Εχ_711 及 Denac〇1 113 20103000.doc 作為所述聚縮水甘油胺化合物,例如可以列舉:N,N-二縮水甘油基苯胺(下述結構式E124)、二縮水甘油基 -鄰甲苯胺(下述結構式Ε125)、Ν,Ν-二縮水甘油基_間甲苯 胺(下述結構式Ε126)、Ν,Ν-二縮水甘油基-2,4,6-三溴苯胺 (下述結構式Ε127)、3_(Ν,Ν-二縮水甘油基)氨基丙基三甲 氧基矽烷(下述結構式£128)、^[,:^,0-三縮水甘油基_對氨基 苯酚(下述結構式Ε129)、Ν,Ν,0-三縮水甘油基·間氨基苯酚 (下述結構式Ε130)、Ν,Ν,Ν’,Ν'-四縮水甘油基-間苯二甲胺 〇 (TETRAD-X(三菱氣體化學(股)),下述結構式Ε132)、1,3-雙(Ν,Ν-二縮水甘油基氨基甲基)環己院(TEtraD-C(三菱 氣體化學(股)),下述結構式Ε133)、1,4-雙(Ν,Ν-二縮水甘 油基氨基曱基)環己烷(下述結構式Ε134)、1,3-雙(Ν,Ν-二縮 水甘油基氨基)環己烧(下述結構式Ε135)、1,4_雙(1<[,]^-二縮 水甘油基氨基)環己烧(下述結構式Ε136)、1,3-雙(Ν,Ν-二縮 水甘油基氨基)苯(下述結構式Ε137)、1,4-雙(Ν,Ν-二縮水甘 油基氨基)苯(下述結構式Ε138)、2,6-雙(Ν,Ν_二縮水甘油基 氨基甲基)雙環Ρ.2.1]庚烷(下述結構式Ε139)、Ν,Ν,:Νη ❹ 四縮水甘油基-4,4’-二氨基二環己基曱烷(下述結構式 Ε140)、2,2-一甲基-(>^,1<[’,]^,-四縮水甘油基)_4,4’-二氨基 二笨基(下述結構式Ε141)、Ν,Ν,Ν,,Ν·-四縮水甘油基_4,4,_ 二氨棊二苯基醚(下述結構式EM2)、U,5_三(4_(1^^」縮 水甘油基)氨基苯氧基)苯(下述結構式E143)、2,4,4,_二 (N,N-二縮水甘油基氨基)二苯基_(下述結構式ei44)、三 114 -i.doc 201030060 (4-(N,N-二縮水甘油基)氨基苯基)甲烷(下述結構式 E145)、3,4,3',4’-四(N,N-二縮水甘油基氨基)聯苯(下述結構 式£146)、3,4,3’,4'-四(风讣二縮水甘油基氨基)二苯基醚(下 述結構式E147)、以下述結構式E148所表示的化合物以及 以下述結構式E149所表示的化合物。(E123) Examples of the glycidyl ester epoxy compound include: 871 872 (all manufactured by Japan Epoxy Resin Co., Ltd.), Epiei〇n 2〇〇, and Epicli〇n 働 (all manufactured by DIC) ), Denac〇1 Εχ_711 and Denac〇1 113 20103000.doc As the polyglycidylamine compound, for example, N,N-diglycidylaniline (the following structural formula E124), diglycidyl-ortho Toluidine (structure formula 下述125 below), hydrazine, hydrazine-diglycidyl-m-toluidine (structure Ε126 below), hydrazine, hydrazine-diglycidyl-2,4,6-tribromoaniline (below)结构127), 3_(Ν,Ν-diglycidyl)aminopropyltrimethoxydecane (the following structural formula: £128), ^[,:^,0-triglycidyl-p-aminophenol ( The following structural formula Ε129), hydrazine, hydrazine, 0-triglycidyl-m-aminophenol (the following structural formula Ε130), hydrazine, hydrazine, Ν', Ν'-tetraglycidyl-m-xylylenediamine oxime (TETRAD-X (Mitsubishi Gas Chemicals Co., Ltd.), the following structural formula Ε132), 1,3-bis(indene, Ν-diglycidylaminomethyl) cyclohexyl (TEtraD-C (Mitsubishi Gas Chemistry ( Share)), the following structural formula Ε1 33), 1,4-bis(indole, fluorene-diglycidylaminomethyl)cyclohexane (the following structural formula Ε134), 1,3-bis(indole, fluorene-diglycidylamino) cyclohexane Burning (the following structural formula Ε135), 1,4_double (1<[,]^- diglycidylamino) cyclohexene (the following structural formula Ε136), 1,3-double (Ν,Ν-二Glycidylamino)benzene (the following structural formula Ε137), 1,4-bis(indole, fluorene-diglycidylamino)benzene (the following structural formula Ε138), 2,6-double (Ν,Ν_二Glycidylaminomethyl)bicycloindole.2.1]heptane (structure Ε139 below), hydrazine, hydrazine, Νη ❹ tetraglycidyl-4,4'-diaminodicyclohexyldecane (structure Ε140), 2,2-monomethyl-(>^,1<[',]^,-tetraglycidyl)_4,4'-diaminodiphenyl (the following structural formula Ε141), Ν ,Ν,Ν,,Ν·-tetraglycidyl_4,4,_ Diaminostilbene diphenyl ether (the following structural formula EM2), U,5_three (4_(1^^" glycidyl) Aminophenoxy)benzene (the following structural formula E143), 2,4,4,-bis(N,N-diglycidylamino)diphenyl- (the following structural formula ei44), three 114-i. Doc 201030060 (4-(N,N-diglycidyl) Aminophenyl)methane (structure E145 below), 3,4,3',4'-tetrakis(N,N-diglycidylamino)biphenyl (structured formula 146 below), 3,4 3', 4'-tetrakis (aerobic diglycidylamino) diphenyl ether (the following structural formula E147), a compound represented by the following structural formula E148, and a compound represented by the following structural formula E149.
115 201030060 [化 80]115 201030060 [化80]
(E124)(E124)
(E126)(E126)
(E136)(E136)
116 201030060 it.doc [化 81]116 201030060 it.doc [化81]
117 201030060 [化 82]117 201030060 [化82]
(Ε148)(Ε148)
作為所述具有環氧乙烷基的單體 ,聚甲基丙稀酸縮水甘油醋。作可以 丙烯酸縮水甘油酯妓努札舉本基馬來醯亞胺-甲基 ^ 物、環己基馬來酿亞胺甲其 酸縮水甘油酯共聚物、田w 亞胺-甲基丙烯 甲基丙烯酸苄酯-曱基丙烯酸縮水甘 118As the monomer having an oxiranyl group, polymethyl methacrylate glycidol vinegar. Glycidyl acrylate 妓 札 举 本 本 基 马 马 醯 醯 甲基 甲基 甲基 甲基 甲基 甲基 甲基 甲基 、 、 、 、 、 、 、 环 环 环 环 环 环 环 环 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚 亚Benzyl ester-mercaptoacrylic acid glycosyl 118
201030060 H —..j-ii.aoc 油酯共聚物、曱基丙烯酸丁酯-甲基丙烯酸縮水甘油酯共聚 物、甲基丙烤酸2-幾基乙醋-曱基丙婦酸縮水甘油醋共聚 物、甲基丙烯酸(3-乙基-3-環氧丙烷基)甲酯-甲基丙婦&縮 水甘油酯共聚物以及苯乙烯-曱基丙烯酸縮水甘油酯共聚 物。 作為所述具有環氧乙烧基的單體,例如可以列舉:(甲 基)丙烯酸縮水甘油酯、(甲基)丙烯酸3,4-環氧環己醋以及 (甲基)丙烯酸甲基縮水甘油酯。 作為所述具有環氧乙烷基的單體的共聚物中的除所 述具有環氧乙烷基的單體以外的其他單體,例如可以列 舉:(甲基)丙烯酸、(曱基)丙烯酸曱酯、(曱基)丙烯酸乙醋、 (甲基)丙烯酸異丙酯、(曱基)丙烯酸丁酯、(甲基)丙烯酸異 丁酯、(甲基)丙烯酸叔丁酯、(甲基)丙烯酸環己酯、(曱基) 丙烯酸苄酯、(甲基)丙烯酸2-羥基乙酯、(甲基)丙稀酸2_ 經基丙酯、苯乙烯、甲基苯乙烯、氯曱基苯乙烯、(曱基) 丙埽酸(3-乙基-3_環氧丙烧基)甲酯、Ν-環己基馬來醯亞胺 φ 以及Ν-苯基馬來醯亞胺。201030060 H —..j-ii.aoc oil ester copolymer, butyl methacrylate-glycidyl methacrylate copolymer, methyl propyl acetoacetate 2-methyl acetoacetate Copolymer, (3-ethyl-3-epoxypropenyl)methyl methacrylate-methylpropanol & glycidyl ester copolymer and styrene-glycidyl methacrylate copolymer. Examples of the monomer having an ethylene oxide group include glycidyl (meth)acrylate, 3,4-epoxycyclohexanacetate (meth)acrylate, and methyl glycidol (meth)acrylate. ester. Examples of the monomer other than the monomer having an oxiranyl group in the copolymer of the oxiranyl group-containing monomer include (meth)acrylic acid and (mercapto)acrylic acid. Ethyl ester, (mercapto) ethyl acrylate, isopropyl (meth) acrylate, butyl (meth) acrylate, isobutyl (meth) acrylate, t-butyl (meth) acrylate, (methyl) Cyclohexyl acrylate, benzyl (meth) methacrylate, 2-hydroxyethyl (meth) acrylate, 2-methyl propyl acrylate, styrene, methyl styrene, chlorodecyl styrene , (mercapto) propionate (3-ethyl-3_glycidyl) methyl ester, fluorene-cyclohexylmaleimide φ and fluorenyl-phenylmaleimide.
作為所述縮水甘油基異氰尿酸醋,例如可以列舉: 1,3,5-三縮水甘油基-1,3,5-三嗪-2,4,6-(1Η,3Η,5Η)-三酮 (l,3,5-triglycidyl-l,3,5-triazine-2,4,6-(lH,3H,5H)-trione)(T 述結構式E150)、1,3-一縮水甘油基-5-稀丙基-1,3,5-三嗓 _2,4,6_(1Ή,3ΡΙ,5ίί)-三酮(下述結構式E151)以及縮水甘油基 異氰尿酸醋型環氧樹脂。 119 201030060 / ^/Ai.doc [化 83]As the glycidyl isocyanuric acid vinegar, for example, 1,3,5-triglycidyl-1,3,5-triazine-2,4,6-(1Η,3Η,5Η)-three Ketone (l,3,5-triglycidyl-l,3,5-triazine-2,4,6-(lH,3H,5H)-trione) (T structural formula E150), 1,3-glycidyl -5-Dilyl-1,3,5-trisole_2,4,6_(1Ή,3ΡΙ,5ίί)-trione (structure E151 below) and glycidyl isocyanurate-type epoxy resin . 119 201030060 / ^/Ai.doc [Chem. 83]
(E150)(E150)
作為所述鏈狀脂肪族型環氧化合物,例如可以列舉環 氧化聚丁二烯以及Epolead PB3600(Daicel化學工業(股)製 造)。 作為所述環狀脂肪族型環氧化合物,例如可以列舉: 2-曱基-3,4-環氧環己基曱基_2,_曱基_3,,4’_環氧環己基羧酸 酯(下述結構式E153),2,3-環氧環戊烷-2,,3,-環氧環戊烷醚 (下述結構式E154),ε-己内酯改性3,‘環氧環己基甲基 -3Ί-環氧環己烷羧酸酯,二環氧檸檬稀 (Celloxide3000(DaiCd化學工業(股)製造)’ 3,4_環氧環己烯 基曱基-3,’4’·環氧環己烯羧酸酯(Celloxide2〇2lp(Daicel化 學工業(股)製造)’下述結構式E155) ’以下述結構式E156 所表示的化合物,CY-175、CY-177、CY-179(均為 CffiA-GEIGY 社製造),EHPD-3150(Daicel 化學工業(股) 製造)以及環狀脂肪族型環氧樹脂。 120 201030060 —^ > / j^ii.doc [化 84]Examples of the chain aliphatic epoxy compound include epoxidized polybutadiene and Epolead PB3600 (manufactured by Daicel Chemical Industry Co., Ltd.). As the cyclic aliphatic epoxy compound, for example, 2-mercapto-3,4-epoxycyclohexylfluorenyl 2,-fluorenyl-3,4'-epoxycyclohexylcarboxylic acid can be exemplified. Ester (Strong Formula E153 below), 2,3-epoxycyclopentane-2,3,-epoxycyclopentane ether (Structure of Formula E154 below), ε-Caprolactone Modification 3, 'Ring Oxycyclohexylmethyl-3Ί-epoxycyclohexanecarboxylate, diepoxide lemon dilute (Celloxide 3000 (DaiCd Chemical Industry Co., Ltd.)' 3,4_epoxycyclohexenylindolyl-3,' 4'·Epoxycyclohexenecarboxylate (Celloxide 2〇2lp (manufactured by Daicel Chemical Industry Co., Ltd.) 'The following structural formula E155) 'The compound represented by the following structural formula E156, CY-175, CY-177, CY-179 (both manufactured by CffiA-GEIGY), EHPD-3150 (manufactured by Daicel Chemical Industry Co., Ltd.), and cyclic aliphatic epoxy resin. 120 201030060 —^ > / j^ii.doc [Chem. 84 ]
(E153) (E154)(E153) (E154)
(E155)(E155)
(E156)(E156)
另外,例如本發明的液晶配向劑可以進一步含有各種 添加劑。作為各種添加劑,例如可以列舉聚醯胺酸及其衍 生物以外的高分子化合物及齡子化合物,可以根據各^ 目的來選擇使用。 # ,例如,作為所述高分子化合物,可以列舉可溶於有機 溶媒的面分子化合物。就控綱形成職晶配向膜的電性 能或配向性的觀點而言,優選將此種高分子化合物添加到 本發明的液晶配向劑中。作為該高分子化合物,例如可以 列舉.聚醯胺、聚氨醋(p〇lyurethane)、聚脲(p〇lyurea)、聚 S曰(polyester)、聚環氧化物(p〇iyep〇xide)、聚酯多元醇 (polyesterP〇iyol)、矽酮改性聚氨酯以及矽酮改性聚酯。 另外,作為所述低分子化合物,例如:1)當期望提高 塗布ί±時可以列舉符合該目的介面活性劑,2)當必須提& 抗靜電性時可以列舉抗靜·,3)#敏提高與基板的密 接除或耐摩擦性時可以列舉碎烧偶合劑(沿如^ agent)或鈦(titanium)系的偶合劑,另外,4)當在低溫下進行 醯亞胺化時可以列舉醯亞胺化催化劑。 121 201030060, —- r」.doc 作為所述石夕烧偶合劑,例如可以列舉:乙稀基三甲氧 基石夕燒(vinyl trimethoxysUane)、⑽基三乙氧基石夕烷、 N-(2-氣基乙基)-3-氨基丙基曱基二曱氧基石夕烧、N♦氣基 乙基)_3_氨基丙基曱基三曱氧基石夕貌、對氨基苯基三甲氧 基石夕燒、對氨基苯基二乙氧基發燒、間氨基笨基三甲氧基 石夕烧、間氨基苯基二乙氧基石夕燒、3_氨基丙基三曱氧基矽 院、3-氨基丙基三乙氧基梦燒' 縮水甘油氧基丙基三曱 氧基矽烷、3-縮水甘油氧基丙基甲基二甲氧基矽烷、2_(3,4_ 環氧環己基)乙基三甲氧基魏、3_氯丙基f基二曱氧基# ⑩ 烷、3-氣丙基三甲氧基矽烷、3_曱基丙烯醯氧基丙基三甲 氧基矽烷、3-酼基丙基三甲氧基矽烷、坏(1,3_二曱基亞丁 基)-3-(三乙氧基曱矽烷基)-1-丙胺以及n,n,-雙[3-(三甲氧 基曱矽烷基)丙基]乙二胺。 作為所述醯亞胺化催化劑,例如可以列舉:三甲胺 (trimethylamine)、三乙胺、三丙胺、三丁胺等脂肪族胺類; N,N-二曱基苯胺、N,N-二乙基苯胺、被甲基取代的苯胺、 被羥基取代的苯胺等芳香族胺類;吡啶、被曱基取代的„比 咬、被經基取代的11比咬、喧嘛(quinoline)、被甲基取代的哇 ® 啉、被羥基取代的喹琳、異喹啉、被甲基取代的異啥琳、 被羥基取代的異喹啉、咪唑(imidazole)、被甲基取代的_ 唑、被羥基取代的咪唑等環式胺類。所述醯亞胺化催化劑 優選選自N,N-二甲基苯胺、鄰羥基苯胺、間羥基苯胺、對 羥基苯胺、鄰羥基吡啶、間羥基吡啶、對羥基吡咬以及異 喹啉中的一種或者兩種或兩種以上。 122 201030060Further, for example, the liquid crystal alignment agent of the present invention may further contain various additives. Examples of the various additives include a polymer compound other than polyglycine and a derivative thereof, and an age-related compound, and can be selected and used according to each purpose. For example, as the polymer compound, a surface molecule compound which is soluble in an organic solvent can be mentioned. From the viewpoint of controlling the electrical properties or the alignment properties of the crystal alignment film, it is preferred to add such a polymer compound to the liquid crystal alignment agent of the present invention. Examples of the polymer compound include polyamine, p〇lyurethane, polyurea, poly S, polyepoxide, and polyepoxide (p〇iyep〇xide). Polyester polyol (polyester P〇iyol), anthrone modified polyurethane and anthrone modified polyester. Further, as the low molecular compound, for example, 1) when it is desired to increase the coating thickness, a surfactant suitable for the purpose may be mentioned, and 2) when it is necessary to mention & antistatic property, antistatic may be mentioned, 3) #敏When the adhesion to the substrate or the rubbing resistance is improved, a coupling agent for a chipping agent (along the agent) or a titanium system may be mentioned, and 4) when the hydrazine imidization is carried out at a low temperature, 醯Imidization catalyst. 121 201030060, —- r”. doc As the zebra calcining agent, for example, vinyl trimethoxys Uane, (10)-based triethoxy oxalate, N-(2-gas) may be mentioned. Ethyl ethyl)-3-aminopropyl fluorenyl dioxime oxime, N ♦ acetoyl ethyl) _ 3 _ amino propyl decyl trimethoxy oxime, p-aminophenyl trimethoxy sulphur, P-aminophenyldiethoxylate, m-amino-p-trimethoxy-zepa-sinter, m-aminophenyldiethoxylate, 3-aminopropyltrimethoxy oxime, 3-aminopropyltriethyl Oxygen-burning 'glycidoxypropyltrimethoxy decane, 3-glycidoxypropylmethyldimethoxydecane, 2_(3,4-epoxycyclohexyl)ethyltrimethoxywei, 3-Chloropropylf-yldimethoxy-#10 alkane, 3-apropylpropyltrimethoxydecane, 3-mercaptopropenyloxypropyltrimethoxydecane, 3-mercaptopropyltrimethoxydecane , (1,3-didecylbutylene)-3-(triethoxydecyl)-1-propylamine and n,n,-bis[3-(trimethoxydecyl)propyl] Ethylenediamine. Examples of the ruthenium amide catalyst include aliphatic amines such as trimethylamine, triethylamine, tripropylamine, and tributylamine; N,N-dimercaptoaniline, N,N-diethyl An aromatic amine such as a aniline, a phenylamine substituted with a methyl group, or an aniline substituted with a hydroxy group; a pyridine substituted with a thiol group, a 11-bit bite substituted by a thiol group, a quinoline, a methyl group Substituted wow® porphyrin, quinolin substituted by hydroxy group, isoquinoline, isoindolin substituted by methyl group, isoquinoline substituted by hydroxy group, imidazole, azole substituted by methyl group, substituted by hydroxy group a cyclic amine such as imidazole. The ruthenium amide catalyst is preferably selected from the group consisting of N,N-dimethylaniline, o-hydroxyaniline, m-hydroxyaniline, p-hydroxyaniline, o-hydroxypyridine, m-hydroxypyridine, p-hydroxypyridyl. One or two or more of biting and isoquinoline. 122 201030060
取贩胺駿或其衍生物的總重量的 0 wt% 1负所不同’通常為 〜30 wt%,優選為 0.1 wt%〜ίο μ%。 妨里^例如本發_液晶_财以林損及本發明 果,圍(優ϋ為所述雜喊或其衍生物的2()感以 内的量)内進—步含有:丙烯酸聚合物,丙稀酸g旨聚合物, 作為吨酸二酐、二舰或其魅物與二胺的反應生 成物的聚醯胺醯亞胺等其他聚合物成分。 〜另外,例如就調整液晶配向劑的塗布性或者所述聚醯 酸戈/、竹生物的濃度的觀點而言,本發明的液晶配向劑 I以進一步含有溶劑。所述溶劑只要是具有溶解高分子成 分的能力的溶劑,那麼可以無特別限制地使用。所述溶劑 廣泛地包括聚醯胺酸、可溶性聚醯亞胺等高分子成分的製 造步驟或用途方面所通常使用的溶劑,可以根據使用目的 而適宜選擇。所述溶劑可以是一種溶劑,也可以是兩種或 兩種以上溶劑的混合溶劑。 作為所述溶劑,可以列舉所述聚醯胺酸或其衍生物的 良溶劑、或者以改善塗布性為目的之其他溶劑。 對於所述聚醯胺酸或其衍生物而言為良溶劑的非質 123 201030060, ___..^^ι.αοο 子性極性有機溶劑可以列舉:Ν-甲基-2-吡咯烷酮 (N-methyl-2-pyrrolidone)、二曱基 _ °坐淋酮(dimethyl imidazolidinone) 、N-甲基己内酿胺(N-methyl caprolactam)、N-曱基丙酿胺(N-methyl propionamide)、Ν,Ν-二甲基乙酿胺、二曱基亞礙(dimethyl sulfoxide)、N,N-二曱 基曱醯胺(N,N-dimethylformamide)、Ν,Ν-二乙基曱醯胺、 二乙基乙酿胺、γ-丁内醋(γ-butyrolactone)等内醋。 作為所述以改善塗布性等為目的之其他溶劑的例 子,可以列舉:乳酸烷基酯、3-曱基-3-甲氧基丁醇 Θ (3-methyl-3-methoxybutanol)、萘滿(tetralin)、異佛爾酮 (isophorone)、乙二醇單丁醚(ethylene glycol monobutylether) 等乙二醇單烷基醚、二乙二醇單乙醚等二乙二醇單烷基 醚、乙二醇單烷基或苯基乙酸酯、三乙二醇單烷基醚、丙 二醇單曱醚、丙二醇單丁醚等丙二醇單烷基醚、丙二酸二 乙酯(diethyl malonate)等丙二酸二烷基酯、二丙二醇單曱醚 等二丙二醇單烧基_、它們的乙酸g旨類等g旨化合物。Between 0 wt% and 1 minus the total weight of the amine or its derivative is usually '~30 wt%, preferably 0.1 wt% to ίο μ%. In the case of the present invention, for example, the present invention is in the form of an acrylic polymer. Acrylic acid-based polymer, other polymer components such as polyamidoximine, which is a reaction product of tonic acid dianhydride, two ships, or a reaction product thereof with diamine. Further, for example, the liquid crystal alignment agent I of the present invention further contains a solvent from the viewpoint of adjusting the coatability of the liquid crystal alignment agent or the concentration of the polyamic acid/the bamboo organism. The solvent is not particularly limited as long as it has a solvent having the ability to dissolve the polymer component. The solvent broadly includes a solvent which is usually used in the production step or use of a polymer component such as polyglycolic acid or soluble polyimine, and can be appropriately selected depending on the purpose of use. The solvent may be a solvent or a mixed solvent of two or more solvents. The solvent may be a good solvent of the polyaminic acid or a derivative thereof or another solvent for the purpose of improving coatability. Non-quality 123 201030060, ___..^^ι.αοο sub-polar organic solvent for the poly-proline or its derivative is Ν-methyl-2-pyrrolidone (N-methyl -2-pyrrolidone), dimethyl imidazolidinone, N-methyl caprolactam, N-methyl propionamide, anthraquinone, Ν-Dimethyl ethoxylated amine, dimethyl sulfoxide, N,N-dimethylformamide, hydrazine, hydrazine-diethyl decylamine, diethyl Internal vinegar such as acetylamine and γ-butyrolactone. Examples of the other solvent for the purpose of improving coatability and the like include alkyl lactate, 3-methyl-3-methoxybutanol, and tetralin ( Tetraethylene glycol monoalkyl ether such as tetralin), isophorone, ethylene glycol monobutylether, diethylene glycol monoalkyl ether such as diethylene glycol monoethyl ether, ethylene glycol Propylene glycol monoalkyl ether such as monoalkyl or phenyl acetate, triethylene glycol monoalkyl ether, propylene glycol monoterpene ether, propylene glycol monobutyl ether, malonic acid such as diethyl malonate A dipropylene glycol monoalkyl group such as an alkyl ester or a dipropylene glycol monoterpene ether, or a compound thereof such as an acetic acid g.
這些化合物中,所述溶劑特別優選N-曱基-2-吡咯烷 酮、二甲基咪唑啉酮、γ-丁内酯、乙二醇單丁醚、二乙二 W 醇單乙醚、丙二醇單丁醚、丙二醇單曱趟以及二丙二醇單 甲謎。 于本發明中,液晶配向劑中的包含所述聚醯胺酸或者 其衍生物的尚分子成分的濃度並無特別限定,優選為Ο} wt%〜40 wt%。將該液晶配向劑塗布在基板上時,有時為 了調整膜厚而必須進行預先利用溶劑來將所含有的高分^ 124 201030060 ·»j^it.doc f分稀獅齡。_,就贿晶配向_喊調整成適 合在液晶配向劑中容易地混合溶劑的钻度的觀點而言,所 述面分子成分的濃度優選彳、於等於4〇wt%。 另外’液晶配向劑中的所述高分子成分的濃度有時也 要根據液晶配向劑的塗布方法來調整。當液晶配向劑的塗 布方法為旋,法或印刷法時,為了良好地保持膜厚,通常 大夕使所述㊉分子成分的濃度小於等於1G wt%。對於其他 塗布方法,例如浸潰(dipping成或噴墨_⑽法來說,有 可f要進-^降低濃度。另—方面,如果所述高分子成分 的》辰度大於等於0.1 wt%,那麼所獲得的液晶配向膜的膜 厚谷易成為最佳的厚度。因此,在通常的旋塗法或印刷法 等中,所述咼分子成分的濃度大於等於wt%,優選為 0.5 wt%〜1〇 wt%。但是,根據液晶配向劑的塗布方法,有 時也可以在更低的濃度下使用。 此外,將本發明的液晶配向劑用於製作液晶配向膜 時,本發明的液晶配向劑的粘度可以根據形成此液晶配向 φ 劑的膜的機構或方法來決定。例如當使用印刷機來形成液 晶配向劑的膜時,就獲得足夠的膜厚的觀點而言,本發明 的液aa配向劑的枯度優選為大於等於5 mPa.s,另外,就抑 制印刷不均的觀點而言,本發明的液晶配向劑的粘度優選 為小於等於lOOmPa.s ’更優選為l〇mpa.s〜8〇mpa.s。當 利用旋塗法(spin coat)來塗布液晶配向劑而形成液晶配向 劑的膜時’就相同的觀點而言,本發明的液晶配向劑的钻 度優選為5 mPa.s〜200 mPa.s,更優選為1〇 mpa.s〜1〇〇 125 201030060, mP a. s。液晶配向劑的粘度可以通過溶劑的稀釋或伴隨著攪 拌的熟化而減小。 本發明的液晶配向劑可以是含有一種聚醯胺酸或其 衍生物的形態,也可以是混合了兩種或兩種以上聚酿胺酸 或其衍生物的所明聚合物摻合物的形態。聚合物摻合物的 形態的液晶配向劑可以列舉如下的液晶配向劑:此液晶配 向劑含有聚醯胺酸或其衍生物A&B,聚醯胺酸或它的衍 生物A包含二胺中以所述通式(1)及通式(11)所表示的具有 側鏈結構的二胺的一種或一種以上,且聚醯胺酸或其衍生 ❹ 物A及B的四羧酸二酐的一方或雙方包含以所述通式 (TC-1)〜通式(TC-14)所表示的四羧酸二酐的一種或一種 以上與其他四羧酸二酐的一種或一種以上。 聚醯胺酸或其衍生物A優選為含有所述具有側鏈結 構的二胺的聚醯胺酸或其衍生物。聚醯胺酸或其衍生物B 優選為含有除具有侧鏈結構的二胺以外的二胺的聚醯胺酸 或其衍生物。以所述通式(TC-1)〜通式(TC_14)所表示的四 鲮酸二酐與其他四羧酸二酐只要包含於聚合物摻合物中所 〇 混合的至少一種聚醯胺酸或其衍生物中即可,可以包含於 聚醯胺酸或其衍生物A及B雙方中,也可以包含於聚合物 摻合物中所混合的所有聚醯胺酸或它們的衍生物中。 本發明的液晶配向膜是對所述本發明的液晶配向劑 的塗膜進行加熱而形成的膜。本發明的液晶配向膜可以使 用由液晶配向劑來製作液晶配向膜的通常方法而獲得,例 如,本發明的液晶配向膜可以通過形成本發明液晶配向劑 126 201030060, 的塗膜的步驟、以及對該塗膜進行加熱並煆燒的步驟而獲 得。對於本發明的液晶配向膜來說,可視需要對所述煆燒 步驟中所獲得的膜進行摩擦處理。 與通常的液晶配向膜的製作相同,所述塗膜可以通過 在液晶顯示元件的基板上塗布本發明的液晶配向劑而形 成。所述基板可以列舉:可以設置氧化鋼錫(Indiuin Tin Oxide ’ ITO)電極等電極或彩色滤光片(c〇i〇r mter)等的玻璃 制基板。 ® 作為將液晶配向劑塗布在基板上的方法,通常已知有 旋塗法、印刷法、浸潰法、落滴法(falling_dr〇p meth〇d)、 喷墨法等。這些方法在本發明中同樣也可以應用。 所述塗膜的煆燒可以在所述聚醯胺酸或其衍生物進 行脫水、閉環反應所需要的條件下進行。所述塗膜的煆燒 通常已知有在烘箱(oven)或紅外爐中進行加熱處理的方 法、在加熱板(hotplate)上進行加熱處理的方法等。這些方 法在本發明中同樣也可以應用。通常優選在15〇。〇〜如一此 ❷ 左右的溫度下進行1分鐘〜3小時。 所述摩擦處理能夠以與通常用來對液晶 配向處理的摩擦處理相同的方式來進行,只Among these compounds, the solvent is particularly preferably N-mercapto-2-pyrrolidone, dimethylimidazolidinone, γ-butyrolactone, ethylene glycol monobutyl ether, diethylenediethanol monoethyl ether, propylene glycol monobutyl ether. , propylene glycol monoterpene and dipropylene glycol single mystery. In the present invention, the concentration of the molecular component containing the polyamic acid or the derivative thereof in the liquid crystal alignment agent is not particularly limited, and is preferably wt} wt% to 40% by weight. When the liquid crystal alignment agent is applied onto a substrate, it is necessary to adjust the film thickness, and it is necessary to use a solvent in advance to separate the high scores contained in the lion. The concentration of the surface molecular component is preferably 彳, which is equal to 4 〇 wt%, from the viewpoint of adjusting the degree of drilling of the solvent in the liquid crystal alignment agent. Further, the concentration of the polymer component in the liquid crystal alignment agent may be adjusted depending on the method of applying the liquid crystal alignment agent. When the coating method of the liquid crystal alignment agent is a spinning method or a printing method, in order to maintain the film thickness favorably, the concentration of the neutron component is usually 1 G wt% or less. For other coating methods, such as dipping (dipping or inkjet_(10) method, there is a possibility to reduce the concentration. On the other hand, if the polymer component has a degree of greater than or equal to 0.1 wt%, Then, the film thickness of the obtained liquid crystal alignment film tends to be an optimum thickness. Therefore, in a usual spin coating method, a printing method, or the like, the concentration of the ruthenium molecular component is greater than or equal to wt%, preferably 0.5 wt%. 1% by weight. However, depending on the method of applying the liquid crystal alignment agent, it may be used at a lower concentration. Further, when the liquid crystal alignment agent of the present invention is used for producing a liquid crystal alignment film, the liquid crystal alignment agent of the present invention The viscosity can be determined according to the mechanism or method of forming the film of the liquid crystal alignment agent. For example, when a film of a liquid crystal alignment agent is formed using a printing machine, the liquid aa alignment of the present invention is obtained from the viewpoint of obtaining a sufficient film thickness. The degree of dryness of the agent is preferably 5 mPa·s or more, and the viscosity of the liquid crystal alignment agent of the present invention is preferably 100 mPa·s or less, more preferably l〇mpa.s. 8〇mpa.s. When the liquid crystal alignment agent is applied by spin coating to form a film of a liquid crystal alignment agent, the degree of penetration of the liquid crystal alignment agent of the present invention is preferably 5 mPa·s to 200 mPa·s. More preferably, it is 1 〇 mpa.s 〜1 〇〇 125 201030060, mP a. s. The viscosity of the liquid crystal alignment agent can be reduced by dilution of the solvent or aging with stirring. The liquid crystal alignment agent of the present invention may contain a kind of The form of the polyaminic acid or a derivative thereof may be in the form of a polymer blend of two or more kinds of polyacrylic acid or a derivative thereof. The liquid crystal of the form of the polymer blend The alignment agent may, for example, be a liquid crystal alignment agent containing polylysine or a derivative thereof A & B, polyamine or its derivative A comprising a diamine in the formula (1) and One or more of the diamines having a side chain structure represented by the formula (11), and one or both of the polycarboxylic acid or the tetracarboxylic dianhydrides of the derivatives A and B thereof contain the above formula (TC-1) - one or more kinds of tetracarboxylic dianhydride represented by the formula (TC-14) and others One or more kinds of carboxylic acid dianhydride. Poly-proline or a derivative A thereof is preferably a polyamine or a derivative thereof containing the diamine having a side chain structure. Polylysine or a derivative thereof Preferably, it is a polyaminic acid or a derivative thereof containing a diamine other than a diamine having a side chain structure. The tetradecanoic acid dianhydride represented by the above formula (TC-1) to (TC_14) The other tetracarboxylic dianhydride may be contained in at least one polyamic acid or a derivative thereof mixed in the polymer blend, and may be contained in both the polyaminic acid or its derivatives A and B. It may also be included in all polyamines or their derivatives mixed in the polymer blend. The liquid crystal alignment film of the present invention is a film formed by heating the coating film of the liquid crystal alignment agent of the present invention. The liquid crystal alignment film of the present invention can be obtained by a usual method of producing a liquid crystal alignment film from a liquid crystal alignment agent, for example, a step of forming a coating film of the liquid crystal alignment film of the present invention by forming the liquid crystal alignment agent 126 201030060 of the present invention, and The coating film is obtained by a step of heating and calcining. For the liquid crystal alignment film of the present invention, the film obtained in the calcining step may be subjected to a rubbing treatment as needed. The coating film can be formed by applying the liquid crystal alignment agent of the present invention onto a substrate of a liquid crystal display element, as in the production of a usual liquid crystal alignment film. The substrate may be a glass substrate such as an electrode such as an Indigo Tin Oxide ITO electrode or a color filter (c〇i〇r mter). ® As a method of applying a liquid crystal alignment agent onto a substrate, a spin coating method, a printing method, a dipping method, a falling method (droping method), an ink jet method, and the like are generally known. These methods are equally applicable in the present invention. The calcination of the coating film can be carried out under the conditions required for the dehydration and ring closure reaction of the polyaminic acid or its derivative. The calcination of the coating film is generally known as a method of heat treatment in an oven or an infrared furnace, a method of heat treatment on a hot plate, and the like. These methods are equally applicable in the present invention. It is usually preferably 15 Torr. 〇 ~ As one ❷ Between the left and right temperatures for 1 minute ~ 3 hours. The rubbing treatment can be performed in the same manner as the rubbing treatment generally used for the alignment treatment of the liquid crystal, only
在可以獲得本發明效果的範圍 I·液晶配向膜進行 ,只要是可以在本 r充分的延遲的條件即可。特別優 U mm〜(U mm’平臺移動速度為 滾筒轉速為5GGrPm〜2,〇G〇rpm。 ’除摩擦法以外,通常已 201030060, 本發妙其他植㈣理方法。 禅,其他步r二=:== :捧==所述塗膜乾燥的步称、或者== 摩擦處理讀⑽進行清洗的步驟等。 燒步驟烟’所述乾燥步驟通常已 〇 ==:進行加熱處理的方法、在加熱板上進行加 :、處理的方法等。這些方法在所述錢步财同樣也可以 應用。乾燥步驟優選在溶舰夠蒸發的範圍内的溫度下實 Ϊ眚ΐ優選在與所述煆燒步_温度相_對較低的溫度 h貫施。 作為使用清洗㈣g&向處理前後的液晶配向膜進行 清洗的清洗方法,可以_: ^(bmshing)、射流霧化⑽ ❹ =ray)、蒸氣清洗或超聲波清洗等。這些方法可以單獨進 行,也可以並用。作為清洗液,可以使用:純水,或者曱 醇(mehtyl alcohol)、乙醇、異丙醇等各種醇類,苯、曱苯 (toluene)、二曱苯(Xylene)等芳香族烴類,二氯甲烧 (methylene chloride)等鹵素類溶劑’丙酮(acet〇ne)、甲基 ^ 基酮(methyl ethyl ketone)等酮類,但並不限定於這些^洗 液。當然,這些清洗液可以使用經充分純化的雜質少的清 洗液。此種清洗方法也可以應用在形成本發明的液晶配向 膜的所述清洗步驟中。 本發明的液晶配向膜的膜厚並無特別限定,優選為1〇 nm〜300nm,更優選為30nm〜150nm。本發明的液晶配 128 201030060 , —..^n.doc 向膜的膜厚可以使用表面輪廊儀或擴偏儀(ellipsometer)等 眾所周知的膜厚測定裝置來測定。 本發明的液晶顯示元件具有:一對基板;液晶層,含 有液晶分子,並形成於所述一對基板之間;電極,對液晶 層施加電壓;以及液晶配向膜’將所述液晶分子配向在預 定的方向上。所述液晶配向膜是使用所述本發明的液晶配 向膜。 所述基板可以使用上文中針對本發明的液晶配向膜 ® 所描述的玻璃制基板,所述電極可以使用上文中針對本發 明的液晶配向膜所描述的形成在玻璃制基板上的ιτο電 〇 所述液晶層由被密封在相對向的一對基板間的間隙 中的液晶組成物形成,該相對向的一對基板是以使所述一 對基板中的一方的基板的形成有液晶配向膜的面朝向另一 方的基板的方式而對向的。 所述液晶組成物並無特別限制,可以使用介電常數各 鬱 肖異性為正或者負的各觀晶組祕。介電常數各向異性 為正的優選的液晶組成物可以列舉在以下專利中所揭示的 液晶組成物:日本專利第3嶋228號公報、日本專利第 263M35號公報、日本專利特表平5_5〇1735號公報、日本 f =開平8_157826號公報、日本專利_平M3· =報、日本專利特開平9_241644號公報(觸%說 明L、利特開平9-302346號公報(ΕΡ806466Α1說 曰 利特開平8]"168號公報(ΕΡ722998Α1說 129 doc 201030060 (EP885271A1 t), g ^ ^ ^ (EP844229A1說明蚩、α ^特開千10-204016號公報 報、日本專利特^ ω2= 利特開平1〇·_6號公 2000-087040公報、日太 號公報、曰本專利特開 介電常數各向異玆==〇〇1養2公報等。 舉在以下專利中所揭:日優、的液晶組成物可以列 57-114532號公報、日太之曰曰組成物.日本專利特開昭 專利特開平專Γ開平2-4725號公報 '曰本 公報、日太直制Γ 公報、日本專利特開平侧3號 10-168076號公報開平8哀_9號公報、日本專利特開平 ^^^^23tr^t,〇-168453 a^- 〇 10-236990號公報 士 ,A報、日本專利特開平 本專利㈣平1G 23=1開平1G·236"2號公報、日 10-236994號公報、日本專利、日本專利特開平 本專利特開平1〇_237〇缺幵10-237000號公報、曰 10-237024號公報太 〜公報、日本專利特開平 本專利㈣平1(>m卩號公報、日 10-237076號公報 ;、日本專利特開平 (Em7261A1 本ϋ特開平ίο-⑽桃號公報 報、日太直曰日本專利特開平10-287874號八 職二1Γ日=875物、日糊特= 本專利特料u__ 丨1·581號公報、曰 就A報、特開2000-256307公報、 130 201030060 ,In the range in which the effects of the present invention can be obtained, the liquid crystal alignment film can be carried out as long as it is sufficiently delayed. Especially excellent U mm ~ (U mm' platform moving speed is 5GGrPm~2, 〇G〇rpm. 'In addition to the rubbing method, it is usually 201030060, the other wonderful plant (four) method. Zen, other steps r two =:== : holding == the step of drying the coating film, or == rubbing treatment reading (10) the step of cleaning, etc. burning step smoke 'the drying step is usually 〇 ==: the method of heat treatment, Adding on the hot plate: a method of treatment, etc. These methods are also applicable to the money step. The drying step is preferably carried out at a temperature within a range in which the dissolved ship is sufficiently evaporated, preferably with the crucible. The burning step _ temperature phase _ is applied to the lower temperature h. As a cleaning method for cleaning the liquid crystal alignment film before and after the treatment using the cleaning (4) g&, _: ^(bmshing), jet atomization (10) ❹ = ray), Steam cleaning or ultrasonic cleaning. These methods can be used individually or in combination. As the cleaning liquid, pure water, various alcohols such as mehtyl alcohol, ethanol, and isopropanol, aromatic hydrocarbons such as benzene, toluene, and xylene, and dichlorobenzene can be used. A ketone such as a halogen solvent such as methylene chloride, such as acetoxime or methyl ethyl ketone, is not limited to these. Of course, these cleaning solutions can use a sufficiently cleaned impurity with less impurities. This cleaning method can also be applied to the cleaning step of forming the liquid crystal alignment film of the present invention. The film thickness of the liquid crystal alignment film of the present invention is not particularly limited, but is preferably from 1 nm to 300 nm, and more preferably from 30 nm to 150 nm. The liquid crystal distribution of the present invention can be measured by using a well-known film thickness measuring device such as a surface turret or an ellipsometer. The liquid crystal display device of the present invention has: a pair of substrates; a liquid crystal layer containing liquid crystal molecules and formed between the pair of substrates; an electrode applying a voltage to the liquid crystal layer; and a liquid crystal alignment film 'aligning the liquid crystal molecules In the intended direction. The liquid crystal alignment film is a liquid crystal alignment film of the present invention. The substrate may use the glass substrate described above for the liquid crystal alignment film of the present invention, and the electrode may be formed on the glass substrate as described above for the liquid crystal alignment film of the present invention. The liquid crystal layer is formed of a liquid crystal composition sealed in a gap between a pair of opposing substrates, wherein the pair of opposing substrates is formed by forming a liquid crystal alignment film on one of the pair of substrates. The faces are facing toward the other substrate. The liquid crystal composition is not particularly limited, and each crystal group having a positive dielectric constant of positive or negative dielectric constant can be used. Preferred liquid crystal compositions having a positive dielectric anisotropy are exemplified by liquid crystal compositions disclosed in Japanese Patent No. 3,228, Japanese Patent No. 263 M35, and Japanese Patent Laid-Open No. 5-5 Japanese Patent Publication No. 1735, Japanese Patent Publication No. 8-157826, Japanese Patent Laid-Open No. Hei 9-241644, Japanese Patent Laid-Open No. Hei 9-241644 (Japanese Patent Publication No. L, Lit Kaiping No. 9-302346 (ΕΡ806466Α1 says 曰利特开平8) ]"168 bulletin (ΕΡ722998Α1 says 129 doc 201030060 (EP885271A1 t), g ^ ^ ^ (EP844229A1 蚩, α ^ 特千千-10-20416, Japanese patent special ω2= Li Tekaiping 1〇· _6 No. 2000-087040, Japanese-Japanese Gazette, 曰本专利Special Dielectric Constants are different from each other. = 〇〇1养2, etc. As disclosed in the following patents: Nissei, liquid crystal composition Japanese Laid-Open Patent Publication No. 57-114532, Japanese Patent Unexamined Patent Publication No. 2-4725, 'Sakamoto Gazette, Japanese Taichi Co., Ltd., Japanese Patent Special Open Side 3 No. 10-168076, Kaiping 8 _ _9 bulletin, This patent is open to the public. ^^^^23tr^t, 〇-168453 a^- 〇10-236990, the A newspaper, the Japanese patent special patent (4) Ping 1G 23=1 Kaiping 1G·236" Japanese Patent No. 10-236994, Japanese Patent, Japanese Patent Laid-Open Patent No. Hei-Ping No. 1-23, No. 10-237000, No. 10-237024, too ~ Bulletin, Japanese Patent Unexamined Patent (four) Ping 1 (>m卩号公告, Japanese No. 10-237076; Japanese Patent Special Kaiping (Em7261A1) ϋ ϋ ί ίο-(10) Peach Bulletin, Japanese Taichi, Japanese Patent Special Open No. 10-287874, Eighth 2nd Japanese = 875, Japanese paste special = Patent No. u__ 丨1. 581, 曰 on A, Special Open 2000-256307, 130 201030060,
-riI.d〇C 特開2001-019965公報、特開2〇〇1_〇72626公報、特開 2001-192657 公報等。 即使向所述介電常數各向異性為正或負的液晶組成 物中添加一種或一種以上的光學活性化合物來使用也沒有 絲毫影響。 本發明的液晶顯示元件是通過下述方式而獲得的:在 一對基板中的至少一方上形成本發明的液晶配向膜,使液 晶配向膜朝内而使所獲得的一對基板經由間隔物(spacer) ® 相對向,在形成於基板間的間隙中封入液晶組成物而形成 液晶層。于本發明的液晶顯示元件的製造中,可以視需要 進一步包含對基板貼附偏光膜等的步驟。 本發明的液晶顯示元件可以形成各種電場方式用液 晶顯示元件。此種電場方式用液晶顯示元件可以列舉:所 述電極在相對於所述基板的表面為水準的方向上對所述液 晶層施加電壓的橫向電場方式用液晶顯示元件、或者所述 電極在相對於所述基板的表面為垂直的方向上對所述液晶 φ 層施加電麼的縱向電場方式用液晶顯示元件。 橫向電場方式用液晶顯示元件即使不顯現較大的預 傾角也無妨,因此,由本發明的液晶配向劑所形成的液晶 配向膜適用於橫向電場方式用液晶顯不元件,其中本發明 的液晶配向劑含有如由不含具有侧鏈結構的二胺之二胺所 得的聚醯胺酸或其衍生物之類的不具有侧鏈結構的聚酿胺 酸或其衍生物。 縱向電場方式用液晶顯示元件需要顯現較大的預傾 131 ...doc 201030060 :於=電ίit明的液晶配向劑所形成的液晶配向膜適 而制相液晶顯示元件,其中本發明的液晶配 =:如由包含具有側鏈結構的二胺之二胺所得的聚醯 2或其射物的之類的具有侧鏈結構的㈣賴 生物。 … 如上所述’將本發明的液晶配向劑作為原料而製作的 液曰曰配向膜了以通過對其原料即聚合物進行適宜選擇,而 應用於各種顯示驅動方式的液晶顯示元件中。 、本發明的液晶顯示元件可轉—步具有所述構成要 素以外的要素。作為此種其他構成要素在本發明的液晶 顯示元件中可以安裝偏光板(偏光膜)、波長板、光散射膜、 驅動電路等液晶顯示元件中通常使用的構成要素。 [實施例]Japanese Laid-Open Patent Publication No. 2001-019965, Japanese Laid-Open Patent Publication No. Hei. No. Hei. Even if one or more optically active compounds are added to the liquid crystal composition having positive or negative dielectric anisotropy for use, there is no influence at all. The liquid crystal display device of the present invention is obtained by forming a liquid crystal alignment film of the present invention on at least one of a pair of substrates, and bringing the liquid crystal alignment film inward so that the obtained pair of substrates pass through the spacer ( Spacer) ® is a liquid crystal layer formed by sealing a liquid crystal composition in a gap formed between the substrates. In the production of the liquid crystal display device of the present invention, a step of attaching a polarizing film or the like to the substrate may be further included as needed. The liquid crystal display element of the present invention can form various liquid crystal display elements for electric field mode. The liquid crystal display element for the electric field method includes a liquid crystal display element for applying a voltage to the liquid crystal layer in a direction in which the electrode is in a level with respect to a surface of the substrate, or the electrode is opposite to The surface of the substrate is a vertical electric field type liquid crystal display element that applies electricity to the liquid crystal φ layer in a vertical direction. The liquid crystal display element for a lateral electric field method does not have a large pretilt angle. Therefore, the liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention is suitable for a liquid crystal display element for a transverse electric field method, wherein the liquid crystal alignment agent of the present invention Polylactoic acid or a derivative thereof having no side chain structure, such as polylysine or a derivative thereof obtained from a diamine having no diamine having a side chain structure. The vertical electric field mode liquid crystal display element needs to exhibit a large pretilt 131 ... doc 201030060: a liquid crystal alignment film formed by a liquid crystal alignment agent formed by a liquid crystal alignment agent, wherein the liquid crystal display element of the present invention =: (4) a bacterium having a side chain structure such as polyfluorene 2 or its emitter obtained from a diamine having a diamine having a side chain structure. As described above, the liquid helium alignment film produced by using the liquid crystal alignment agent of the present invention as a raw material is suitably used in a liquid crystal display device of various display driving methods by appropriately selecting a polymer which is a raw material. The liquid crystal display element of the present invention can be rotated to have elements other than the constituent elements. In the liquid crystal display device of the present invention, a constituent element which is generally used for a liquid crystal display element such as a polarizing plate (polarizing film), a wavelength plate, a light-scattering film, and a driving circuit can be mounted. [Examples]
以下,利用實施例來說明本發明,但本發明並不限定 於這些實施例。實施例中所使用的化合物如下所述。 <四羧酸二酐>Hereinafter, the present invention will be described by way of examples, but the invention is not limited to the examples. The compounds used in the examples are as follows. <tetracarboxylic dianhydride>
化合物:乙二胺四醋酸二酐:EDDA 化合物:1,4-苯二胺四醋酸二酐:PhDDACompound: Ethylenediaminetetraacetic acid dianhydride: EDDA Compound: 1,4-phenylenediamine tetraacetic acid dianhydride: PhDDA
化合物.乙二醇-雙-(2-氨基乙基峻)四醋酸二酐: EGDACompound. Glycol-bis-(2-aminoethyljun)tetraacetic acid dianhydride: EGDA
化合物:1,2-雙-(氨基曱基)-環己烧四醋酸二酐:CDA 化合物:均苯四曱酸二酐:PMDA 化合物:環丁烷四曱酸二酐:CBDA 化合物:丁烷四曱酸二酐:BUTDA 132 ii.doc 201030060 化合物:3,3’-4,4’-二苯甲酮四曱酸二酐:311)八 化合物.3,3’-4,4’-二苯基四曱酸二酐:册〇八 化合物·秦-2,3,6,7-四甲酸二酐:NTCA 化合物:萘-1,4,5,8-四曱酸二針:灿〇入 <二胺>Compound: 1,2-bis-(aminoindenyl)-cyclohexene tetraacetic acid dianhydride: CDA compound: pyromellitic acid dianhydride: PMDA compound: cyclobutane tetraphthalic acid dianhydride: CBDA compound: butane Tetraphthalic acid dianhydride: BUTDA 132 ii.doc 201030060 Compound: 3,3'-4,4'-benzophenone tetradecanoic acid dianhydride: 311) Eight compounds. 3,3'-4,4'- Phenyltetradecanoic acid dianhydride: 〇8 compound·Qin-2,3,6,7-tetracarboxylic dianhydride: NTCA compound: naphthalene-1,4,5,8-tetradecanoic acid two needles: <Diamine>
化合物:4,4'-二氨基二苯基甲烷:DDMCompound: 4,4'-diaminodiphenylmethane: DDM
化合物:4,4’-二氨基二笨基乙烷:DDETCompound: 4,4'-diaminodiphenylethane: DDET
化合物:4,4’-二氨基二苯基_ : DDECompound: 4,4'-diaminodiphenyl_ : DDE
化合物:2,2-雙{4-[4-氨基苯氧基]苯基}丙烷:baPP 化合物:4-雙(4-氨基苯基二氮環己烷:dAcCompound: 2,2-bis{4-[4-aminophenoxy]phenyl}propane: baPP Compound: 4-bis(4-aminophenyldiazolidine:dAc
化合物:N,N’-雙(4-氨基苯基⑼界二曱基乙二胺: DMEDACompound: N,N'-bis(4-aminophenyl(9)-di-didecylethylenediamine: DMEDA
化合物:1,3,5-二氨基七,‘三唑:DATACompound: 1,3,5-diamino-7, ‘triazole: DATA
化合物:1,1-雙((氨基苯氧基)苯基)_4_(戊基環己基)環 己烷:5HHBACompound: 1,1-bis((aminophenoxy)phenyl)_4_(pentylcyclohexyl)cyclohexane: 5HHBA
化合物:U-雙{4-[(4-教基苯基)曱基]苯基}_4-正庚基 環己烷:7HBZCompound: U-bis{4-[(4-cylylphenyl)indenyl]phenyl}_4-n-heptylcyclohexane: 7HBZ
化合物:1,1-雙(4-(4_氨基苯氧基)苯基)_4_正庚基環己 烷:7HBACompound: 1,1-bis(4-(4-aminophenoxy)phenyl)_4_n-heptylcyclohexane: 7HBA
化合物:1,1-雙((氨基苯氧基)苯基)_4_(庚基環己基)乙 基)環己烷:7H2HBA <溶劑> NMP · N-甲基-2-*»比嘻燒酮 BC . 丁基溶纖劑(乙二醇單丁謎) 133 201030060,Compound: 1,1-bis((aminophenoxy)phenyl)_4-(heptylcyclohexyl)ethyl)cyclohexane: 7H2HBA <solvent> NMP · N-methyl-2-*» Ketone BC. Butyl cellosolve (ethylene glycol monobutyl) 133 201030060,
-----j-I.QOC <1.聚醯胺酸的合成> [合成例1] 在具備溫度計、攪拌機、原料投入添加口和氮氣導入 口的100 mL的四口燒瓶中加入2.7320 g的DDM以及75.0 g的脫水NMP,在乾燥氮氣流下進行攪拌溶解。接著,添 加 1.7652 g 的 EDDA 與 1.5028 g 的 PMDA,反應 30 小時 後’加入19.0 g的BC而合成濃度為6 wt%的聚醯胺酸溶 液(以下也稱為清漆(Varnish))(Al)。當於原料的反應中因反 應溫度而導致溫度上升時,將反應溫度抑制在約70。(:或70 ® °(:以下而進行反應。此外,所獲得的A1中的聚醯胺酸的 重量平均分子量為70,700。 聚醯胺酸的重量平均分子量是以如下方式求出的:利 用磷酸-DMF混合溶液(磷酸/DMF = 〇.6/l〇〇:重量比)來稀 釋所獲得的聚醯胺酸以使聚醯胺酸濃度約為1 wt%,然後 使用2695分離模組(separati〇n module)、2414差示折射計 (Waters製造),將所述混合溶液作為展開劑並使用Gpc法 進行測定,再進行聚苯乙烯換算。此外,管柱使用HSPgel ❹ RTMB-M(Waters製造)’並在管柱溫度為4〇〇c、流速為〇 35 mL/min的條件下進行測定。 [合成例2〜合成例47] 除如表1〜4所示那樣變更四羧酸二酐和二胺以外, 依據合成例1來製備聚酿胺酸溶液(A2)〜聚醯胺酸溶液 (A44)及聚醯胺酸溶液(B1)〜聚酿胺酸溶液(B3)。包括合成 例1 ’將結果匯總於表1〜表4。 134 s 1X20 e —die 【Ϊ】 H < i Ί Γ Γ »t Η 70700 66100 46200 108000 74700 191200 99400 130100 154400 I 69100 91000 83600 79100 116100 ! 58300 68200 98700 , 73200 65000 80500 59100 二胺(mol%) I DATA I DMEDA ο ο ο ο ο ο ο BAMPP 〇 〇 〇 〇 g § 冢 I BAPPj 〇 DDE 〇 DDET 〇 〇 〇 DDM 〇 o ο 四叛酸二酐(mol%) NPDA (N NTCA *Ti BPDA ν-> cn BTDA ! m BUTDA »Λ> <Ν CBDA : ο (S ο ο ο Ο PMDA 沄 o Ο EDDA 〇 〇 〇 〇 〇 〇 (N m CO *Ti <Ν CN V% m 配向劑 < 寸 < < \〇 < 00 < A10 1 All I |Α12 I 1 Α13 I La14…I 1 A15 I A16 I Α17 1 Α18 Α19 1 1 A20 | A21 合成例l 合成例2 合灰例3 合成例4 | 1合成例5 1 合展例6 | 合成例7 |合成例8 |合成例9 1 I合成例ίο | 1合成例11 | 1合成例12 1 1合成例13 1 |合成例14 1 I合成例15 | |合成例16 1 1合成例17^ 1合成例18 1 1合成例19 1 合成例20 1合成例21 1 ο s 1Χ20 oOP.J-a—ε 【<Nd υ bml *«pi … φ ίΓ »w •JauI 77600 94900 86400 78200 102100 91000 72500 42800 81900 側鏈型二胺(mol%) | 7H2HBA | 〇 | 7HBA | 〇 | 7HBZ | 〇 | 5HHBA | 〇 T—< 〇 〇 〇 〇 〇 二胺(mol%) | DMEDA | | DAC | 〇 BAMPP § | DDET | § | DDM | § 四叛酸二針(mol%) | CBDA | 〇 | PMDA | 〇 | EDDA | 〇 4 K , I A22 I A23 I LA24 J I A25 I I A26 I I A27 I | A28 I A29 I A30 合成例22 合成例23 合成例24 合成例25 |合成例26 I |合成例27 I 合成例28 |合成例29 I 合成例30 201030060 o gFJ-az,寸 6<Νε 【s 00-ε 00卜6寸 000¾ 00卜s 00寸S卜 00¾卜 ΟΟΖΌΟΙ 009- 0S- 00寸S寸 00638 00A66 0096寸 oos^ οι ΟΙ °l-----jI.QOC <1. Synthesis of Polyproline> [Synthesis Example 1] 2.7320 g was placed in a 100 mL four-necked flask equipped with a thermometer, a stirrer, a raw material input port, and a nitrogen inlet. DDM and 75.0 g of dehydrated NMP were stirred and dissolved under a stream of dry nitrogen. Next, 1.7652 g of EDDA and 1.5028 g of PMDA were added, and after reacting for 30 hours, 19.0 g of BC was added to synthesize a 6 wt% polylysine solution (hereinafter also referred to as Varnish) (Al). When the temperature rises due to the reaction temperature in the reaction of the raw material, the reaction temperature is suppressed to about 70. (: or 70 ® ° (: The reaction is carried out below. Further, the weight average molecular weight of the polylysine obtained in A1 is 70,700. The weight average molecular weight of polyglycine is determined as follows: using phosphoric acid - DMF mixed solution (phosphoric acid / DMF = 〇.6 / l 〇〇: weight ratio) to dilute the obtained poly-proline to make the polyglycine concentration about 1 wt%, and then use the 2695 separation module (separati 〇n module), 2414 differential refractometer (manufactured by Waters), and the mixed solution was used as a developing solvent and measured by the Gpc method, and then converted into polystyrene. In addition, the column was made of HSPgel ❹ RTMB-M (manufactured by Waters). The measurement was carried out under the conditions of a column temperature of 4 〇〇c and a flow rate of mL35 mL/min. [Synthesis Example 2 to Synthesis Example 47] The tetracarboxylic dianhydride was changed as shown in Tables 1 to 4. In addition to the diamine, a poly-bristamine solution (A2) to a poly-proline solution (A44) and a poly-proline solution (B1) to a poly-branched acid solution (B3) were prepared according to Synthesis Example 1. 1 'The results are summarized in Table 1 to Table 4. 134 s 1X20 e — die [Ϊ] H < i Ί Γ Γ »t Η 70700 66100 46200 1 08000 74700 191200 99400 130100 154400 I 69100 91000 83600 79100 116100 ! 58300 68200 98700 , 73200 65000 80500 59100 Diamine (mol%) I DATA I DMEDA ο ο ο ο ο ο ο BAMPP 〇〇〇〇g § 冢I BAPPj 〇DDE 〇DDET 〇〇〇DDM 〇o ο Four oxo-dianhydrides (mol%) NPDA (N NTCA *Ti BPDA ν-> cn BTDA ! m BUTDA »Λ><Ν CBDA : ο (S ο ο ο Ο PMDA沄o Ο EDDA 〇〇〇〇〇〇(N m CO *Ti <Ν CN V% m aligning agent <inch<<\〇< 00 < A10 1 All I |Α12 I 1 Α13 I La14 ...I 1 A15 I A16 I Α17 1 Α18 Α19 1 1 A20 | A21 Synthesis Example 1 Synthesis Example 2 Ashing Example 3 Synthesis Example 4 | 1 Synthesis Example 5 1 Synthesis Example 6 Synthesis Example 7 Synthesis Example 8 Synthesis Example 9 1 I synthesis example ίο | 1 synthesis example 11 | 1 combination Example 12 1 1 Synthesis Example 13 1 Synthesis Example 14 1 I Synthesis Example 15 | | Synthesis Example 16 1 1 Synthesis Example 17 1 Synthesis Example 18 1 1 Synthesis Example 19 1 Synthesis Example 20 1 Synthesis Example 21 1 ο s 1Χ20 oOP .Ja—ε [<Nd υ bml *«pi ... φ ίΓ »w •JauI 77600 94900 86400 78200 102100 91000 72500 42800 81900 Side chain diamine (mol%) | 7H2HBA | 〇| 7HBA | 〇 | 7HBZ | 5HHBA | 〇T—< 〇〇〇〇〇 diamine (mol%) | DMEDA | | DAC | 〇BAMPP § | DDET | § | DDM | § Four rebel two needles (mol%) | CBDA | PMDA | ED | EDDA | 〇4 K , I A22 I A23 I LA24 JI A25 II A26 II A27 I | A28 I A29 I A30 Synthesis Example 22 Synthesis Example 23 Synthesis Example 24 Synthesis Example 25 | Synthesis Example 26 I | Synthesis Example 27 I Synthesis Example 28 | Synthesis Example 29 I Synthesis Example 30 201030060 o gFJ-az, inch 6<Νε [s 00-ε 00 b 6 inch 0003⁄4 00 s 00 inch S 242 003 4 009 009- 0S- 00 inch S inch 00638 00A66 0096 inch oos^ οι ΟΙ °l
(0/οϊ 鍩 M (o/olouofed 镏赛 0 ddwvffl 1ωαα 001 001 001 0°l 06 ΟΟΪ 001 06 00- 06 2αα 02 001 001 001 vas να20· V8 va〇3 vai νααω os Ο寸 0*° 0寸 °寸 Ο寸 ο寸 0寸 0寸 0寸 Ο寸 ο寸 0寸 0寸 Ο寸 Ο寸 οε οε οε οε 02 οε °e οε οε 02 οε ιεν β § οι εεν 03 寸εν 寸 £5^φ οι 03 οι 00- οι 9εν L2 8εν 6εν ο对ν(0/οϊ 鍩M (o/olouofed 镏赛0 ddwvffl 1ωαα 001 001 001 0°l 06 ΟΟΪ 001 06 00- 06 2αα 02 001 001 001 vas να20· V8 va〇3 vai νααω os Ο inch 0*° 0 inch ° inch inch ο inch 0 inch 0 inch 0 inch inch inch ο inch 0 inch 0 inch inch inch inch inch οε οε οε οε 02 οε °e οε οε 02 οε ιεν β § οι εεν 03 inch εν inch £5^φ οι 03 οι 00- οι 9εν L2 8εν 6εν ο vs ν
-V-V
寸寸ν ε寸ν 9V 6£ 5噠<0 一对 5^φ 201030060, [表4] 配向劑 四幾酸二肝(m〇i%) 二胺(mol%) 重量平均分子量 PMDA CBDA DDM DDET 合成例45 B1 50 50 100 51500 合成例46 B2 50 50 100 48000 合成例47 B3 65 > 35 100 62600 將合成例23、合成例36以及合成例30中所合成的濃 度為6wt%的聚醯胺酸溶液(A23、A36以及A30)與合成例 45〜合成例47中所合成的濃度為6 wt°/〇的聚醯胺酸溶液 (B1〜B3)以重量比為20/80(前者/後者)進行混合,從而製 Θ 成液晶配向劑(A45〜A51)。將A45〜A51的組成匯總於表 5 ° [表5]Inch ν ε inch ν 9V 6£ 5哒<0 A pair of 5^φ 201030060, [Table 4] Alignment agent tetradecanoic acid (m〇i%) diamine (mol%) Weight average molecular weight PMDA CBDA DDM DDET Synthesis Example 45 B1 50 50 100 51500 Synthesis Example 46 B2 50 50 100 48000 Synthesis Example 47 B3 65 > 35 100 62600 Polyamine prepared at a concentration of 6 wt% synthesized in Synthesis Example 23, Synthesis Example 36, and Synthesis Example 30 The acid solutions (A23, A36, and A30) and the polyglycine solution (B1 to B3) having a concentration of 6 wt/min synthesized in Synthesis Examples 45 to Synthesis 47 were 20/80 by weight (the former/the latter). The mixture was mixed to form a liquid crystal alignment agent (A45 to A51). The composition of A45~A51 is summarized in Table 5 ° [Table 5]
配向劑 清漆 清漆重量比 A45 A23 B1 A23/B 1=2/8 — A46 A23 B2 A23/B2^2/8 A47 A23 B3 Α23/Β3^2?8~~~ A48 A36 B1 Α36/Β1=2/8 A49 A36 B2 Α36/Β2=2^ A50 A36 B3 Α36/Β3=2/8 A51 A30 B1 Α30/Β 1=2/8 向合成例4、合成例14以及合成例32中所合成的濃 度為6 wt%的聚醯胺酸溶液(A4、A14以及A32)中分別添 加平均聚合物重量為10 wt°/〇的雙{4-(烯丙基雙環[2,2,1:|庚 缔_2,3_二羧基醯亞胺)苯基}甲烷、N’N-(1,2-二經基次乙 基)雙丙烯醯胺、2-(3,4-環氧環己基)乙基三甲氧基矽烷、氨 138 201030060^ 基丙基三乙氧基矽烷、4,4’-亞曱基雙(N,N-二縮水甘油基笨 胺)以及1,3-雙(4,5-二氫-2-惡唑基)苯,從而製成液晶配向 劑(A52〜A60)。將A52〜A60的組成匯總於表6。Additive varnish varnish weight ratio A45 A23 B1 A23/B 1=2/8 — A46 A23 B2 A23/B2^2/8 A47 A23 B3 Α23/Β3^2?8~~~ A48 A36 B1 Α36/Β1=2/ 8 A49 A36 B2 Α36/Β2=2^ A50 A36 B3 Α36/Β3=2/8 A51 A30 B1 Α30/Β 1=2/8 The concentration synthesized in Synthesis Example 4, Synthesis Example 14 and Synthesis Example 32 is 6 A double {4-(allylbicyclo[2,2,1:|heptane-2) with an average polymer weight of 10 wt°/〇 was added to the wt% polyaminic acid solution (A4, A14, and A32). , 3_dicarboxy quinoid imine) phenyl}methane, N'N-(1,2-di-ethylidene) bis acrylamide, 2-(3,4-epoxycyclohexyl)ethyltrimethyl Oxydecane, ammonia 138 201030060^ propyl triethoxy decane, 4,4'-fluorenylene bis (N,N-diglycidyl amide) and 1,3-double (4,5-di Hydrogen-2-oxazolyl)benzene to form a liquid crystal alignment agent (A52 to A60). The composition of A52 to A60 is summarized in Table 6.
❹ 139 .doc 201030060 [表6] 配向劑 清漆 添加劑 添加畢(wt%、 Α52 Α4 雙{4-(烯丙基雙環丨2,2,11廣_5-婦·2,3_二羧基醢亞胺)苯基丨甲烷 10 Α53 Α4 ...... ... 二羥基次乙基)雙丙烯醯胺 10 Α54 Α14 雙{4·(稀丙基雙環[2,2,11庚-5-烯-2,3-二羧基酿_亞胺)笨基}甲烷 10 — 10 Α55 Α14 2:(3,4-環氣環己基)乙基=甲氧基梦烷 Α56 Α14 氛基丙基=广氧」暮·炫1 10 1〇 Α57 Α14 4,4-亞甲基替w N--縮水甘油基苯胺) Α58 Α32 雙{4-(缔内基雙環[2,2,η庚-5-稀-2,3--羧基醢亞胺)笨基丨甲烷 1〇 Α59 Α32 彡-(3,4-環氧環己基)乙基=甲氧基梦烷 10 Α60 Α14 1,3-雙(4,5--氫-2-惡唑基)苯 10 (2.液晶顯示元件的製作) [實施例1] 向合成例1中所合成的濃度為6加%的聚醯胺酸溶液 (A1)中添加NMP/BC=l/l(;t量比)的混合溶媒並將整體稀 釋成4 wt% ’從而製成液晶配向劑。使用所獲得的液晶配 向劑,以如下方式製作液晶顯示元件。 (液晶顯示元件的製作方法) 利用旋轉器將液晶配向劑塗布在二片附有IT〇電極的 玻璃$板上’形成媒厚為7〇nm的膜。塗膜後在赃下加 ,乾燥約5分鐘’然後在21()t下進行2()分鐘加熱處理, ί = 晶配向膜。接著’用摩擦裝置對形成了液晶配 二相❹*的表面進彳Τ摩擦處理而實行配向處理。然後, f中於120。,液ί配向膜進行5分鐘超聲波清洗後,在供 箱中於120 C下乾燥30分鐘。 在方的玻璃基板上散佈7叫 她_,以使形成了液晶配向_面為_且摩擦方向Ρ 140 20103006(^ —..^n.doc 平行的方式進行對向配置,然後用環氧硬化劑進行密 向從而製成間隙為7 μιη的反平行單元(antiparallel cell)。 二鸪單元中注入如下所示的液晶組成物,並使用光固化劑 來密封注入口。❹ 139 .doc 201030060 [Table 6] Additives for varnish additives (wt%, Α52 Α4 double {4-(allylbicycloindole 2,2,11 broad _5-female 2,3_dicarboxy fluorene) Amine) phenyl hydrazine methane 10 Α 53 Α 4 ...... dihydroxyethylidene bis acrylamide 10 Α 54 Α 14 double {4 · (dilyl propyl bicyclo [2, 2, 11 g-5- Alkene-2,3-dicarboxy styrene]imine}methane 10-10 Α55 Α14 2:(3,4-cyclohexylcyclohexyl)ethyl=methoxyoxane Α56 Α14 arylpropyl=wide Oxygen 暮· Hyun 1 10 1〇Α57 Α14 4,4-methylene-substituted w N--glycidyl aniline) Α58 Α32 double {4-(Anobinylbicyclo[2,2,ηhept-5-lean -2,3-carboxy quinone imine) 笨 丨 丨 methane 1 〇Α 59 Α 32 彡-(3,4-epoxycyclohexyl)ethyl = methoxy montane 10 Α 60 Α 14 1,3- double (4, 5-Hydroxy-2-oxazolyl)benzene 10 (Production of Liquid Crystal Display Element) [Example 1] To a polyglycine solution (A1) having a concentration of 6% by mass synthesized in Synthesis Example 1 A mixed solvent of NMP/BC=l/l (;t ratio) was added and the whole was diluted to 4 wt%' to prepare a liquid crystal alignment agent. Using the obtained liquid crystal alignment agent, a liquid crystal display element was produced in the following manner. (Manufacturing method of liquid crystal display element) A liquid crystal alignment agent was applied to two glass plates with IT 〇 electrodes attached by a rotator to form a film having a thickness of 7 〇 nm. After the film is applied, it is added under the crucible, dried for about 5 minutes' and then heat treated at 21 () t for 2 () minutes, ί = crystal alignment film. Then, the alignment treatment is performed by rubbing the surface on which the liquid crystal is provided with the two-phase ❹* by a rubbing device. Then, f is at 120. After the solution was ultrasonically cleaned for 5 minutes, it was dried in a container at 120 C for 30 minutes. Spreading 7 on the square glass substrate is called _, so that the liquid crystal alignment _ surface is formed and the rubbing direction Ρ 140 20103006 (^ —..^n.doc is arranged in parallel, and then hardened with epoxy. The agent was subjected to a dense direction to form an antiparallel cell having a gap of 7 μm. The liquid crystal composition shown below was injected into the diterpene unit, and a photocuring agent was used to seal the injection port.
I7wt. %I7wt. %
CaH7 CeHn CzHsCaH7 CeHn CzHs
17WL% iewt.% 10Wt% C3H717WL% iewt.% 10Wt% C3H7
F 5wL% C5H11 C2H5 C3H7 C5H11F 5wL% C5H11 C2H5 C3H7 C5H11
F 10WL % 6wt % 0Mft % 13wt% 141 201030060, [實施例2〜實施例51] 向 A2〜A5、A10〜A29、A31 〜A37、A39、A40、A42、 A43、A45〜A50 及 A52〜A60 中添加 NMP/BC=1/1(重量比) 的混合溶媒並稀釋以使聚醯胺酸的濃度在整體中成為4.0 wt%〜5.0 wt%,從而製成液晶配向劑。使用所獲得的液晶 配向劑,以與實施例1相同的方式製作液晶顯示元件。 [比較例1〜比較例9] 向 A6〜A9、A30、A38、A41、A44 及 A51 中添加 NMP/BOIA(重量比)的混合溶媒並稀釋以使聚醯胺酸的 ⑩ 濃度在整體中成為4.0 wt°/〇〜5.0 wt%,從而製成液晶配向 劑。使用所獲得的液晶配向劑,以與實施例1相同的方式 製作液晶顯示元件。 (流動配向的確認) 將以所述方法製作的液晶顯示元件夾在配置於正交 尼科耳棱鏡(crossnicol)上的偏光板之間,並以目視確認能 否看見流動配向。 (延遲測定用基板的製作) 所述測定用基板的基板使用透明玻璃基板。 ® 利用旋轉器將合成例1中所獲得的清漆A1塗布在所 述的透明玻璃基板上。塗布條件為2,000 、15秒。塗 膜後在80°C下預煆燒約3分鐘,然後在21〇〇c下進行2〇 分鐘加熱處理,形成膜厚大約為7〇nm的液晶配向膜。使 用Iirmma-gauge製作所股份有限公司製作的摩擦處理裝 置’在摩擦布(毛長為L8mm :人造絲㈣⑽))的毛壓入量 142 ii.doc 201030060 為0.40 mm,平軎敕命t、*也从 rpm , fi^^K6〇mm/SQCi^^ ^000 而獲得測定縣板㈣祕亞賴進行雜處理,從 (延遲(R)測定)F 10WL % 6wt % 0Mft % 13wt% 141 201030060, [Example 2 to Example 51] To A2 to A5, A10 to A29, A31 to A37, A39, A40, A42, A43, A45 to A50 and A52 to A60 A mixed solvent of NMP/BC = 1/1 (weight ratio) was added and diluted so that the concentration of polyproline was 4.0 wt% to 5.0 wt% as a whole, thereby preparing a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Comparative Example 1 to Comparative Example 9] A mixed solvent of NMP/BOIA (weight ratio) was added to A6 to A9, A30, A38, A41, A44 and A51, and diluted so that the concentration of polyglycine was 10 as a whole. 4.0 wt ° / 〇 ~ 5.0 wt%, thereby preparing a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. (Confirmation of Flow Orientation) The liquid crystal display element produced by the above method was sandwiched between polarizing plates placed on a crossed Nicoles, and it was visually confirmed whether or not the flow alignment could be seen. (Preparation of Substrate for Delay Measurement) A transparent glass substrate is used as the substrate of the measurement substrate. ® The varnish A1 obtained in Synthesis Example 1 was coated on the transparent glass substrate by a spinner. The coating conditions were 2,000 and 15 seconds. After coating, the film was pre-baked at 80 ° C for about 3 minutes, and then heat-treated at 21 ° C for 2 minutes to form a liquid crystal alignment film having a film thickness of about 7 Å. The friction processing device made by Iirmma-gauge Co., Ltd. 'in the rubbing cloth (hair length L8mm: rayon (4) (10))) has a hair injection amount of 142 ii.doc 201030060 of 0.40 mm, and the flat life is t, * From rpm, fi^^K6〇mm/SQCi^^ ^000 to obtain the measurement of the county plate (four) secret Yalai for miscellaneous treatment, from (delay (R) determination)
使用橢偏光譜儀(spect_〇pic elliPS〇meter)M_2000UaA.woollam c〇Jnc 製造)求出配向 膜的延遲(R)。R的值越大’液晶配向_在摩擦方向上延 伸,從而具有高單轴配向性。結果,可以說黑色顯示良好。 在本發明的實施例的試驗方法中,延遲優選大於等^The retardation (R) of the alignment film was determined using an ellipsometer (spect_〇pic elliPS〇meter) M_2000UaA.woollam c〇Jnc. The larger the value of R, the liquid crystal alignment _ extends in the rubbing direction, thereby having high uniaxial alignment. As a result, it can be said that the black display is good. In the test method of the embodiment of the present invention, the delay is preferably greater than equal ^
143 doc 201030060 [表7] 配向劑 流動配向 延遲(nm) 實施例1 A1 〇 0.399 實施例2 A2 〇 0.301 實施例3 A3 〇 0.337 實施例4 A4 〇 0.655 實施例5 A5 〇 0.516 比較例1 A6 X 0.102 比較例2 A7 X 0.054 比較例3 A8 X 0.081 比較例4 A9 X 0.169 實施例6 A10 〇 0.771 實施例7 All 〇 0.615 實施例8 A12 〇 0.690 實施例9 A13 〇 0.574 實施例10 A14 〇 0.689 實施例11 A15 〇 0.551 實施例12 A16 〇 0.647 實施例13 A17 〇 0.622 實施例14 A18 〇 0.833 實施例15 A19 〇 0.457 實施例16 A20 〇 0.936 實施例17 A21 〇 0.452 實施例18 A22 〇 0.334 實施例19 A23 〇 0.612 實施例20 A24 〇 0.599 實施例21 A25 〇 0.590 實施例22 A26 〇 0.602 實施例23 A27 〇 0.618 實施例24 A28 〇 0.511 實施例25 A29 〇 0.485 〇 :無流動配向,χ:有流動配向 _i.doc 201030060 [表8]143 doc 201030060 [Table 7] Directional agent flow alignment delay (nm) Example 1 A1 〇 0.399 Example 2 A2 〇 0.301 Example 3 A3 〇 0.337 Example 4 A4 〇 0.655 Example 5 A5 〇 0.516 Comparative Example 1 A6 X 0.102 Comparative Example 2 A7 X 0.054 Comparative Example 3 A8 X 0.081 Comparative Example 4 A9 X 0.169 Example 6 A10 〇 0.771 Example 7 All 〇 0.615 Example 8 A12 〇 0.690 Example 9 A13 〇 0.574 Example 10 A14 〇 0.689 Implementation Example 11 A15 〇0.551 Example 12 A16 〇0.647 Example 13 A17 〇0.622 Example 14 A18 〇0.833 Example 15 A19 〇0.457 Example 16 A20 〇0.936 Example 17 A21 〇0.452 Example 18 A22 〇0.334 Example 19 A23 〇 0.612 Example 20 A24 〇 0.599 Example 21 A25 〇 0.590 Example 22 A26 〇 0.602 Example 23 A27 〇 0.618 Example 24 A28 〇 0.511 Example 25 A29 〇 0.485 〇: no flow alignment, χ: flow alignment _i.doc 201030060 [Table 8]
配向劑 流動配向 延遲(nm) 比較例5 A30 X 0.109 實施例26 A31 〇 0.325 實施例27 A32 〇 0.566 實施例28 A33 〇 0.489 實施例29 A34 〇 0.410 實施例30 A35 〇 0.463 實施例31 A36 〇 0.422 實施例32 A37 〇 0.736 比較例6 A3 8 X 0.060 實施例33 A39 〇 0.578 實施例34 A40 〇 0.550 比較例7 A41 X 0.088 實施例35 A42 〇 0.495 實施例36 A43 〇 0.471 比較例8 A44 X 0.069 實施例37 A45 〇 0.349 實施例38 A46 〇 0.496 實施例39 A47 〇 0.376 實施例40 A48 〇 0.322 實施例41 A49 〇 0.349 實施例42 A50 〇 0.331 比較例9 A51 X 0.080 實施例43 A52 〇 0.310 實施例44 A53 〇 0.312 實施例45 A54 〇 0.677 實施例46 A55 〇 0.471 實施例47 A56 〇 0.406 實施例48 A57 〇 0.422 實施例49 A58 〇 0.482 實施例50 A59 〇 0.450 實施例51 A60 〇 0.577 〇 :無流動配向,χ :有流動配向 如表7及表8所示,在使用由如下液晶配向劑所獲得 的液晶配向膜的液晶顯示元件中,取得流動配向被消除, 145 201030060, —…,fi.doc 延遲極其高的效果,所述液晶配向劑是含有單體中包含 EDDA與其他四羧酸二酐的聚醯胺酸的液晶配向劑。 雖然本發明已以實施例揭露如上,然其並非用以限定 本發明’任何所屬技術領域中具有通常知識者,在不脫離 本發明之精神和範圍内,當可作些許之更動與潤舞,故本 發明之保護範圍當視後附之申請專利範圍所界定者為準。 【圖式簡單說明】 無。 【主要元件符號說明】Alignment agent flow alignment retardation (nm) Comparative Example 5 A30 X 0.109 Example 26 A31 〇0.325 Example 27 A32 〇0.566 Example 28 A33 〇0.489 Example 29 A34 〇0.410 Example 30 A35 〇0.463 Example 31 A36 〇0.422 Example 32 A37 〇0.736 Comparative Example 6 A3 8 X 0.060 Example 33 A39 〇0.578 Example 34 A40 〇0.550 Comparative Example 7 A41 X 0.088 Example 35 A42 〇0.495 Example 36 A43 〇0.471 Comparative Example 8 A44 X 0.069 Implementation Example 37 A45 〇0.349 Example 38 A46 〇0.496 Example 39 A47 〇0.376 Example 40 A48 〇0.322 Example 41 A49 〇0.349 Example 42 A50 〇0.331 Comparative Example 9 A51 X 0.080 Example 43 A52 〇0.310 Example 44 A53 〇0.312 Example 45 A54 〇0.677 Example 46 A55 〇0.471 Example 47 A56 〇0.406 Example 48 A57 〇0.422 Example 49 A58 〇0.482 Example 50 A59 〇0.450 Example 51 A60 〇0.577 〇: No flow alignment , χ : Flow alignment shown in Table 7 and Table 8, liquid crystal display using a liquid crystal alignment film obtained by the following liquid crystal alignment agent In the case, the obtained liquid alignment is eliminated, 145 201030060, -..., fi.doc has an extremely high retardation effect, and the liquid crystal alignment agent is a liquid crystal containing a polyamic acid containing EDDA and other tetracarboxylic dianhydride in the monomer. An aligning agent. The present invention has been disclosed in the above embodiments, and it is not intended to limit the invention to those skilled in the art, and may be modified and practiced without departing from the spirit and scope of the invention. Therefore, the scope of the invention is defined by the scope of the appended claims. [Simple description of the diagram] None. [Main component symbol description]
146146
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008306690 | 2008-12-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201030060A true TW201030060A (en) | 2010-08-16 |
| TWI458754B TWI458754B (en) | 2014-11-01 |
Family
ID=42363108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW098140868A TWI458754B (en) | 2008-12-01 | 2009-11-30 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP5434490B2 (en) |
| KR (1) | KR101600910B1 (en) |
| CN (1) | CN101747908B (en) |
| TW (1) | TWI458754B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101878518B1 (en) * | 2010-10-19 | 2018-07-13 | 닛산 가가쿠 고교 가부시키 가이샤 | Liquid crystal aligning agent suitable for photo-alignment process, and liquid crystal alignment film using same |
| JP5655507B2 (en) * | 2010-11-01 | 2015-01-21 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| JP2012155311A (en) * | 2011-01-05 | 2012-08-16 | Jnc Corp | Liquid crystal aligning agent for forming photo-aligning liquid crystal alignment layer, liquid crystal alignment layer and liquid crystal display element using the same |
| JP5929298B2 (en) * | 2011-03-02 | 2016-06-01 | Jnc株式会社 | Diamine, liquid crystal aligning agent, liquid crystal display element using the same, and method for forming liquid crystal alignment film |
| WO2013157463A1 (en) * | 2012-04-16 | 2013-10-24 | Jnc株式会社 | Liquid-crystal alignment material for forming liquid-crystal alignment film for photo-alignment, liquid-crystal alignment film, and liquid-crystal display element including same |
| CN108410476B (en) * | 2012-04-24 | 2021-10-08 | 捷恩智株式会社 | Liquid crystal aligning agent for photo-alignment, liquid crystal alignment film for photo-alignment, and liquid crystal display module |
| JP6057070B2 (en) * | 2012-04-25 | 2017-01-11 | Jnc株式会社 | Liquid crystal aligning agent and liquid crystal display element using the same |
| JP6350795B2 (en) * | 2013-05-29 | 2018-07-04 | Jsr株式会社 | Liquid crystal alignment agent |
| KR20140146522A (en) * | 2013-06-17 | 2014-12-26 | 엘지디스플레이 주식회사 | Liquid crystal display apparatus, and method of manufacturing the same |
| KR102266365B1 (en) * | 2013-10-01 | 2021-06-16 | 닛산 가가쿠 가부시키가이샤 | Liquid crystal aligning agent for in-plate switching, liquid crystal alignment film and liquid crystal display element using same |
| WO2015060357A1 (en) * | 2013-10-23 | 2015-04-30 | 日産化学工業株式会社 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
| JP6701635B2 (en) * | 2014-10-08 | 2020-05-27 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device |
| JPWO2017094786A1 (en) * | 2015-11-30 | 2018-09-27 | 日産化学株式会社 | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element |
| US20180373099A1 (en) | 2016-11-28 | 2018-12-27 | Lg Chem, Ltd. | Liquid crystal alignment film, method for preparing the same and liquid crystal display device using the same |
| KR102065718B1 (en) | 2017-10-17 | 2020-02-11 | 주식회사 엘지화학 | Liquid crystal alignment film and liquid crystal display using the same |
| WO2019078502A1 (en) * | 2017-10-17 | 2019-04-25 | 주식회사 엘지화학 | Liquid crystal alignment film and liquid crystal display device using same |
| KR102391473B1 (en) | 2019-01-17 | 2022-04-26 | 주식회사 엘지화학 | Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display using the same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0471650B1 (en) * | 1990-08-17 | 1995-05-03 | Ciba-Geigy Ag | Copolyimides, process for their preparation and their use |
| WO1997045497A1 (en) * | 1996-05-31 | 1997-12-04 | Amoco Corporation | Photoimageable polyimides coatings based on non-aromatic dianhydrides |
| JP3978754B2 (en) * | 1997-12-29 | 2007-09-19 | チッソ株式会社 | Polyamic acid composition, liquid crystal alignment film, and liquid crystal display element |
| JP4606541B2 (en) * | 2000-03-23 | 2011-01-05 | シャープ株式会社 | Liquid crystal display device |
| JP2003161946A (en) * | 2001-11-27 | 2003-06-06 | Fujitsu Display Technologies Corp | Liquid crystal display device manufacturing method and liquid crystal display device |
| WO2004021076A1 (en) * | 2002-08-29 | 2004-03-11 | Nissan Chemical Industries, Ltd. | Material for liquid crystal alignment and liquid crystal displays made by using the same |
| KR101212135B1 (en) * | 2005-06-14 | 2012-12-14 | 엘지디스플레이 주식회사 | Liquid Crystal Display Device, and method of fabricating the same |
| JP4714522B2 (en) * | 2005-07-25 | 2011-06-29 | 株式会社 日立ディスプレイズ | Liquid crystal display device |
| JP4894237B2 (en) | 2005-11-17 | 2012-03-14 | Jnc株式会社 | Liquid crystal aligning agent and liquid crystal display element |
| JP5116287B2 (en) * | 2005-11-21 | 2013-01-09 | 株式会社ジャパンディスプレイイースト | Liquid crystal display |
| JP4941120B2 (en) * | 2006-09-01 | 2012-05-30 | Jnc株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| JP5245329B2 (en) * | 2006-09-15 | 2013-07-24 | Jnc株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| KR20080025316A (en) * | 2006-09-15 | 2008-03-20 | 칫소가부시키가이샤 | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element |
| JP5321781B2 (en) * | 2007-01-09 | 2013-10-23 | Jsr株式会社 | Liquid crystal aligning agent and liquid crystal display element |
-
2009
- 2009-11-06 JP JP2009254774A patent/JP5434490B2/en active Active
- 2009-11-24 KR KR1020090113859A patent/KR101600910B1/en not_active Expired - Fee Related
- 2009-11-30 CN CN2009102462273A patent/CN101747908B/en active Active
- 2009-11-30 TW TW098140868A patent/TWI458754B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100062923A (en) | 2010-06-10 |
| CN101747908B (en) | 2013-11-13 |
| CN101747908A (en) | 2010-06-23 |
| JP2010156953A (en) | 2010-07-15 |
| TWI458754B (en) | 2014-11-01 |
| KR101600910B1 (en) | 2016-03-08 |
| JP5434490B2 (en) | 2014-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW201030060A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
| TWI492966B (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display | |
| JP5556482B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI596138B (en) | Method to form liquid crystal photo-alignment film, and liquid crystal display | |
| TWI606081B (en) | Method of forming liquid crystal alignment film for photo-alignment, and liquid crystal displays | |
| TWI609853B (en) | Photosensitive diamine, polyamic acid or derivatives thereof, liquid crystal aligning agents, liquid crystal aligning film and liquid crystal display devices | |
| TW200936695A (en) | Composition for forming liquid crystal alignment film and liquid crystal display device | |
| TWI586709B (en) | Polyamic acid and derivatives thereof, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device using the same | |
| TWI421280B (en) | Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display | |
| TWI592437B (en) | Liquid crystal alignment agent for forming liquid crystal alignment film for photoalignment, liquid crystal alignment film and liquid crystal display device using the same | |
| TW200930760A (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display | |
| TW201022331A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
| TW201343790A (en) | Liquid crystal aligning agents for forming photo-aligning liquid crystal alignment layers, liquid crystal alignment layers and liquid crystal display devices using the same | |
| TW201237068A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element, and polyamic acid and polyimide for producing thereof | |
| TW200922973A (en) | Photo-alignment agent of liquid crystal, photo-alignment film of liquid crystal including the agent, and liquid crystal display including the film | |
| TW201016751A (en) | Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device | |
| TW201030095A (en) | Alignment agent and liquid crystalline polyimide used therein | |
| TWI485183B (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display device, polyamic acid and polyimide | |
| TW201132703A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
| TW201005004A (en) | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element | |
| TW201200507A (en) | Liquid-crystal alignment formulation, and liquid-crystal aligning film and liquid-crystal display element prepared by using the same | |
| TW200811553A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TW201219380A (en) | Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element | |
| TW200946563A (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TWI275630B (en) | Composition of containing polyamic acid blends and liquid crystal alignment layer and cell using them |